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Abstract	
Bronchopulmonary	dysplasia	(BPD)	is	a	neonatal	disease	affecting	the	lungs	of	premature	infants.	 Prematurely	 born	 infants	 have	 under-developed	 lungs	 and	 require	 invasive	ventilation	technologies	to	provide	sufficient	oxygen	for	survival.	Artificial	ventilation	is	thought	to	exacerbate	BPD	by	causing	mechanical	and	oxygen	stress	on	the	lung	tissue.	Despite	 improvements	 in	paediatric	respiratory	management,	BPD	care	 is	 limited	by	a	lack	 of	 appropriate	 treatment	 options	 and	 remains	 a	 key	 challenge	 for	 clinicians.	 The	pathogenesis	of	BPD	remains	poorly	understood	and	currently	relies	on	animal	models	for	investigation.	This	study	looks	at	developing	a	hydrogel	to	provide	a	human	relevant	
in	 vitro	 BPD	 model	 to	 investigate	 the	 potential	 regenerative	 capabilities	 of	 placenta	mesenchymal	stem	cells	as	a	cell-based	therapy	for	BPD.			We	successfully	developed	a	collagen-elastin	hydrogel	representative	of	the	human	lung	alveolus.	 This	 allows	 the	 co-culture	 of	 multiple	 lung	 cells	 in	 addition	 to	 an	 air-liquid	interface	 which	 achieves	 hyperoxygen	 exposure	 (equivalent	 to	 clinical	 ventilation	interventions)	and	allows	assessment	of	output	measures	such	as	hydrogel	contraction,	imaging	techniques	and	DNA	quantification.			We	 identified	 a	 protocol	 to	 extract	 and	 expand	 cells	 from	 the	 tracheal	 suctions	 of	ventilated	 infants.	We	 cultured	 these	 cells	within	 the	 previously	 developed	model	 for	assessment	at	hyperoxygen	and	compared	cell	function	with	human	adult	lung	cells.	We	established	that	hyperoxygen	had	a	detrimental	effect	on	adult	lung	cell	proliferation	and	the	ability	of	cells	to	contract	collagen-elastin	hydrogels.	Hyperoxygen	had	no	observed	effect	on	neonatal	lung	cells.				
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Finally,	 placenta	 derived	 MSCs	 (pMSCs)	 were	 isolated	 from	 the	 amnion	 and	 chorion	membrane.	We	found	hyperoxygen	exposure	has	an	adverse	effect	on	the	expression	of	MSC	cell	markers,	 cell	proliferation	and	cell	morphology.	This	 could	have	 implications	when	developing	a	cell	therapy	for	the	treatment	of	BPD.		When	co-cultured	with	adult	lung	 fibroblast,	 pMSCs	 positively	 influenced	 the	 proliferation	 of	 adult	 lung	 fibroblasts	through	a	paracrine	mechanism.	These	results	suggest	that	pMSCs	have	the	potential	to	alleviate	the	oxygen	stress	that	lung	cells	of	BPD	infants	experience.						
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1.1 Prematurity	and	Bronchopulmonary	Dysplasia	
Prematurity	is	defined	by	the	World	Health	Organisation	(WHO)	as	babies	born	before	37	weeks	gestational	age	(GA).	It	is	the	leading	cause	of	death	in	new-borns1	and	is	associated	with	 significant	 long-term	 morbidity	 and	 financial	 expense2.	 Amongst	 other	 health	problems	respiratory	complications	account	 for	a	 large	majority	of	neonatal	 intensive-care	unit deaths3.	Bronchopulmonary	Dysplasia	(BPD)	is	a	chronic	paediatric	lung	disease	affecting	 very	 premature	 babies	 usually	 receiving	 prolonged	 oxygen	 ventilation.	Originally	described	in	1967,	BPD	was	recognised	in	infants	with	lungs	which	failed	to	recover	 after	 being	 given	 mechanical	 ventilation	 to	 alleviate	 respiratory	 distress	syndrome	 (RDS)4.	 The	 high	 oxygen	 content	 and	 excessive	 pressure	 from	 artificial	ventilation	resulted	in	fibrosis	and	inflammation	of	the	lungs5.	This	is	now	referred	to	as	“classic”	BPD.			In	the	 last	30	years	there	have	been	substantial	 improvements	 in	the	care	for	preterm	babies	with	the	introduction	of	incubators,	surfactant	treatment,	steroids	and	the	use	of	less	invasive	respiratory	support6,7.	These	improvements	in	neonatal	care	have	resulted	in	the	high	survival	rate	of	very	low	birth	weight	(VLBW,	<1,500g)	or	extremely	low	birth	weight	(ELBW,	<1,000g)	infants.	Between	1995	and	2006	there	was	a	13%	increase	in	survival	of	babies	born	between	22	weeks	and	25	weeks	GA.	Infants	born	at	25	weeks	GA	now	have	a	75%	chance	of	survival8.	This	increase	in	survival	is	a	trend	seen	at	each	week	of	GA8.	These	vulnerable	babies	are	delivered	several	weeks	premature	when	the	lungs	are	still	under-developed	and	incapable	of	providing	the	respiratory	support	necessary	for	 survival.	 This	 is	 referred	 to	 as	 “new”	 BPD	which	 still	 remains	 one	 of	 the	 leading	morbidities	associated	with	premature	birth	with	around	40%	of	extremely	premature	infants	 (<29	weeks	 GA)	 developing	 BPD8.	 A	 comparison	 of	 “new”	 BPD	 versus	 “classic	“BPD”	is	shown	in	Table	1.1.	The	pathophysiology	of	new	BPD	includes	a	dysmorphic	lung	
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development	and	an	arrest	in	alveolar	formation	due	to	interrupted	secondary	septation	resulting	in	a	reduction	in	surface	area	for	gas	exchange.	The	lungs	are	unable	to	provide	sufficient	oxygen	to	the	body	for	normal	function	and	rely	on	artificial	ventilation	(Table	1.2)9.	The	most	severe	BPD	infants	require	an	endotracheal	tube	which	supplies	oxygen	directly	into	the	lungs	using	pressure.	The	oxygen	percentage	supplied	is	based	on	the	patients	arterial	blood	oxygen	saturation	and	can	vary	from	atmospheric	oxygen	(21%)	to	over	40%	oxygen	in	the	most	severe	cases.				
Table	1.1	Old	BPD	versus	New	BPD	
Old	BPD	 New	BPD	Larger	preterm	infants	(>30	weeks	GA)	 Extremely	premature	infants	(<30	weeks	GA)	Smooth	muscle	hypertrophy	 Abnormal	vascularization	Alveolar	oedema	 Arrested	alveolarisation	Airway	fibrosis	and	inflammation	 Less	inflammation	and	fibrosis										
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Table	1.2	The	common	types	of	ventilation	methods	used	clinically	for	premature	
infants	
Ventilation	type	 Description	
Endotracheal	
tube	
A	 tube	 is	 inserted	 through	 the	 nose/mouth	 and	 oxygen	 is	mechanically	blown	in/out.	
Continuous	
positive	airway	
pressure	(CPAP)	
Prongs/mask	positioned	over	the	nose	and	oxygen	in	at	a	constant	pressure	to	keep	the	alveoli	inflated.		 		 	
Nasal	prong	
oxygen	
Prongs	positioned	over	the	nostrils	to	deliver	higher	oxygen	levels	directly	into	the	respiratory	system		
Incubator	 Oxygen	supplied	into	an	incubator	which	the	baby	can	breathe	by	their	own	means		
1.1.1 Incidence	BPD	is	the	most	common	morbidity	associated	with	premature	infants	10	with	an	inverse	correlation	between	the	risk	of	developing	BPD	and	GA.	There	are	few	reports	providing	accurate	details	of	the	incidence	of	BPD.	The	EPICure	is	a	series	of	studies	examining	the	survival	and	health	of	babies	born	between	22	and	26	weeks	GA.8.	Data	were	collected	from	almost	200	maternity	hospitals	in	England	in	1995	and	then	again	in	2006.	The	2006	study	revealed	39%	and	61%	infants	born	between	22	and	26	weeks	GA	and	still	receiving	oxygen	 at	 36	 postmenstrual	 age	were	 diagnosed	 as	 having	moderate	 and	 severe	 BPD	respectively8.		A	similar	picture	is	seen	in	a	Norwegian	study	which	found	45.1%	of	infants	born	between	22	and	27	weeks	GA	were	diagnosed	with	moderate/severe	BPD	11.	Of	note,	the	proportion	of	premature	 survivors	 suffering	with	BPD	did	not	 change	 in	11	years	(between	1995	and	2006)	8.	It	is	likely	that	this	is	because	the	incidence	of	“classic”	BPD	has	fallen	but	the	incidence	of	“new”	BPD	has	risen.	
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1.1.2 Diagnosis,	causes	and	treatment	In	June	2000	National	Institute	of	Child	Health	and	Human	Development/National	Heart,	Lung,	 and	 Blood	 Institute	Workshop	 proposed	 a	 severity-based	 definition	 of	 BPD	 for	infants	<32	weeks	GA	(Table	1.3)12.	This	has	been	acknowledged	as	an	accurate	definition	for	the	BPD	spectrum13	and	represents	the	current	clinical	diagnosis	for	BPD.			
Table	1.3	Severity	based	definition	of	BPD	
Diagnosis Description at <32 weeks GA 
Mild Supplemental oxygen for over 28 days but not at 36 weeks’ PMA 
Moderate Supplemental oxygen for over 28 days plus treatment with <30% O2 at 36 
weeks’ PMA 
Severe Supplemental oxygen for over 28 days plus >30% oxygen and/or positive 
pressure at 36 weeks’ PMA 		BPD	 aetiology	 is	 thought	 to	 be	 a	 multifactorial	 disease	 with	 genetic14,	 post-natal	infection15,	prenatal	infection16,	intrauterine	epigenetics17,		and	placenta	abnormalities18	all	associated	as	predisposing	factors.	The	most	significant	predisposing	factors	are	low	birth	 weight	 and	 extreme	 immaturity19.	 BPD	 is	 not	 just	 a	 neonatal	 disease	 but	 has	consequences	 long-term.	 Patients	 often	 continue	 to	 suffer	with	 long-term	morbidities	such	as		respiratory	problems20,	reduced	lung	function	into	adulthood21,	and	retinopathy	(Figure	1.1).	There	is	also	an	increased	risk	of	complications	later	in	life	including	early-onset	emphysema	and	COPD	(chronic	obstructive	pulmonary	disease)22.	This	longevity	of	the	BPD	 takes	a	 considerable	hit	on	health	 care	 resources	with	an	estimated	cost	of	 a	premature	baby	with	BPD	being	between	£40,000	and	£100,000	(figures	based	on	data	from	 the	 Spanish	 Ministry	 of	 Health)5,23.	 Currently	 there	 are	 no	 effective	 treatment	
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options	for	BPD,	only	preventative	and	supportive	measures	exist	for	the	management	of	BPD.	Surfactant	treatment	was	introduced	in	20086	and	is	routinely	given	to	premature	babies	at	risk	of	RDS	(respiratory	distress	syndrome)24.	The	surfactant	reduces	the	need	for	prolonged	aggressive	 respiratory	 support	 and	 therefore	prevents	 injury.	Antenatal	corticosteroids	 are	 often	 considered	 for	women	who	 are	 at	 risk	 of	 pre-term	 birth25,26	however	 the	 long-term	effects	have	been	scrutinized	with	emerging	evidence	 they	are	associated	with	 neurological	 developmental	 problems	 and	 reduced	 cognitive	 function	later	in	life27,28.		
		
Figure	1.1	Complications	associated	with	BPD						
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1.1.3 Lung	development	and	BPD	pathogenesis	Comprising	of	over	40	cell	types29,	the	lung	is	a	complex	organ	and	can	be	described	as	two	sections:	the	proximal	airway	which	consists	of	the	trachea	and	the	bronchus	and	the	distal	airway	which	consists	of	the	bronchioles	and	the	gas	exchange	units,	the	alveoli.	Embryonic	 lung	 development	 is	 a	 complex	 and	 rapid	 process	 beginning	 from	embryogenesis.	The	process	is	described	as	having	five	overlapping	stages	(Table	1.4).	The	beginning	phase	of	lung	development	consists	of	the	Embryonic	and	Pseudoglandular	stages,	 which	 form	 the	 conducting	 airways.	 In	 the	 later	 stages	 of	 development	(Canalicular,	Saccular	and	Alveolar	stages),	there	is	a	reduction	in	the	mesenchyme	and	the	functional	respiratory	portions	of	the	lung	form.		
 
Table	1.4	The	development	of	the	lung	consists	of	5	over-lapping	stages	30	
Stage	 Gestational		
age	(weeks)	
Main	events	
Embryonic	 3-7	 The	 primitive	 lung	 bud	 forms	 from	 the	 foregut	endoderm		
Pseudoglandular	 7-16	 Branching	 morphogenesis	 completes.	 Cartilage	and	 smooth	muscles	 forms	 around	 the	 airways.	Columnar	 epithelium,	 and	 some	 ciliated	 and	goblet	cells	line	the	airways.		
Canalicular	 16-24	 Capillarization	 and	 pulmonary	 acinar	 units	develop		
Saccular	 24-36	 Thinning	of	the	epithelium	and	differentiation	of	type	1	 and	2	 alveolar	 epithelial	 cells	 to	 provide	the	air-liquid	interface.	
Alveolar	 36-104	(2	years)	 Alveolar	 expansion	 and	 septation	 continues.	Parenchyma	remodelling		As	described	earlier,	advances	in	perinatal	care	have	improved	the	survival	for	extremely	preterm	babies,	allowing	survival	at	just	22-24	weeks	GA.	At	this	age	the	lungs	have	only	
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reached	the	Canalicular/Saccular	stage	of	development	when	the	functional	respiratory	units	 are	 just	 beginning	 to	 develop	 (Figure	 1.2).	 This	 results	 in	 “new”	 BPD	 which	 is	characterized	by	the	following:	
• Dysmorphic	 lung	 development	 with	 abnormal	 collagen-elastin	deposition/arrangement31	
• Arrest	in	alveolar	formation	due	to	interrupted	secondary	septation	resulting	in	fewer,	simplified	alveoli32.	This	can	be	seen	 in	Figure	1.3	which	shows	a	biopsy	taken	from	a	healthy	infant’s	lung	compared	with	a	BPD	lung.		
• Abnormal	pulmonary	vascular	development33	
• Reduced	inflammation	as	with	“classic”	BPD34			
	
Figure	1.2	The	development	of	the	lung	consists	of	5	main	stages.	Premature	birth	can	 occur	 as	 early	 as	 22	 weeks	 gestational	 age	 (GA).	 As	 GA	 decreases	 the	 risk	 of	bronchopulmonary	dysplasia	(BPD)	increases.	Image	adapted	from	C.	McEvoy	et	al.	35.	
		
	
Figure	1.3	Lungs	of	a	normal	 full-term	infant	and	a	BPD	infant.	Haematoxylin	and	eosin	stained	biopsies	from	the	lung	of	a	normal	healthy	baby	(A)	and	a	BPD	infant	born	at	28	weeks	GA	(B).	The	alveoli	of	BPD	infants	are	more	simplified	in	structure	causing	enlarged	air	spaces	and	a	reduced	surface	area.	Image	taken	from	A.	H.	Jobe36.	
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1.1.3.1 Disruption	to	alveologenesis	In	premature	birth	lung	development	is	interrupted	during	the	final	stages.	In	these	final	stages	of	 development,	 the	distal	 airway	and	 alveoli	 are	 being	 formed.	To	understand	disease	pathogenesis,	it	is	necessary	to	understand	the	alveolus	development	including	cellular	interaction	and	the	alveolus	structure.		Alveologenesis	 relies	 on	 the	 co-ordination	 of	multiple	 specialised	 cell	 types	 (listed	 in	Table	1.5).	The	alveolar	epithelium	is	lined	by	2	cell	types:	type	1	alveolar	epithelial	cells	(AEC1)	and	type	2	alveolar	epithelial	cells	(AEC2).	AEC1	occupy	a	large	surface	area	of	around	93%	and	mediate	 gas	 exchange37.	 AEC2	 are	 cuboidal	 cells	 containing	 lamellar	bodies	which	produced	surfactant,	a	vital	substance	for	reducing	surface	tension	during	gas	 exchange38.	 	 These	 cells	 have	 long	 been	 recognized	 as	 the	 progenitor	 cells	 for	AEC139,40.	 Research	 by	 Desai	 et	 al.	 suggests	 that	 during	 lung	 development	 bipotent	progenitors	give	rise	to	both	AEC1	and	AEC2	cells,	however	after	birth	only	a	sub-set	of	AEC2	cells	 function	as	 the	progenitor	cells	 for	AEC1	cells	which	contribute	 to	repair41.	These	bipotent	progenitor	cells	express	bronchiolar	and	alveolar	markers	and	possess	stem	cell	properties42.	This	means	during	normal	cell	turnover	or	following	injury	AEC2	have	the	capacity	to	proliferate	and	differentiate	into	AEC1	to	repopulate	the	damaged	epithelium43.	Surrounding	the	alveoli	is	a	capillary	network	lined	with	endothelial	cells	which	allows	blood	oxygenation	and	the	lung	interstitium.	The	interstitium	contains	other	cells	like	macrophages	and	a	fibroblast	population	which	are	thought	to	predominantly	control	 the	 synthesis	 of	 the	 non-cellular	 components,	 such	 as	 collagen	 and	 elastin,	providing	the	lung	with	its	mechanical	properties44,45.	Lipofibroblasts	(LIF)	reside	in	the	mesenchyme	containing	lipid	droblets46.	It	is	speculated	that	the	LIF	communicate	with	AEC2	to	stimulate	the	production	of	surfactant47.	Also	residing	within	the	mesenchyme	are	 alpha-smooth	 muscle	actin	 (a-SMA) expressing myofibroblasts	 (MYF)	 which	 are	thought	to	be	the	driving	force	behind	alveolus	maturation	through	secondary	septation	
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(Figure	 1.4).	 It	 is	 speculated	 that	 PDGFRA	 (Platelet	 Derived	 Growth	 Factor	 Receptor	Alpha)	 expressing	 myofibroblasts	 progenitor	 cells	 migrate	 towards	 sites	 of	 septae	initiation48.	 The	 theory	 of	 septation	 has	 been	 based	 on	 the	 appearance	 of	 finger-like	protrusions	(septae)	in	2D	lung	sections.	The	co-location	of	MYF	and	elastin	deposits	at	the	tips	of	the	septae	suggested	that	these	cells	were	driving	septae	towards	the	lumen	of	the	alveolus.	However,	Branchfield	et	al.	examined	alveologenesis	using	3D	imaging	and	speculates	 septal	 ridges	 underlined	 by	 a	 network	 of	 α-SMA	 and	 elastin	 are	 a	 more	accurate	 representation	 of	 alveologenesis49.	 The	 work	 suggestions	 that	 a	 “fishnet”	 of	elastin	surrounds	the	alveolus	and	allows	the	alveolus	epithelial	wall	not	lined	by	elastin	to	bulge	outwards	through	the	pores	creating	mature	alveoli	with	a	large-surface	area.	In	BPD	this	elastin	network	is	defective	and	creates	a	“cheese	cloth”	preventing	the	epithelial	walls	form	bulging	reducing	the	surface	area	of	the	alveolus.		The	 molecular	 and	 cellular	 processes	 of	 BPD	 still	 remain	 poorly	 understood.	 The	expression	 of	 many	 growth	 factors	 has	 been	 investigated	 as	 contributing	 to	 the	development	of	BPD	 including	keratinocyte	growth	 factor50,51,	 fibroblast	growth	 factor	(FGF)52,	transforming	growth	factor	(TGF)53	and	interrupted	cytokine	synthesis	such	as	Interlukin-1054–56.	 Vascular	 endothelial	 growth	 factor	 (VEGF)	 is	 a	 stimulator	 of	alveolarisation	and	vascularization	and	is	therefore	likely	to	be	a	key	modulator	in	BPD.	Many	studies	have	revealed	abnormal	levels	of	VEGF	associated	with	the	development	of	BPD57.	Many	of	the	molecular	and	cellular	processes	involved	in	lung	development	are	likely	to	be	involved	in	lung	repair	and	regeneration.	Therefore	lung	development	is	an	important	framework	for	understanding	lung	repair	and	potential	therapeutic	options58.					
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Table	1.5	Cell	types	involved	in	alveologenesis.	
Cells	 Acronym	 Location	 Function	Myofibroblasts	 MYF	 Tip	of	septae	formation	 Express	 alpha-smooth	 muscle	 actin	 and	produce	extracellular	matrix	fibres.	Lipofibroblasts	 LIF	 Close	 to	AECII	 Source	 and	 transport	 lipids	 to	 AECII	 for	surfactant	production.	Endothelial	cell	 EC	 Lung	mesenchyme		 Provides	surface	area	of	blood	vessels.	Alveolar	epithelial	 cell	type	1	
AEC1	 Alveolar	epithelium	 Provides	most	of	the	surface	of	the	alveoli	to	facilitate	gas	exchange.	
Alveolar	epithelial	 cell	type	2	
AEC2	 Alveolar	epithelium	 Stem	cell	 to	AEC1,	covers	a	small	area	of	alveolus	 surface	 area	 and	 produces	surfactant.			
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Figure	1.4	Diagram	showing	the	Saccular	and	Alveolar	stages	of	lung	development.	Primitive	 alveoli	 are	 formed	 during	 the	 saccular	 stage	 (a)	 which	 are	 surrounded	 by	collagen	fibres	and	blood	vessels.	AEC1	and	AEC2	are	present,	forming	the	saccule	walls	and	 producing	 surfactant.	 Fibroblasts	 produce	 collagen	 and	 elastin	 (b).	 Secondary	septation	occurs	which	subdivides	the	saccules	and	forms	mature	alveoli	(c).	One	theory	suggests	 this	 process	 is	 driven	 by	 the	 deposition	 of	 elastin	 by	 the	myofibroblasts	 (d).	Later,	double	layer	capillaries	fuse	to	become	thinner	for	efficient	gas	exchange.	Shown	are	 the	 AEC1	 and	 2	 alveolar	 epithelial	 cells,	 BADJ	 broncho-alveolar	 duct	 junction,	 LIF	lipofibroblasts	(e).	Image	taken	directly	from	Chao	et	al.	59.				
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1.2 BPD	research	
The	pathogenesis	of	BPD	remains	poorly	understood.	Research	has	relied	significantly	on	the	use	of	animal	models,	cadavers	and	some	in	vitro	cell	culture60.	Figure	1.5	summarises	the	 various	 methods	 BPD	 research	 has	 utilised.	 Here,	 we	 describe	 the	 use	 of	 animal	models	and	in	vitro	study	in	detail.		
	
Figure	1.5	Schematic	showing	the	various	methods	utilised	in	BPD	research.			
1.2.1 Animal	models	Early	experiments	using	animal	models	have	helped	shape	our	understanding	of	BPD61.	This	originated	in	1932	when	Smith	et	al.	exposed	rats	to	compressed	air	conditions62.		Since	 then	other	animals	have	been	used	 to	model	BPD,	 including	rodents61,	 rabbits31,	lambs63,	sheep64	and	baboons65.	Animal	models	are	currently	the	most	favoured	research	method	for	lung	research	due	to	the	complexity	of	respiratory	diseases,	however	they	are	limited	in	terms	of	clinical	utility	due	to	interspecies	variation.			
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	1:	Introduction	
	 15	
1.2.1.1 Rodents	Rodents	are	a	popular	animal	model	in	all	areas	of	medical	research	due	to	their	small	size,	 short	 life	 span,	 the	 large	availability	of	 reagents	 and	 low	upkeep	 cost.	They	have	provided	significant	insight	into	the	effects	of	oxygen	toxicity.	Rodents	are	considered	an	ideal	model	for	BPD	since	their	lungs	are	at	the	saccular	stage	of	development	at	birth	(postnatal	day	5-3066),	which	is	the	same	stage	of	lung	development	as	premature	babies.	However,	unlike	humans,	birth	at	this	stage	of	lung	development	is	normal	for	rodents,	they	are	surfactant	sufficient	and	able	to	exchange	gas	normally	without	any	intervention.	In	 contrast,	 human	 alveologenesis	 should	 normally	 begin	 in	 the	 uterus	 before	 birth.	Premature	 VLBW	 infants	 may	 have	 only	 progressed	 to	 the	 canalicular	 stage	 of	 lung	development58	and	the	lungs	are	classed	as	under-developed.			Hyperoxia-induced	neonatal	rodents	are	the	most	commonly	used	BPD	model.	New-born	rodents	are	kept	in	chambers	containing	high	oxygen	levels,	usually	90%	or	over53,56,67–
69.	Human	babies	are	rarely	exposed	to	oxygen	levels	higher	than	40%.	Therefore,	though	the	hyperoxia	exposure	is	clinically	relevant,	the	levels	of	oxygen	are	not60.	There	is	also	a	lack	of	standardisation	with	rodent	models.	Investigators	have	employed	various	strains	of	 mouse	 including	 BALB/c,	 C57BL/6	 and	 FVB/N,	 making	 comparisons	 difficult70.	Although	 often	 considered	 interchangeable,	mice	 and	 rats	 are	 dissimilar	 in	 their	 lung	anatomy	with	mice	displaying	a	smaller	lung	capacity	and	alveoli71.			Hyperoxygen	 exposure	 is	 a	 key	 tool	 used	 in	 BPD	 research,	 a	 disease	 exacerbated	 by	oxygen	toxicity.	Exposure	of	new	born	mouse	pups	to	hyperoxygen	is	a	key	in	vivo	method	to	model	BPD.	 	However,	 there	 is	no	standardised	oxygen	regime	(oxygen	percentage,	exposure	time	and	exposure	window)	which	has	caused	some	difficulties	when	drawing	study	 conclusions.	 Exposed	 mice	 also	 do	 not	 experience	 mechanical	 stretch	 that	endotracheal	ventilated	babies	will	experience70.			
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1.2.1.2 Baboons	and	lambs	Larger	 animals	 are	 considered	 an	 expensive	 option;	 however,	 the	 preterm	models	 of	baboons	or	lambs	are	an	attractive	alternative	to	rodents.	Their	large	size	means	they	can	be	mechanically	ventilated	easily	and	have	a	very	similar	lung	development	making	them	clinically	 relevant	 for	 “new”	 BPD	 60,72.	 The	 baboon	 and	 lamb	models	 has	 consistently	shown	similar	pathological	findings	as	that	of	BPD	in	human	infants,	including	interrupted	alveolarization	 and	 vascularization63,65,73,74.	 These	 animals	 also	 allow	 the	 use	 of	pharmacology	 interventions	 such	 as	 vitamin	 A	 supplementation75	 and	 surfactant	treatment76.		
1.2.1.3 Rabbit	The	rabbit	models	have	similar	advantages	to	rodents	in	that	they	have	a	short	gestation	period,	 a	 large	number	of	offspring	and	are	easy	 to	handle.	Their	kitten	 size	 is	 larger,	which	 permits	 the	 use	 of	 certain	 instruments	 such	 as	 ventilation	 equipment63.	 Rabbit	models	have	a	similar	lung	development	to	humans	in	that	full-term	rabbits	are	born	in	the	early	to	middle	alveolar	stage	and	have	a	mature	surfactant	system.	Moreover,	 the	rabbit	lung	is	anatomically	more	similar	to	human	lungs	and	can	provide	preterm	delivery	whilst	maintaining	a	reduced	alveoli	number77.The	animals	show	pathological	injuries	on	the	lung	architecture	which	are	similar	to	those	found	in	BPD31.	New-born	rabbits	have	also	demonstrated	hyperoxia	resistance	which	is	lost	during	adulthood,	a	phenomenon	not	shared	by	other	animals31,78.	The	rabbit	model	is	inhibited	by	a	lack	of	rabbit-specific	reagents	to	allow	for	scientific	assessment.			
1.2.2 In	vitro	models	In	 the	past	 there	has	been	a	reliance	on	animal	models	 that	mimic	key	 features	of	 the	disease	 due	 to	 availability	 of	 only	 basic	 in	 vitro	 cell	 culture	 techniques	 to	 model	
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alveolarization.	The	rapidly	developing	field	of	tissue	engineering	has	enabled	cell	culture	to	become	a	feasible	alternative	to	model	disease.	This	is	due	to	the	employment	of	tissue	engineered	constructs	that	can	mimic	the	native	3D	environment	of	in	vivo	structures	and	the	improvement	of	research	analysis	techniques	and	equipment79.	In	the	last	60	years	the	3Rs	has	come	at	the	forefront	of	medical	research	as	ethical	values	to	strive	for80,81.	Standing	 for	 Replacement,	 Reduction	 and	 Refinement	 the	 principals	 hope	 to	 employ	alternative	strategies	to	promote	research	without	the	reliance	of	animal	models.	This	has	helped	to	catapult	advances	with	in	vitro	modelling.	In	lung	research,	development	of	in	
vitro	models	has	focused	on	the	conducting	zone	of	the	respiratory	tract82,	an	easier	tissue	to	 model	 with	 simpler	 architecture.	 Some	 of	 these	 models	 are	 now	 commercially	available83.	Modelling	the	respiratory	section	of	the	lung	is	a	more	complicated	task	due	to	the	intricate	architecture	of	the	alveoli,	the	multicellular	components	and	the	functional	aspect	(illustrated	in	Figure	1.6).	The	ideal	alveolus	in	vitro	model	would	encompass	4	key	elements:	 a	 3D	 structure,	 human	 relevant	 cell	 co-culture,	mechanical	 stimulation	 and	oxygen	exposure.	These	aspects	have	now	been	described	in	more	detail.		
1.2.2.1 3D	models	Current	in	vitro	research	of	the	respiratory	system	lacks	biological	relevance.	Single	cell	type	 monolayer	 cultures	 are	 becoming	 out-dated	 as	 they	 lack	 the	 physiological	complexity	of	the	multi-cellular	lung79	and	they	often	fail	to	translate	to	in	vivo.	3D	in	vitro	modelling	of	the	respiratory	system	was	first	seen	in	197084	and	since	then	has	become	a	popular	choice	in	the	laboratory.	Materials	which	have	been	used	as	lung	tissue	constructs	included	 synthetic	 polymers85,	 Gelfoam	 sponges86,	 electrospun	 polymer	 fibres87	 and	collagen	hydrogels88.		3D	models	of	lung	tissue	offer	the	ability	to	investigate	the	biological	interactions	 leading	 to	 BPD	 and	 potential	 therapeutic	 application.	 The	 functional	importance	of	the	lung	ECM	means	that	incorporation	into	any	lung	model	is	important.	
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Engineering	functional	3D	engineered	constructs	is	a	rapidly	developing	area	of	research	for	 most	 tissue	 types.	 The	 conducting	 airway	 has	 been	 successfully	 engineered	 and	implanted	in	vivo89.	However,	modelling	the	complex	functional	alveoli	in	vitro	is	a	bigger	challenge	that	so	far,	remains	unmet.		The	 respiratory	 zone	 of	 the	 lung	 is	 a	 complex	 architecture	 composed	 of	 bronchioles	terminating	 at	 alveoli	 air	 sacs.	 Secondary	 septation	 during	 the	 final	 stages	 of	 lung	development	increases	the	surface	area	of	the	alveoli	considerably.	The	surrounding	lung	interstitium	goes	through	remodelling	to	provide	a	collagen	and	elastin	rich	environment	which	 impacts	 on	 lung	 development90,	 structural	 integrity	 and	 mechanical	capabilities45,91–93.	Disrupted	synthesis	and	assembly	of	collagen	and	elastin	network	has	been	a	histological	finding	in	both	animal	models	and	human	infants	with	BPD32,66,94–96.	Hyperoxia	exposure	has	been	shown	to	affect	the	cross-linking	of	collagen	and	elastin66.		Surprisingly,	few	studies	have	examined	the	possibility	of	including	these	2	components	in	an	in	vitro	construct.	Dunphy	et	al.	created	cell	seeded	collagen-elastin	constructs	to	assess	the	Young’s	modulus97.	The	study	found	that	the	Young’s	modulus	of	the	hydrogels	was	 similar	 to	 the	 theoretical	 Young’s	 modulus	 value	 of	 an	 alveolus.	 The	mechanical	properties	of	such	a	construct	makes	 it	an	 ideal	3D	construct	to	 include	 in	an	alveolus	model.			Another	possible	approach	to	 this	challenge	could	be	to	use	decellularized	 lung	tissue.	Studies	have	shown	that	when	the	decellularised	tissue	is	re-popularised,	the	mechanical,	topography,	tissue	architecture	and	functional	aspects	of	the	tissue	remain	the	same98,99.	The	 mechanical	 and	 chemical	 cues	 have	 been	 shown	 to	 influence	 cell	 behaviour,	influencing	cell	proliferation,	differentiation	and	gene	expression100–103.	This	could	be	a	more	accurate	method	to	use	in	lung	research	where	hierarchical	structure	is	complex.	This	 technique	of	decellularizing	and	re-introducing	native	cells	has	proved	successful	
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with	rat	lungs104	and	porcine	lungs105	however	currently	the	technique	may	be	unsuitable	for	research	purposes	due	to	its	costly	and	time	consuming	approach	and	doesn’t	allow	high-throughput.		
	
Figure	1.6	Diagram	of	the	lung	alveolus	and	surrounding	interstitium.	There	are	an	estimated	 480	 million	 alveoli	 in	 each	 lung	 of	 a	 human	 adult106.	 Each	 alveolus	 is	surrounded	 by	 the	 lung	 parenchyma	 composed	 of	 extracellular	 matrix	 (collagen	 and	elastin	mostly)	produced	by	lung	fibroblasts,	and	a	vast	network	of	blood	capillaries	(A).		Each	alveolus	is	composed	of	AEC1	and	AEC2	which	sit	on	a	basement	membrane.	AEC2	produce	surfactant	to	decrease	surface	tension	during	breathing	(B).			
1.2.3 Cell	type	and	co-culture	Most	in	vitro	BPD	research	uses	a	single	cell	culture	in	a	hyperoxic	environment	which	doesn’t	allow	for	cell-cell	interactions	to	be	assessed.	The	A549	cell	line	is	a	popular	choice	for	modelling	lung	biology107.	First	derived	by	Giard	et	al.	in	1973,	it	is	a	human	alveolar	cell	 carcinoma	 cell	 line	 regularly	used	 to	 represent	AEC2	 in	 vitro108.	 The	 cells	 express	lamellar	bodies	capable	of	producing	surfactant.	However	the	suitability	of	the	cell	line	has	 come	 under	 scrutiny	 with	 questions	 regarding	 their	 surfactant	 protein	
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composition109,	 expression	markers110	 	 and	 their	 lack	 of	 ability	 to	 differentiate	 into	 a	AEC1.	Interruption	of	differentiation	of	AEC2	to	AEC1	may	be	a	contributing	factor	to	BPD	development	and	 is	 therefore	an	 important	 factor	to	consider43.	 Immortalised	alveolar	type	1	 cell	 line	 (TT1)	developed	by	Kemp	et	al.	 has	been	 suggested	as	a	possible	 lung	model	111.	In	2010,	Swain	et	al	investigated	the	cell	markers	by	using	Raman	microscopy	and	showed	they	made	a	suitable	candidate	for	the	modelling	of	AEC1110.	Animal	cell	lines	MLE-12	(mouse	 lung	epithelial	cell	 line)	and	RFL-6	(rat	 foetal	 lung	 fibroblast	cell	 line)	have	also	been	used	in	BPD	models	but	are	less	common	and	usually	only	used	as	a	cell	culture	comparison	to	animal	models53.			As	previously	described	(section	1.1.3.1)	 the	 lung	parenchyma	 is	a	multicellular	 tissue	involving	sophisticated	cross-talk	between	AEC1,	AEC2,	myofibroblasts,	 lipofibroblasts	and	 macrophages.	 Cell-cell	 interactions	 are	 likely	 to	 be	 an	 important	 factor	 when	considering	 an	 in	 vitro	 model	 for	 any	 disease.	 Despite	 this,	 few	 BPD	 studies	 have	incorporated	co-culture	techniques	in	BPD	research.	A	lung	fibroblast-tracheobronchial	epithelial	cell	co-culture	model	was	employed	by	Chetty	et	al.	to	investigate	the	migration	of	 fibroblasts	 through	 collagen	 gels	 in	 hyperoxia	 conditions112.	 The	 epithelial	 cells	promoted	 cell	 migration	 of	 the	 lung	 fibroblast	 and	 indicated	 the	 importance	 of	understanding	cell-cell	interactions.	More	recently	in	2014,	an	epithelial	(A549)	cell	line	and	foetal	mouse	lung	mesenchymal	co-culture	was	employed	by	Greer	et	al.113.	Tall	peaks	were	formed	consisting	of	a	mesenchyme	cell	core	covered	by	epithelial	cells.	The	study	demonstrated	 that	 a	 co-culture	 model	 could	 be	 used	 to	 test	 mesenchymal-epithelial	interactions	following	injury.			Lung-on-chip	 methodologies	 provide	 a	 platform	 to	 assess	 cell-cell	 interactions	 for	example	replicating	alveolar-capillary	barrier	114.	This	is	a	similar	story	for	precision	cut	organ	slices	which	allow	the	assessment	of	tissue-tissue	interaction	such	as	airway	and	
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vessels	 in	 the	 lung115.	 These	 models	 are	 still	 limited	 by	 a	 lack	 in	 availability	 of	 the	appropriate	tissue	source.			Providing	 a	 platform	 to	 allow	 co-culture	 of	 human	 lung	 specific	 cells	would	 allow	 the	analysis	 of	 cell-cell	 interactions	 and	 could	 provide	 vital	 information	 into	 lung	development	and	lung	repair.		
1.2.4 Mechanical	stretching	Artificial	ventilation	has	long	been	thought	of	as	a	contributing	factor	to	BPD	pathogenesis	causing	inflammation	and	ROS	(reactive	oxygen	species)	injury	due	to	over-inflation	of	alveoli116.	Although	gentler	 respiratory	aids	are	now	employed	 in	clinical	practice,	 the	under-developed	premature	lung	is	suddenly	exposed	to	continuous	inflation	leading	to	a	danger	of	overstretching.	This	may	have	an	important	consequence	on	lung	interstitium	deposition	and	maturation.	Multiple	studies	have	shown	that	mechanical	forces	between	the	 lung	 ECM	 and	 cells	 directly	 influence	 cell	 signalling	 during	 lung	 development,	surfactant	release	and	tissue	remodelling117–120.			The	 lung	ECM	provides	mechanical	stability	 through	collagen	and	elastin	cross-linking	which	 is	 a	 continuous	 process	 during	 the	 later	 stages	 of	 lung	 development.	 Elastin	turnover	is	thought	to	be	a	slow	process	and	as	such	the	deposition	of	elastin	during	foetal	development	must	 sustain	 normal	 tissue	 function	 throughout	 a	 lifetime121.	 Therefore,	interrupted	elastin	deposition	during	development	may	cause	irrevocable	damage.	At	22-26	 weeks	 GA	 the	 premature	 lung	 parenchyma	 is	 potentially	 not	 mechanically	 stable	enough	to	sustain	the	physical	forces	experienced	when	the	infant	begins	to	breath	for	the	first	time.	Despite	its	importance,	few	studies	have	incorporated	mechanical	stimulus	
in	 vitro122.	 	 In	 recent	 years	 novel	 bioreactors	 have	 been	 developed	 in	 other	 areas	 of	
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research	to	create	physiological	relevant	mechanical	stimuli123.	In	BPD	research,	there	are	few	examples	of	the	incorporation	of	bioreactor	systems	in	vitro.	Strain	units	such	as	the	Flexcell	strain	unit	(Flexcell	International)	and	the	Bio-Stretch	System	from	ICCT124	have	been	 used	 to	 expose	 lung	 cells	 to	 cyclic	 strain	 regimes.	 Pro-inflammatory	 cytokines,	chemokines,	cell	apoptosis	and	MMP	release	have	all	been	shown	to	increase	when	foetal	lung	cells	are	exposed	to	stimulation54,125,126.	Mechanical	stretching	has	also	been	shown	to	 affect	 airway	 smooth	 muscle-cell	 phenotype127	 and	 promotes	 the	 secretion	 of	surfactant		from	AEC2128.		Although	predominately	used	for	bone	and	cartilage	research,	the	hydrostatic	bioreactor129	possess	attributes	which	may	bode	well	for	lung	research130.	It	 can	 provide	 cyclic	 influxes	 of	 air	 pressure	 that	 mimic	 clinical	 ventilators.	 The	hydrostatic	bioreactor	allows	alteration	of	pressure	and	frequency	to	provide	clinically	relevant	environments131.		
1.2.5 Oxygen	exposure		Although	BPD	is	considered	a	multifactual	disease,	 it	 is	 largely	associated	with	oxygen	toxicity.	 Oxygen	 requirements	 form	 the	 basis	 of	 BPD	 diagnosis	 and	 are	 an	 essential	treatment	for	premature	infants.	The	most	premature	infants	require	oxygen	ventilation	of	>40%	to	maintain	healthy	blood	saturation	levels.	Oxygen	toxicity	was	first	reported	by	Northway	et	al.	who	demonstrated	that	exposing	mice	pups	to	100%	oxygen	caused	a	BPD-like	 injury4.	 Studies	 have	 expanded	 this	 further	 by	 showing	 preterm	 baboons	exposed	to	30%	oxygen	had	less	lung	injury	than	those	exposed	to	100%	oxygen132.	This	highlights	 the	 importance	 of	 employing	 relevant	 oxygen	 exposure	 in	 an	 in	 vitro	 BPD	model.	The	demand	 for	oxygen	 control	has	 increased	 in	 recent	years	due	 to	 the	more	recent	 understanding	 of	 replicating	 physiological	 oxygen.	 This	 has	 allowed	 the	development	of	technologies	that	provide	ambient	oxygen	control.	The	simplest	form	is	a	re-sealable	chamber	that	can	hold	cell	culture	plates,	be	flushed	with	a	pre-mixed	gas	of	
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the	desired	gas	mixture,	sealed	with	a	tight	stopper	and	placed	inside	an	incubator.	The	most	 expensive	 technologies	 included	 whole	 incubators	 which	 maintain	 a	 constantly	supply	of	the	desired	gas	mix133.		
1.2.6 Developed	in	vitro	models	Previous	studies,	as	listed	in	Table	1.6	have	made	attempts	to	include	one	or	two	of	the	described	elements	to	mimic	the	alveolus	in	vitro.	This	includes	using	collagen	hydrogels	to	 provide	 a	 3D	 scaffold,	 using	 co-culture	 cell	 culture	 techniques	 and	 incorporating	mechanical	stimulus.	Despite	this,	there	is	still	much	to	be	desired.	The	complexity	of	the	respiring	lung	requires	the	development	of	an	advanced	model	to	include	most	if	not	all	of	the	aspects	previously	described.		
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Table	 1.6	 Examples	 of	 in	 vitro	 studies	which	 have	 attempted	 to	model	 the	 lung	
alveoli.	All	 the	studies	 include	co-culture	techniques,	mechanical	stimulus	or	hydrogel	scaffolds	to	mimic	the	complex	lung	alveoli.	Description	 Authors	 Year	Fibroblast	 cultured	 on	 collagen	 gel	 substrates	 and	covered	by	a	second	layer	of	collagen	gel.	Epithelial	cells	then	cultured	on	collagen	gel	surface	and	exposed	to	95%	oxygen	112.	
Chetty	A.	et	al.	 1999	
Lung-on-a-chip	 microdevice.	 Epithelial	 and	 endothelial	cells	 cultured	 either	 side	 of	 a	 porous	 membrane.	 The	membrane	is	mechanically	stretched	using	a	vacuum	134.	
Huh	D.	et	al.	 2010	
Foetal	 pulmonary	 cells	 resuspended	 in	 1.2mg/ml	collagen	solution.	Fibroblast	growth	 factors	10,	7	and	2	were	added	to	culture	medium	in	various	combinations	88.	
Mondrinos	M.	et	al.	 2007	
Primary	 foetal	 lung	 mesenchymal	 cells	 grown	 to	confluency	then	A549	cells	overlaid	to	cover	underlying	primary	cells	and	cultured	at	95%	air	113.	
Greer	R.	et	al.	 2014	
A549	cells,	rat	alveolar	epithelial	cells,	human	bronchial	epithelial	cells	and	human	foetal	lung	fibroblast	cell	line	were	 cultured	with	 collagen	 gels	 and	 on	 the	 surface	 of	collagen	 gels.	 Gel	 contraction	 was	 examined	 under	various	conditions	135.	
Umino	T.	et	al.	 2000	
Foetal	 mouse	 lung	 fibroblast	 exposed	 to	 20%	 cyclic	stretch	using	Flexcell	Strain	Unit	54.	 Hawwa	R.	et	al.	 2011	Collagen–elastin	constructs	seeded	with	lung	fibroblasts	possess	lung	modulus	similar	to	the	theoretical	value	of	a	lung	alveolus	97.	
Dunphy	S.	et	al.	 2014	
		
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	1:	Introduction	
	 25	
1.3 Stem	cells	as	therapies	
Stem	cells	are	a	valuable	cell	type	capable	of	self-renewal	and	differentiation	into	multiple	cell	lineages.	They	are	a	critical	component	for	tissue	generation	during	development	and	tissue	repair136.		Due	to	these	properties,	they	are	being	harnessed	for	use	as	cell	therapies	in	human	disease,	including	BPD.		The	complex	lung	structure,	cell	diversity	and	varying	cell	niches	has	made	it	difficult	to	identify	 the	 key	 progenitor	 cells	 in	 the	 lung137.	 Research	 examining	 the	 effect	 of	stem/progenitor	cells	has	shown	potential	for	the	prevention	or	the	alleviation	of	BPD.		Since	BPD	is	a	multifactorial	disease,	it	may	be	difficult	to	determine	the	most	appropriate	cell	 type	 and	 ultimately	 a	 combination	 of	 cell	 types	may	 be	 required	 for	 optimal	 cell	therapy.			
1.3.1 Endothelial	progenitor	cells	Endothelial	 progenitor	 cells	 (EPC)	 are	 circulating	 cells	 that	 have	 been	 described	 as	contributing	to	angiogenesis138.	The	 lung	vasculature	houses	a	population	of	EPCs	that	are	proliferative	and	capable	of	vasculogenesis139.	As	previously	mentioned,	simplified	pulmonary	vascularization	is	a	hallmark	of	BPD	so	EPCs	are	an	attractive	candidate	as	a	therapeutic	 treatment	 for	BPD69.	 Impaired	or	 low	numbers	of	EPC	have	been	 found	to	contribute	to	alveolar	growth	arrest69	and	BPD	pathogenesis140–142.		
1.3.2 Amnion	epithelial	stem	cells	The	advantage	of	using	amnion	epithelial	cells	is	that	they	possess	stem	like	features,	they	are	 readily	available	 from	 the	placenta,	 and	 they	do	not	 form	 teratomas143,144.There	 is	emerging	evidence	that	amnion	epithelial	cells	have	the	capability	to	repair	lung	injury.	One	 investigation	examined	 the	effect	of	amnion	epithelial	 cells	 to	protect	 lambs	 from	
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	1:	Introduction	
	 26	
ventilation	 induced	 lung	 injury.	 The	 cells	 helped	 maintain	 the	 lung	 architecture	 and	prevent	injury145.	Recently,	the	first-in-human	clinical	trial	of	hAECs	in	infants	with	BPD	was	completed	and	no	adverse	effects	were	seen146.	Further	trials	are	likely	to	be	planned	to	assess	the	efficacy	of	these	cells.	 				
1.3.3 Pluripotent	stem	cells	Pluripotent	 stem	 cells	 are	 capable	 of	 differentiating	 into	 multiple	 cell	 lineages.	 They	include	induced	pluripotent	stem	cell	(iPSC)147	and	embryonic	stem	cells	(ESC)148.	iPSCs	offer	the	ability	to	provide	patient-specific	lung	progenitor	cells.	ESC	and	iPSCs	have	been	successfully	differentiated	into	lung	progenitor	cells	which	were	able	to	form	airway	and	alveolar	 cells149,150.	 Research	 into	 the	 use	 of	 pluripotent	 stem	 cells	 in	 BPD	 is	 still	developing	 but	 is	 continually	 growing.	 Although	 there	 are	 concerns	 with	 the	tumorigenicity	and	ethical	considerations151,	their	therapeutic	potential	is	showing	great	promise152.		
1.3.4 Mesenchymal	stem	cells	Mesenchymal	 Stem	 cells	 (MSC)	 offer	 a	 promising	 cell	 type	 and	 are	 the	 most	 widely	researched	 stem	 cell.	 Their	 wide	 distribution,	 ability	 to	 home	 to	 sites	 of	 injury153,	immunosuppressive	 properties154,	 differentiation	 and	 proliferative	 capabilities	 makes	them	 an	 attractive	 progenitor	 cell.	 MSCs	 have	 been	 identified	 in	 human	 lungs155–157.	Although	little	is	known	about	their	function	in	the	lung,	they	are	regarded	as	having	a	great	 therapeutic	 potential	 for	 the	 treatment	 of	 BPD.	 Researchers	 have	 investigated	various	 sources	 of	 MSCs	 for	 BPD	 including	 bone	 marrow158,159	 adipose	 tissue160	 and	gestational	tissue161.	Gestational	tissues	(the	placenta,	Wharton’s	jelly	and	the	umbilical	cord)	are	particularly	attractive	sources	of	MSCs	since	the	tissues	are	considered	waste	material	and	therefore	possess	few	ethical	dilemmas.	Gestational	tissue-derived	MSCs	can	
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be	easily	 extracted	 from	 the	 tissues	and	 they	 show	 less	 immunomodulatory	effects162.	Animal	 studies	 have	 demonstrated	 that	 umbilical	 cord	 blood	 derived	MSCs	 attenuate	hyperoxic	injury	in	rats163.	A	recent	study	by	Ahn	et	al.	examined	the	optimal	cell	type	to	protect	against	neonatal	rat	hyperoxic	lung	injury.	Human	umbilical	cord	blood-derived	MSCs	 have	 been	 shown	 to	 have	 a	 protective	 effect	 against	 hyperoxic	 stress	 when	compared	to	bone	marrow	MSC	and	adult	tissue	MSC107.	This	was	supported	by	Chang	et	
al.		who	found	intratracheal	transplantation	of	umbilical	cord	blood	MSC	is	more	effective	than	 intraperitoneal	 transplantation163.	 Similarly,	 the	 placenta	 is	 a	 valuable	 source	 of	stem	cells	where	a	variety	of	stem	cell	types	can	be	isolated,	including	haematopoietic,	amniotic	epithelial,	chorionic	mesenchymal	and	amniotic	mesenchymal	stem	cells164,165.	Of	 particular	 interest	 are	 placental	 MSCs	 which	 have	 been	 shown	 to	 have	 similar	properties	to	bone	marrow	MSCs166	with	a	high	capacity	for	self-renewal,	the	capability	to	differentiate	into	multiple	lineages161,167,168	and	promote	angiogenesis169.  	The	therapeutic	effect	of	MSCs	has	been	frequently	investigated	in	rodent	models158,159,163.	Translation	of	MSCs	 into	 the	clinic	has	already	begun.	PNEUMOSTEM® is	an	allogeneic	umbilical	cord	blood	derived	MSC	medicine170.	It	is	currently	in	the	US	phase	1/2a	clinical	trial	for	the	treatment	of	BPD	in	premature	infants.	The	treatment	still	has	a	long	way	to	go	 before	 being	 established	 safe	 and	 effective.	 However	 early	 results	 suggest	 the	treatment	is	well	tolerated,	the	severity	of	BPD	in	transplanted	subjects	is	lower	and	there	is	 a	 reduction	 in	 interleukin-6,	 interleukin-8,	 matrix	 metalloproteinase-9,	 tumour	necrosis	 factor	 α,	 and	 TGF	 β1	 in	 tracheal	 aspirates171.	 These	 promising	 results	demonstrate	the	effectiveness	of	harnessing	MSC	attributes.		Recent	reports	have	suggested	that	MSC	transplantation	is	not	necessarily	required	but	that	MSCs	potentially	alleviate	BPD	through	paracrine	mediators	rather	than	regenerative	capabilities	107,158,172–174.	Knoll	et	al	employed	a	co-culture	technique	to	culture	foetal	rat	
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fibroblasts	or	type	II	cells	with	bone	marrow	stem	cells	(BMSCs)	using	a	transwell	insert.	The	 results	 indicated	 that	 BMSCs	 promote	 AEC2	 maturation	 via	 a	 paracrine	mechanism173.	On	a	clinical	point	of	view,	this	may	allow	cell-free	conditioned	media	to	be	used	therapeutically	which	would	remove	the	risk	of	tumorigenesis174.		
1.4 The	future	for	BPD	and	remaining	challenges		
There	is	still	much	to	be	learned	about	BPD.	The	disease	mechanism	remains	unknown	and	is	limited	by	the	complex	nature	of	the	lung.	Animal	models	have	provided	most	of	our	 current	 knowledge	 however	 are	 limited	 by	 cost,	 ethical	 considerations,	 biological	variability,	 inconsistent	 experimental	 set-up	 and	 differences	 in	 animal	 lung	development60.	Furthermore,	BPD	research	 in	animals	has	used	non-clinically	relevant	and	inconsistent	oxygen	concentrations	to	cause	hyperoxic	injury.	With	the	development	of	tissue	engineering,	3D	in	vitro	models	are	becoming	an	attractive	research	tool,	as	it	is	possible	to	more	accurately	mimic	the	lung	architecture	and	allow	co-culture.	This	will	enable	researchers	to	accurately	examine	the	molecular,	cellular	and	ECM	interactions.	Finding	the	most	appropriate	scaffold	design	will	require	extensive	research.			In	recent	years	extensive	knowledge	about	stem/progenitor	cells	has	been	uncovered.	As	previously	 described,	 there	 are	 various	 cell	 types	which	 have	 the	 potential	 to	 offer	 a	therapeutic	 treatment	 for	 BPD.	 Phase	 I	 UCB-MSC	 dose-escalated	 clinical	 study	 for	 the	prevention	of	BPD	have	been	reported.	Although	the	efficacy	has	not	been	established,	the	report	 did	 demonstrate	 the	 short-term	 safety	 of	 MSC	 administration	 in	 premature	babies171.	There	are	still	questions	remaining	regarding	dose,	timing,	mechanisms,	long-term	 safety	 and	 efficacy	 of	 MSC	 therapy	 for	 BPD.	 Standardized	 techniques	 for	 cell	definition,	extraction	and	expansion	are	yet	to	be	achieved	before	routine	translation	of	cell	 therapies	 to	 the	 clinic.	 Translating	 stem	 cell	 therapies	 will	 rely	 on	 partnership	
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between	 industry	 and	 funding	 bodies	 and	 incentives	 for	 companies	 to	 research	 the	neonatal	population35.		
	
1.5 Summary	and	hypothesis	
In	the	last	50	years	there	have	been	considerable	improvements	in	neonatal	health	care	resulting	in	the	survival	of	extremely	premature	infants	at	a	high	risk	of	developing	BPD.	The	disease	results	from	interruption	to	alveolarisation,	vascularization	and	extracellular	matrix	arrangement.	Current	therapeutic	options	are	limited	and	intended	for	palliative	management	rather	than	to	be	curative.	The	disease	remains	a	major	cause	of	morbidity	and	 a	 burden	 on	health	 resources	 due	 to	 the	 long	 term	health	 impact	 on	 the	 affected	population175.	 There	 is	 a	 significant	 clinical	 need	 to	 develop	 novel	 strategies	 for	 the	treatment	of	BPD.	The	complex	and	poorly	understood	pathogenesis	of	BPD	 instigates	challenges	 for	 developing	 a	 successful	 therapeutic	 treatment.	 Identifying	 and	understanding	the	role	of	the	lung	stem	and	progenitor	cells	in	the	developing	lung	may	offer	 new	 understanding	 into	 BPD	 pathogenesis	 and	 new	 therapeutic	 avenues.	 MSCs	possess	 the	potential	 to	prevent	 injury,	 promote	 repair/regeneration	 in	 the	 immature	lung	and	are	a	promising	therapeutic	option.	The	development	of	clinical	therapies	for	BPD	will	likely	rest	on	our	understanding	of	the	repair	and	regenerative	capacity	of	lung	progenitor	cells176.			BPD	research	has	been	restricted	by	a	lack	of	adequate	research	methodologies.	Animal	studies	have	provided	much	of	what	is	currently	known	about	the	disease,	but	they	are	limited	by	a	lack	of	biological	relevance	and	promotion	of	the	3Rs	initiative.	Although	a	cheaper	option,	rodent	models	do	not	represent	the	same	lung	development	as	humans.	Larger	animals	such	as	rabbits	and	mammals	over	come	this	limitation	but	are	associated	with	 much	 higher	 costs.	 In	 vitro	 models	 can	 provide	 a	 controlled	 way	 of	 modelling	
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	1:	Introduction	
	 30	
biologically	 relevant	 respiratory	disease.	This	would	allow	researchers	 to	examine	 the	molecular	and	cellular	interactions	that	lead	to	BPD.	The	use	of	engineered	mechanically	relevant	 3D	 constructs	 and	 co-culture	 techniques	 offers	 a	 promising	 research	 tool	 by	allowing	the	investigation	of	cell-cell	and	cell-ECM	interaction.			The	work	described	in	this	thesis	investigates	the	possibility	of	developing	an	alveolus	in	
vitro	 model	 capable	 of	 providing	 a	 BPD	 relevant	 environment	 in	 terms	 of	 cell-cell	interaction,	cell-ECM	interaction	and	clinically	relevant	oxygen	toxicity.	The	potential	of	extracting	and	culturing	cells	 from	BPD	infants	undergoing	ventilation	 is	examined	for	use	in	the	model	to	provide	disease	relevance.	In	addition,	the	model	is	used	as	a	platform	to	assess	the	therapeutic	potential	of	placenta	derived	MSCs	for	BPD	and	the	effect	that	clinically	relevant	hyperoxygen	has	on	cell	performance.				
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2.1 Materials	and	equipment	
This	chapter	details	the	fundamental	methods	used	throughout	the	thesis.	Table	2.1	and	Table	2.2	list	the	materials	and	equipment	which	were	used.			
Table	 2.1	 List	 of	materials,	 catalogue	 code	 and	 suppliers	 used	 for	 experimental	
work	
Materials Order number Supplier 
3-isobutyl-1-methylxanthine (IBMX) I7018 Sigma-Aldrich 
Agarose BP1356-500 Fisher Scientific 
Alamar Blue Cell viability reagent 10161053 Invitrogen 
Alcian blue A3157 Sigma-Aldrich 
Alizarin red S A5533 Sigma-Aldrich 
Ascorbic acid phosphate A8960 Sigma-Aldrich 
BEGM Bullet kit CC-3170 Lonza 
Beta-glycerophosphate disodium salt hydrate G5422 Sigma-Aldrich 
Ciprofloxacin 13541640 Fisher Scientific 
Collagen type i rat tail high concentration 100mg 354249 Corning Scientific 
Collagenase type IV 10780004 
ThermoFisher 
Scientific 
Dexamethasone D2915 Sigma-Aldrich 
Dimethylsulphoxide (DMSO) D2650 Sigma-Aldrich 
DNA ladder 
CSL-MDNA-
100BP Cleaver Scientific 
Dulbecco's Modified Eagle Medium (DMEM) 4.5g/L 
glucose w/ LG LZBE12-604F Lonza 
Dulbecco's Modified Eagle Medium (DMEM) 4.5g/L 
glucose w/ LG powder D5648-10L Sigma-Aldrich 
Elastin soluble from bovine neck ligament E6527 Sigma-Aldrich 
EpiVita w/ supplements 511-500 Cell Applications 
Ethanol (absolute) E0650/17 
ThermoFisher 
Scientific 
Ethidium bromide E1510 Sigma-Aldrich 
Ethylene diamine tetra-acetic acid (EDTA) BP2482-1 
ThermoFisher 
Scientific 
Foetal bovine serum (FBS) FB-1001/500 Biosera 
Gel loading dye G2526-5ML Sigma-Aldrich 
Gentamicin sulphate 600I.U./mg 15435139 Fisher Scientific 
High Capacity cDNA Reverse Transcription Kit  4368814 
Applied 
Biosystems 
Human TGF-beta 3 (E. coli) 100-36E PeproTech 
Indomethacin I7378 Sigma-Aldrich 
Insulin, Transferrin, Selenium (ITS) I3146 Sigma-Aldrich 
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L-Glutamine BE17-605E Lonza 
L-Proline P5607 Sigma-Aldrich 
LHC-9 12680013 
ThermoFisher 
scientific 
LIVE/DEAD Viability/Cytotoxicity Kit 10237012 Invitrogen 
MEM Eagle NEAA (100X) LZBE13-114E Lonza 
Oil Red O O0625 Sigma-Aldrich 
Pen/Strep/Fungizone 10K/10K/25ug LZ17-745E Lonza 
Penicillin/Streptomycin LZDE17-603E Lonza 
Phosphate buffered saline  LZBE17-516F Lonza 
Phycoerythrin conjugated antibodies CD105 130-098-845 Miltenyi Biotec 
Phycoerythrin conjugated antibodies IgG1isotype 130-098-849 Miltenyi Biotec 
Phycoerythrin conjugated antibodies IgG2a isotype 130-098-849 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD14 130-098-167 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD19 130-098-168 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD34 130-098-140 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD45 130-098-141 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD73 130-097-932 Miltenyi Biotec 
Phycoerythrin conjugated antibody CD90 130-098-906 Miltenyi Biotec 
Phycoerythrin conjugated antibody HLA-DR 130-098-177 Miltenyi Biotec 
PicoGreen dsDNA quantification kit 10398702 Invitrogen 
Proteinase K EO0491 Thermo Fisher 
QuantiFast SYBR Green PCR kit  204054 Qiagen 
RNeasy Minikit 74104 Qiagen 
Sodium pyruvate S8636 Sigma-Aldrich 
Thincerts cell culture inserts, 0.4µm pore diameter 665641 Greiner Bio-one 
Tris Acetate-EDTA buffer T9650-4L Sigma-Aldrich 
TRIzol Reagent 15596026 
ThermoFisher 
Scientific 
TrypLE Express Enzyme  12604013 
ThermoFisher 
scientific 
Trypsin/Versene (EDTA) LZBE02-007E Lonza 
UltraPure DNase/RNase-Free Distilled Water 10977049 
ThermoFisher 
Scientific 						
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Table	2.2	List	of	equipment	and	suppliers	used	in	experimental	work	
Equipment Supplier 
TEER Millicell ERS-2 
Plate reader BioTek Synergy 2 
OCT Thorlabs 
PCR machine Agilent Technologies Stratagene Mx3000P 
Thermal cycler  MJ Research PTC-200 Thermal Cycler Laser	confocal	microscope  Olympus FluoView 1200 
Phase contrast inverted microscope Olympus CKX41 
Nanodrop ThermoScientific 		
2.2 Cell	culture	
To	maintain	sterility	all	 cell	procedures	were	handled	 in	a	class	 II	microbiology	safety	cabinet	using	sterile	equipment.	Unless	otherwise	stated	all	cells	were	cultured	in	media	high	glucose	DMEM	4.5g/L	glucose	with	L-glutamine	supplemented	with	10%	FBS	and	1%	Penicillin	 5.000	U/ml	 Streptomycin	 5.000	U/ml,	 henceforth	 referred	 to	 as	 culture	media.	All	cells	were	expanded	in	a	humidified	incubator	at	37°C	in	the	presence	of	5%	CO2	and	95%	air.	The	cell	 lines	and	primary	cells	used	 for	experiments	are	detailed	 in	Table	2.3.											
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Table	2.3	Cells	cultured	for	experiments.	
Cell	type	 Description	 Origin	
A549	
Human	 lung	 type	 II	 alveolar	 epithelial	 cell	line	 ATCC	
35FL	
Human	 lung	 fibroblasts	 originating	 from	a	35-year-old	 female	 lung.	 The	 cells	 have	been	 retrovirally	 infected	 to	 express	telomerase	rendering	the	cells	immortal.	
Coriell	Institute	for	Medical	Research	177.	
IMR-90	
Human	 lung	 fibroblast	 originating	 from	 a	16-week	gestational	aged	foetus.	 ATCC	
NLF	
Human	 lung	 cells	 extracted	 from	 the	tracheal	aspirate	of	endotracheal	ventilated	babies.	
Tracheal	aspirates	from	suctioning	of	ventilated	neonates	as	part	of	clinical	care	during	NICU	admission.	
aMSCs	
Human	amnion	mesenchymal	stem	cells		 Extracted	from	the	amniotic	membrane	of	a	healthy	human	term	placenta.	
cMSCs	
Human	chorion	mesenchymal	stem	cells		 Extracted	from	the	chorion	membrane	of	a	healthy	human	term	placenta.		
2.2.1 Trypsinisation	and	sub-culture	Cells	were	sub-cultured	when	70-90%	confluency	was	achieved.	Cells	in	a	T75	flask	were	gently	washed	with	PBS	before	adding	0.05%	(w/v)	trypsin/0.02%	(w/v)	EDTA	solution	and	incubated	at	37°C.	Trypsinisation	was	checked	under	a	light	microscope	to	observe	cells	becoming	rounded	and	detached	from	the	flask	surface.	The	flask	was	tapped	against	
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the	hand	palm	to	ensure	all	cells	were	dislodged.	Cell	culture	medium	was	added	to	the	flask	to	neutralize	the	trypsin.	The	cell	suspension	was	removed	into	a	15ml	centrifuge	tube	and	centrifuged	at	1200	rpm	for	3	minutes	to	form	a	cell	pellet.	The	supernatant	was	aspirated	and	cells	re-suspended	in	culture	media.	Cells	35FL,	IMR90,	aMSCs,	cMSCs	and	NLF	were	sub-cultured	at	a	split	ratio	of	1:4.	Cells	A549	were	sub-cultured	at	a	ratio	of	1:20.	Medium	was	changed	every	2-3	days		
2.2.2 Cell	cryopreservation	and	recovery	For	cell	preservation,	all	cells	were	trypsinised	as	described	in	2.2.1	and	resuspended	in	1ml	freezing	medium	(composed	of	culture	medium	supplemented	with	10%	DMSO)	per	1x106	 cells.	1ml	 cell	 suspension	was	placed	 into	 cryovials	 and	 frozen	at	 -80°C	using	a	CoolCell	cell	freezing	container	(BioCision)	to	control	cooling	at	a	rate	of	-1°C	per	minute.	Cells	 were	 transferred	 to	 liquid	 nitrogen	 24	 hours	 later	 for	 long	 term	 storage.	When	necessary	cryopreserved	cells	were	recovered	by	removing	the	required	cryovial	 from	liquid	 nitrogen	 and	 thawing	 in	 a	 water	 bath	 at	 37°C.	 Once	 thawed	 the	 cells	 were	resuspended	in	cell	culture	medium	in	T75	flasks.	The	cells	were	incubated	at	37°C	for	24	hours	after	which	the	medium	was	replaced	to	remove	the	remaining	DMSO.				
2.2.3 Haemocytometer	cell	counting	All	cell	counts	were	achieved	by	trypsinizing	(as	described	in	2.2.1)	to	attain	a	uniform	cell	suspension.	10µl	of	cell	suspension	was	pipetted	under	the	cover	slip	on	a	Neubauer	haemocytometer	by	capillary	action.	If	trypan	blue	exclusion	assay	was	being	used	10µl	of	 trypan	 blue	was	 added	 to	 10µl	 cell	 suspension	 before	 being	 added	 to	 a	 Neubauer	haemocytometer.	The	mean	average	cell	count	was	achieved	by	counting	the	cells	within	4,	 1mm2	 corner	 regions	 under	 a	 phase	 contrast	 microscope.	 The	 mean	 average	 cell	number	was	multiplied	by	104	to	give	cells/ml	and	then	multiplied	by	the	volume	of	cell	
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suspension	in	ml	to	give	total	cell	count.	If	trypan	blue	was	used	the	dilution	factor	was	taken	into	account.	
	
2.3 Human	neonatal	tracheal	cell	extraction	and	culture	
2.3.1 Sample	collection	Ethical	approval	was	sought	for	a	pilot	study	to	collect	lung	tracheal	aspirates	from	infants	on	 endotracheal	 ventilation	 at	 UHNM	 NICU,	 REC	 reference	 number	 16/WA/0265	(appendix	A	and	B).	Once	 informed	consent	was	achieved	 the	 tracheal	 suctioning	was	collected	 from	patients	as	per	routine	practice.	Samples	were	 labelled	by	medical	staff	with	 a	 unique	 ID	 number	 and	 stored	 at	 room	 temperature	 ready	 for	 collection	 and	transportation	to	the	Guy	Hilton	research	Centre	Laboratory	for	processing	immediately	(Figure	2.2).	Once	the	suctioned	material	entered	the	 laboratory,	samples	were	 logged	and	 given	 a	 unique	 HTA	 (Human	 Tissue	 Act)	 appropriate	 number.	 This	 number	 was	designed	by	using	the	following	information	(Figure	2.1):	initials	of	research	group	lead	(PW),	patient	number	(1-6),	sample	number	from	that	patient	(1-4),	cell	culture	surface	(tissue	culture	plastic,	P	or	collagen,	C).	Patients	remained	anonymous	 throughout	 the	experiment	work.		
	
Figure	2.1	Human	tissue	labelling	method.	
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Figure	2.2	Tracheal	aspirate	collected	from	an	infant	on	ventilation	at	UHNM	NICU			
2.3.2 Sample	processing	Tracheal	suctions	were	transfer	to	a	12ml	centrifuge	tube	and	centrifuged	at	400	g	for	20	minutes.	Supernatant	was	aspirated	and	stored	at	-80°C.	The	pellet	was	resuspended	in	1ml	growth	medium	and	a	cell	 count	was	performed	with	 trypan	blue	as	described	 in	section	2.2.3.	Cells	were	seeded	at	200,000	cells/well	of	a	24	well	plate	with	1ml	of	culture	medium	(high	glucose	DMEM	4.5g/L	glucose	with	L-glutamine	supplemented	with	10%	FBS	 and	 1%	 Pen/Strep/Fungizone)	 at	 37°C.	 After	 1	 hour	 of	 culture	 it	 was	 anticipated	fibroblasts	 would	 have	 attached	 so	 the	 supernatant	 of	 each	 well	 was	 aspirated	 and	transferred	to	a	collagen	coated	well	of	a	24	well	plate	to	encourage	the	attachment	of	epithelial	cells.	A	representative	 flow	diagram	of	the	sample	processing	can	be	seen	 in	Figure	2.3.	Samples	were	checked	daily	with	phase	contract	microscopy	to	observe	cell	attachment	and	proliferation.	
	
Figure	2.3	Flow	diagram	demonstrating	the	processing	of	tracheal	aspirates.	
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2.3.3 Fibroblast	cell	culture	Cells	 isolated	from	the	lung	tracheal	aspirates,	henceforth	called	NLF,	were	cultured	at	37°C	in	a	humidified	incubator	with	growth	media	at	5%	CO2	and	95%	air	37°C.	Once	90%	confluency	was	achieved	cells	were	trypsinised,	counted	and	reseeded	(as	described	in	section	2.2.1)	in	a	T75	culture	flask	at	a	1:4	split	ratio.	At	each	passage	cells	were	also	cryopreserved	as	described	previously	in	section	2.2.2.			
2.3.4 Epithelial	cell	culture	To	encourage	epithelial	cell	growth	3	types	of	commercially	available	lung	epithelial	cell	culture	media	were	obtained	(Table	2.4).	The	samples	were	processed	as	described	in	2.3.2	but	this	time	the	pellet	was	resuspended	in	specific	epithelial	cell	culture	media	to	encourage	lung	epithelial	growth.	Media	changes	were	completed	every	3-4	days.													
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Table	2.4	Commercial	culture	media	used	to	promote	the	growth	of	human	 lung	
epithelial	cells.	
Epithelial	
media	name	
Description	 Source	
LHC-9	
Serum	 free	 media	 used	 for	 bronchial	epithelial	cells	 ThermoFisher	Scientific,	UK		
EpiVita	w/	
supplements	
EpiVita	 Basal	 Medium	 used	 in	 conjunction	with	 Human	 Bronchial/Tracheal	 Epithelial	Cell	Growth	Supplement	
Cell	Applications,	Inc.	San	Diego,	US	
BEGM	bullet	
kit	
BEGMTM	 Bronchial	 Epithelial	 BulletKitTM	containing	 BEBMTM	 Bronchial	 Epithelial	 Cell	Growth	Basal	Medium	and	BEGMTM Bronchial	Epithelial	Cell	Growth	Medium	SingleQuotsTM	Supplements	and	Growth	Factors.	
Lonza,	UK	
	
	
2.4 Human	placenta	MSC	extraction	and	culture	
2.4.1 Placenta	processing	and	MSC	extraction	Ethical	 approval	 was	 sought	 to	 collect	 placentas	 from	 routine	 caesarean	 sections	 at	UHNM,	 REC	 reference	 number	 15/WM/0342	 (appendix	 C).	 The	 term	 placentas	 were	collected	 and	 processed	 immediately,	 following	 the	 arrival	 of	 the	 placenta	 at	 the	laboratory,	in	a	class	II	laminar	flow	hood	to	prevent	contamination.	The	MSC	isolation	procedure	was	based	on	a	previous	published	protocol165.	An	X-shaped	incision	was	made	from	the	umbilical	cord	towards	the	outer	sides	of	the	placenta.	The	amnion	membrane	was	gently	peeled	off	and	placed	in	PBS	to	prevent	drying.	The	chorion	membrane	was	cut	 away	 from	 the	 placenta	 and	 placed	 into	 PBS	 (Figure	 2.4).	 Both	membranes	were	
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thoroughly	washed	in	PBS,	cut	into	smaller	pieces	(around	2cm2	squares)	and	any	blood	clots	gently	 removed.	The	membranes	were	placed	 into	 trypsin-EDTA	 for	1	hour	with	vigorous	shaking	every	20	minutes,	after	which	the	maternal	tissue	was	removed	from	the	chorion	membrane	using	tweezers.	All	membranes	were	washed	thoroughly	in	PBS	and	placed	into	serum	free	medium	containing	10%	collagenase	IV	and	incubated	at	37°C	until	 the	membranes	were	digested.	The	digest	solution	was	centrifuged	at	250G	for	5	minutes.	The	supernatant	was	removed,	the	pellet	resuspended	in	PBS	and	the	solution	centrifuged	as	before.	The	pellet	was	resuspended	in	culture	media	(high	glucose	DMEM	4.5g/L	glucose	with	L-glutamine	supplemented	with	10%	FBS	and	1%	Pen/Strep)	divided	into	three	T175	cell	culture	flasks	for	each	membrane	and	incubated	at	37°C.	A	medium	change	 was	 performed	 2	 hours	 after	 plating	 the	 cells	 to	 remove	 any	 contaminating	epithelial	cells.		
	
Figure	2.4	Isolation	of	Placenta	derived	MSCs.	Whole	placenta	(labelled	P)	at	arrival	into	laboratory	with	the	umbilical	cord	(labelled	U)	(A).	An	X-shaped	incision	was	made	into	the	amnion	membrane	where	the	umbilical	cord	met	the	placenta	(B),	the	chorion	membrane	(labelled	CM)	(C),	and	the	amnion	membrane	(labelled	AM)	were	lifted	away	
(D).		
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2.4.2 Placenta	MSC	culture	and	expansion	Placenta	derived	amnion	MSCs	(aMSCs)	and	chorion	MSCs	(cMSCs)	were	cultured	 in	a	humidified	incubator	at	37°C	in	the	presence	of	5%	CO2	and	95%	air	(Figure	2.5).	Culture	medium	(high	glucose	DMEM	4.5g/L	glucose	with	L-glutamine	supplemented	with	10%	FBS	and	1%	Pen/Strep)	was	changed	every	2-3	days	and	cells	were	sub-cultured	once	80-90%	confluency	was	achieved	using	the	previously	described	method	(section	2.2.1).		
	
Figure	2.5	Isolated	placenta	MSCs.	MSCs	were	isolated	from	the	chorion	membrane	(A)	and	the	amnion	membrane	(B)	of	a	healthy	full-term	placenta.	The	MSC	cells	are	elongated	with	a	spindly-morphology.	Smaller	rounded	cells	can	be	observed	with	the	cMSCs	(A).	These	cells	are	likely	to	be	epithelial	cells	which	would	later	be	removed	through	media	changes.			
2.5 Tri-lineage	differentiation	to	assess	MSC	functionality	
The	differentiation	potential	of	placenta	derived	MSCs	was	determined	by	seeding	4x104	cells/well	in	a	24	well	plate	in	culture	media.	Cell	were	incubated	overnight	to	allow	for	cell	attachment.	Cells	were	then	cultured	in	the	appropriate	differentiation	media	for	21	days	with	media	 changes	 every	 3-4	 days.	 For	 controls,	 cells	were	 seeded	 in	 the	 same	manner	and	maintained	with	culture	media.			
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2.5.1 Chondrogenic	differentiation	For	chondrogenic	differentiation	1x105	cells	in	7µl	of	medium	was	seeded	as	a	micromass	in	 the	 centre	 of	 a	 well.	 After	 1-2	 hours	 for	 cell	 attachment	 cells	 were	 cultured	 with	chondrogenic	media	consisting	of	DMEM	high	glucose,	1%	FBS	(v/v),	1%	ITS	(v/v),	0.1µM	dexamethasone,	50µM	ascorbic	acid	phosphate,	40µg/ml	L-proline	and	10ng/ml	TGF-b3.		
2.5.2 Adipogenic	differentiation	Adipogenesis	was	induced	with	DMEM	high	glucose	supplemented	with	10%	FBS,	0.5µM	dexamethasone,	 0.5mM	 3-isobutyl-1-methylxanthine,	 10µg/ml	 insulin	 and	 0.1mM	indomethacin.		
2.5.3 Osteogenic	differentiation	Cells	 seeded	 for	 osteogenesis	 were	 cultured	 with	 DMEM	 supplemented	 with	 50µM	ascorbic	acid	phosphate,	10mM	b-glycerophosphate	and	0.1µM	dexamethasone.		
2.6 Histological	staining	of	tri-lineage	differentiation	
Following	3	weeks	of	culture	cells	were	fixed	using	10%	formalin	for	20	minutes	at	room	temperature,	washed	with	PBS	and	stored	at	4°C	until	staining.		
2.6.1 Stain	preparation:	alizarin	Red,	oil	red	O	and	alcian	Blue	1%	Alizarin	Red	solution	was	prepared	by	dissolving	0.5g	of	Alizarin	Red	in	50ml	of	dH2O	and	 filtered	 through	Whatman	 filter	paper	grade	1	 .	A	stock	solution	of	Oil	Red	O	was	prepared	by	dissolving	0.175g	of	Oil	Red	O	powder	 in	50ml	of	100%	 isopropanol	and	filtered	 using	 filter	 paper.	 Before	 each	 use,	 a	 40%	working	 solution	was	 prepared	 by	dissolving	 the	 stock	 solution	 in	 dH2.	 O.	 1%	 Alcian	 Blue	 solution	 was	 prepared	 by	
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dissolving	0.5g	of	Alcian	Blue	8GX	in	50ml	of	3%	acetic	acid	(pH	1.5).	Solution	was	filtered	using	filter	paper.		
2.6.2 Histological	staining		Mineral	deposition	of	osteo-induced	cells	was	determined	using	Alizarin	Red	solution.	Stain	was	added	to	cells	and	incubated	at	room	temperature	for	10	minutes.	The	stain	was	removed,	and	cells	were	washed	3	times	with	tap	water	and	imaged.	For	adipogenesis	cells	were	washed	with	isopropanol	before	adding	Oil	Red	O	solution	for	10	minutes	at	room	temperature.	The	stain	was	removed,	and	the	cells	washed	with	isopropanol.	Cells	were	imaged	immediately.	The	chondrogenic	cells	were	incubated	with	Alcian	Blue	over	night	at	room	temperature.		Samples	were	then	washed	three	times	were	tap	water	and	imaged.	All	samples	were	imaged	using	an	inverted	light	microscope	with	attached	colour	CCD	camera.		
2.7 LIVE/DEAD	viability/cytotoxicity	assay	Kit		
The	LIVE/DEAD	Viability/Cytotoxicity	Assay	Kit	for	mammalian	cells	(Invitrogen)	allows	the	 simultaneous	determination	of	 live	 and	dead	 cells.	The	kit	 encompasses	2	probes,	calcein	 AM	 and	 ethidium	 homodimer	 (EthD-1),	 which	 detect	 intracellular	 esterase	activity	and	plasma	membrane	integrity	respectively.	Cells	were	prepared	by	removing	culture	media	and	washing	samples	twice	with	PBS.	The	staining	solution	was	prepared	by	diluting	2µl	 of	2mM	EthD-1	 stock	 solution	and	0.5µL	of	 the	4mM	calcein	AM	stock	solution	into	1ml	of	PBS.	An	appropriate	volume	of	the	staining	solution	was	added	to	cover	 samples.	The	 samples	were	 left	 at	37°C	 for	30-45	minutes.	Before	 imaging	on	a	confocal	microscope,	the	staining	solution	was	aspirated	and	samples	were	gently	washed	with	PBS.	A	small	volume	of	PBS	was	left	on	the	samples	to	prevent	them	drying	out	whilst	imaging.	
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2.8 Flow	cytometry	
Placenta	derived	MSCs	were	cultured	in	growth	media	in	T25	culture	flasks	at	37°C	until	confluency	was	achieved	(as	described	in	section	0).	Cells	were	trypsinised	(section	2.2.1)	and	the	cell	pellet	resuspended	in	11ml	flow	cytometry	buffer	(PBS	with	0.5%	(w/v)	BSA	and	2mM	EDTA)	and	approximately	1x105	cells	aliquoted	into	microcentrifuge	tubes.	The	samples	were	centrifuged	at	300	g	for	5	minutes	and	supernatant	discarded.	Each	pellet	was	resuspended	in	PE	(phycoerythrin)conjugated	antibodies	(CD14,	CD19,	CD34,	CD45,	CD73,	 CD90	 and	 CD105,	 HLA-DR,	 IgG1	 and	 IgG2a	 isotype	 controls)	 diluted	 in	 flow	cytometry	buffer and incubated	 in	at	4°C	for	15minutes.	1ml	buffer	was	added	to	each	samples	and	samples	were	centrifuged	again.	The	supernatant	was	discarded,	and	 the	pellet	was	resuspended	 in	200µl	PBS	and	transferred	to	 the	Beckton	Dickinson	FC500	flow	cytometer	for	analysis.	A	minimum	of	50,000	events	was	recorded	and	analysed	by	gating	positive	events	to	exclude	99%	of	the	appropriate	 isotype	control	events	(IgG1:	CD19,	CD73,	CD90	and	CD105,	IgG2a:	CD14,	CD34,	CD45,	HLA-DR) 		
2.9 Hydrogels	
Collagen	hydrogels	were	prepared	according	 to	 the	manufactures	protocol	except	 that	10X	 DMEM	 replaced	 10X	 PBS	 to	 provide	 the	 cells	 with	 appropriate	 nutrients	 for	 cell	survival	and	proliferation.	10X	DMEM	was	prepared	by	dissolving	50g	DMEM	powder	and	3.7g	sodium	bicarbonate	into	100	mL	sterile	deionised	water.	Elastin	solution	was	also	included	into	the	collagen	gelation	procedure	as	described	in	previous	published	work97.	A	10mg/ml	elastin	stock	solution	was	prepared	by	dissolving	0.1g	soluble	elastin	in	10ml	sterile	deionised	water.	1N	NaOH	which	neutralises	 the	collagen	to	allow	gelation	was	prepared	by	dissolving	2g	of	NaOH	in	25	mL	sterile	deionised	water.	All	solutions	were	sterile	 filtered	 in	a	 flow	hood	using	a	 syringe	and	0.2	micron	 filter	 (Millipore,	USA)	 to	remove	impurities.	The	collagen,	10X	DMEM,	sterile	dH2O	and	1N	NaOH	were	placed	on	
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ice	until	ready	to	use.	The	appropriate	volumes	of	each	reagent	were	calculated	using	the	following	formulas:		𝑉𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	10𝑋𝐷𝑀𝐸𝑀 = 01234	564789	6:	;94	<647=162>? 		𝑉𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	𝑐𝑜𝑙𝑙𝑎𝑔𝑒𝑛 = :1234	564789	6:	<647=162	×	:1234	E6443;92	E62E92=F3=162<=3F=12;	E6443;92	<647=162	 		𝑉𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	1𝑁	𝑁𝑎𝑂𝐻 = 𝑣𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	𝑐𝑜𝑙𝑙𝑎𝑔𝑒𝑛	𝑔𝑒𝑙	𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛	 × 	0.023		𝑉𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	𝑒𝑙𝑎𝑠𝑡𝑖𝑛	𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛 = :1234	564789	6:	;94	<647=162	×	:1234	943<=12	E62E92=F3=162<=3F=12;	943<=12	E62E92=F3=162 		𝑉𝑜𝑙𝑢𝑚𝑒	𝑜𝑓	𝑑𝐻2𝑂 = 𝐹𝑖𝑛𝑎𝑙	𝑔𝑒𝑙	𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛	𝑣𝑜𝑙𝑢𝑚𝑒 − (𝑐𝑜𝑙𝑙𝑎𝑔𝑒𝑛	𝑣𝑜𝑙𝑢𝑚𝑒 +																																					10 × 𝐷𝑀𝐸𝑀	𝑣𝑜𝑙𝑢𝑚𝑒 + 1𝑁	𝑁𝑎𝑂𝐻	𝑣𝑜𝑙𝑢𝑚𝑒 + 𝑒𝑙𝑎𝑠𝑡𝑖𝑛	𝑣𝑜𝑙𝑢𝑚𝑒)				Each	component	was	added	to	a	sterile	tube	held	on	ice	in	the	following	order:	10xDMEM,	1N	 NaOH,	 elastin,	 dH2O	 and	 finally	 the	 collagen.	 For	 collagen	 only	 hydrogels	 (i.e.	 no	elastin)	elastin	was	omitted	from	the	calculations.	The	contents	were	mixed	thoroughly	but	caution	was	taken	to	avoid	introducing	bubbles.	For	hydrogels	containing	cells,	the	appropriate	 number	 of	 cells	 was	 trypsinised	 (as	 described	 in	 2.2.1)	 and	 pelleted	 by	centrifugation.	The	supernatant	was	aspirated	and	200-300µl	of	 	collagen	solution	was	then	added	to	the	cell	pellet	and	mixed	before	adding	to	the	remaining	collagen	solution.	The	 solution	was	mixed	 by	 pipetting	 up	 and	 down	 gently	 but	 swiftly	 to	 avoid	 the	 gel	setting.	 An	 appropriate	 volume	 of	 collagen	 solution	was	 then	 pipetted	 into	 the	 tissue	culture	plate	or	cell	culture	well	insert	(Figure	2.6).	The	gels	were	allowed	to	set	at	37°C	for	 30	 minutes	 to	 1	 hour	 before	 culture	 medium	 was	 added.	 Medium	 changes	 were	performed	every	2-3	days	being	careful	not	to	disturb	the	gel.			
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	2:	Materials	&	Methods	
	 47	
	
Figure	 2.6	 Cell	 seeded	 collagen-elastin	 hydrogel.	 Collagen-elastin	 hydrogels	(concentration	 3.5mg/ml)	 seeded	with	 35FL	were	 set	 within	 	 ThinCert™	 12	well	 cell	culture	inserts	PET	(polyethylene	terephthalate),	0.4μm	pore	size.	Scale	bar	15mm.			
2.10 Gel	measurements	
Hydrogel	depth	and	diameter	were	measured	noninvasively	every	5	days	during	culture	(Figure	 2.7).	 Hydrogel	 diameter	 was	 measured	 using	 a	 ruler	 placed	 underneath	 the	culture	plate	(Figure	2.7	B).	A	commercially	available	spectral	domain	optical	coherence	tomography	(OCT)	(Thorlabs)	was	used	to	determine	the	gel	depth.	Changes	in	hydrogel	dimensions	were	measured	in	millimetres	and	percentage	change	was	calculated	using	the	 following	equation	 (where	day	𝜒	can	represent	any	other	day	a	measurement	was	taken):		%	𝑐ℎ𝑎𝑛𝑔𝑒	𝑖𝑛	𝑑𝑒𝑝𝑡ℎ = 𝑑𝑎𝑦	0	𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡	(𝑚𝑚) ÷ 𝑑𝑎𝑦	𝜒	𝑚𝑒𝑎𝑠𝑢𝑟𝑒𝑚𝑒𝑛𝑡	(𝑚𝑚) × 100	
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Figure	 2.7	 Measuring	 hydrogel	 depth	 and	 diameter.	 The	 Thorlabs	 OCT	 imaging	system	(A)	scans	a	collagen	hydrogel	within	a	tissue	culture	well	plate	(B)	and	provides	a	 computerised	 2D	 cross-sectional	 image	 of	 the	 collagen	 hydrogel	 (C)	 that	 can	 be	measured	 using	 the	 ThorImageOCT	 software.	 Hydrogel	 diameter	 is	measured	 using	 a	ruler	placed	underneath	the	tissue	culture	plate	of	the	hydrogel	(B).		
2.11 Two-step	real-time	PCR	
2.11.1 RNA	extraction	Two	different	methods	of	RNA	extraction	were	compared:	the	TRIZOL	method	and	the	RNeasy	kit.	 Six	3.5mg/ml	 collagen-elastin	 (at	 a	1:1	 ratio)	hydrogels	 seeded	with	35FL	were	made	using	 the	protocol	 described	 in	 section	2.9.	 Before	 gelation	1x105cells/gel	were	 resuspended	 in	 the	 solution	 and	 500µl	 was	 pipetted	 into	 a	 12	 well	 plate.	 The	
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samples	were	incubated	at	21%	oxygen	37°C	for	24	hours.	Three	hydrogels	for	each	group	underwent	the	appropriate	treatment	for	either	the	TRIZOL	RNA	extraction	procedure	or	the	RNeasy	kit.		
2.11.1.1 RNA	extraction:	TRIZOL	method	Hydrogels	 were	 placed	 into	 1ml	 of	 TRIZOL	 reagent	 in	 a	 microcentrifuge	 tubes	 and	incubated	 for	 5	minutes	 at	 room	 temperature.	 200µl	 of	 chloroform	was	 added	 to	 the	samples	and	shaken	vigorously	for	15	seconds.	The	samples	were	centrifuged	at	10,000	rpm	 for	 15	 minutes	 at	 4°C	 at	 which	 point	 the	 mixture	 separates	 into	 lower	 organic,	interphase	and	upper	aqueous	phase	containing	the	RNA.	The	upper	aqueous	phase	was	transferred	into	a	fresh	microcentrifuge	tube.	500µl	of	100%	isopropanol	was	added	to	each	 sample	 and	 incubated	 at	 room	 temperature	 for	 20	 minutes.	 The	 samples	 were	centrifuged	at	10,000rpm	for	10	minutes	at	4°C.	The	supernatant	was	removed	by	tipping	to	avoid	disturbing	the	precipitated	pellet.	1ml	of	75%	ethanol	was	added	to	the	pellet	and	the	samples	were	vortexed	briefly.	The	samples	were	centrifuged	at	7500	rpm	for	5	minutes	at	4°C	and	the	remaining	ethanol	was	aspirated.	The	pellets	are	left	to	air	dry	until	 the	 ethanol	 has	 evaporated.	 The	 remining	 pellet	 were	 gently	 mixed	 in	 15µl	RNase/DNase	free	H2O	and	incubated	at	55°C	in	a	water	bath.	The	RNA	concentration	was	measured	 using	 a	 NanoDrop	 2000	 spectrophotometer	 (Thermo	 Scientific)	 instrument	and	the	samples	stored	at	-80°C.		
2.11.1.2 RNA	extraction:	RNeasy	kit	Total	RNA	extraction	was	performed	using	the	RNeasy	mini	kit	(Qiagen).	For	collagen	gels	medium	was	aspirated	and	discarded.	The	gels	were	gently	removed	using	tweezers	and	placed	into	microcentrifuge	tubes	containing	350µl	RLT	lysis	buffer.	Samples	were	left	for	
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20-30	minutes	and	briefly	vortexed	occasionally	until	the	gels	had	been	digested.	For	cells	in	monolayer,	medium	was	removed	and	350µl	RLT	buffer	was	added	directly	to	cells	and	left	 for	20-30	minutes.	Cell	 lysate	was	pipetted	into	microcentrifuge	tubes.	All	samples	were	stored	at	-80°C	until	ready	for	extraction	protocol.			Hydrogel	RLT	buffer	 lysate	were	placed	on	 ice	 for	 thawing.	350µl	of	70%	ethanol	was	added	 to	 lysate	 and	 mixed	 by	 pipetting.	 The	 solution	 was	 added	 to	 the	 RNeasy	 spin	column	and	centrifuged	for	15	seconds	at	17,000	g.	The	flow	through	was	discarded	and	the	 column	 membrane	 was	 washed	 using	 the	 appropriate	 buffers	 according	 to	 the	manufactures	protocol	and	centrifuged	at	17,000	g.	All	flow	through	was	discarded	after	each	centrifugation.	After	the	final	buffer	was	discarded	the	collection	tube	was	replaced	with	a	clean	1ml	centrifuge	tube.	15µl	of	RNase	free	water	(provided	by	the	manufacture)	was	added	to	the	spin	column	to	elute	the	RNA.	The	spin	column	was	centrifuged	for	1	minute	at	17,000	g.	The	eluted	water	was	then	re-added	onto	the	spin	column	membrane	and	the	tube	was	centrifuged	again	at	17,000	g	for	1	minute.	Extracted	RNA	concentration	was	quantified	using	the	Nanodrop	and	stored	at	-80°C	freezer.			
Table	2.5	RNA	extracted	 from	collagen	hydrogels	 seeded	with	35FL	human	 lung	
fibroblasts.	Two	RNA	extraction	methods	were	compared;	TRIZOL	method	and	RNeasy	kit.	 One	 sample	 from	 the	 TRIZOL	 method	 was	 lost	 during	 the	 procedure	 so	 no	quantification	could	be	achieved.			 TRIZOL	method	 RNeasy	method	
Sample	 Nucleic	acid	(ng/µl)	 260/280nm	 Nucleic	acid	(ng/µl)	 260/280nm	
1	 14.2	 1.92	 19.1	 2.07	2	 15.8	 1.94	 20.4	 2.09	3	 -	 -	 13.8	 2.05		
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2.11.2 Comparing	RNA	extraction	methods	Both	 the	 TRIZOL	 method	 and	 RNeasy	 kit	 extracted	 RNA	 from	 the	 collagen-elastin	hydrogels.	One	 sample	 from	 the	TRIZOL	method	was	 lost	 during	 the	procedure	 so	no	quantification	could	be	achieved.	This	method	required	more	handling	time	and	was	a	more	difficult	procedure	compared	with	the	RNeasy	method.	The	RNeasy	kit	produced	higher	quantities	of	nucleic	acid	whilst	maintaining	a	high	purity	(Table	2.5,	indicated	by	the	260/280nm	ratio)	and	was	used	henceforth	for	RNA	extraction.		
2.11.3 Reverse	transcription-	cDNA	synthesis	The	RNA	samples	were	diluted	in	RNase/DNase	free	water	to	a	concentration	of	1µg/µl.	The	 Thermo	 Fisher	 high	 capacity	 cDNA	 reverse	 transcription	 kit	 was	 used.	 The	appropriate	 volume	 of	 2x	 reverse	 transcription	master	mix	was	made	 by	 preparing	 a	solution	 of	 RT	 buffer,	 dNTP	 mix,	 10x	 RT	 random	 primers,	 MultiScribe™	 Reverse	Transcriptase	and	Nuclease-free	H2O.	This	master	mix	was	added	to	a	microcentrifuge	tube	with	the	extracted	RNA	to	make	a	1x	solution.	The	samples	were	then	placed	into	a	thermal	cycler	and	set	to	the	following	conditions:	1. 25°C	for	10	minutes	2. 37°C	for	120	minutes	3. 85°C	for	5	minutes	4. 4°C	∞		Samples	were	stored	at	-20°C	until	ready	for	processing.	
 
2.11.4 Primer	design	and	optimisation	Appropriate	primers	associated	with	BPD	were	narrowed	down	by	examining	previous	published	in	vitro	and	in	vivo	work	and	specificity	was	checked	using	NCBI	Primer-BLAST.	Markers	which	were	most	strongly	associated	with	BPD	were	chosen	(listed	in	Table	2.6)	and	 purchased	 from	 Integrated	 DNA	 Technologies.	 RT-PCR	 was	 run	 with	 all	 the	
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established	primers	to	check	for	product	amplification.	The	housekeeping	gene	GAPDH	was	 included.	 Primers	 were	 dissolved	 in	 RNase/DNase-free	 water	 according	 to	 the	manufactures	instructions	to	achieve	100µM.	10µM	stock	solutions	were	stored	at	-20°C.		
Table	2.6	RT-PCR	primer	 sequences.	The	 sense	 and	 antisense	 sequence	of	 primers,	their	annealing	temperature	for	PCR	and	the	product	length	
	
		
2.11.5 Real	time-qPCR		The	QuantiFast	SYBR	Green	PCR	Kit	was	used	to	determine	the	relative	gene	expression	of	mRNA	COL1A,	ELN,	ACTA2,	TGFB1	and	NQO1.	In	short,	1µl	forward	primer,	1µl	reverse	primer,	4µl	RNase	free	water,	1.5µl	cDNA	and	7.5µl	2X	QuantiFast	SYBR	Green	PCR	Master	Mix	were	mixed	in	PCR	tubes.	The	thermal	cycling	protocol	is	demonstrated	in	Figure	2.8.	Relative	gene	expression	in	the	form	of	2^-ΔCT	fold	change	values	were	calculated.  
Gene Sense sequence (5' to 3') Antisence sequence (5' to 3') Annealing temperature 
Product 
length
GAPDH  (Glyceraldehyde-3-
phosphate dehydrogenase) ACTTCAACAGCACACCCACT  GCCAAATTCGTTGTCATACCAG 58 103
ACTA2  (α-smooth muscle 
actin) CCGACCGAATGCAGAAGGA ACAGAGTATTTGCGCTCCGGA 60 88
ELN  (Elastin) GCAGGAGTTAAGCCCAAGG TGTAGGGCAGTCCATAGCCA 60 148
COL1A1  (Collagen type 1) GTCACCCACCGACCAAGAAAC AAGTCCAGGCTGTCCAGGGATG 60 121
TGFB1  (Transforming 
Growth Factor Beta 1) GCGACTCGCCAGAGTGGTTA GTTGATGTCCACTTGCAGTGTGTTA 58 143
NQO1  (NAD(P)H quinone 
dehydrogenase 1) GGTCGGCAGAAGAGCACTGA CCAGAACAGACTCGGCAGGA 60 221
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Figure	 2.8	 qRT-PCR	 thermal	 cycle	 programme.	Segment	 1	 corresponds	 to	 the	 PCR	initial	activation	step,	segment	2	and	3	correspond	to	denaturing	and	annealing.			
2.11.6 Gel	electrophoresis	Gel	electrophoresis	was	used	to	validate	the	primer	design	and	PCR	optimisation.	A	2%	(w/v)	agarose	gel	was	prepared	by	dissolving	agarose	in	1xTAE	(tris-acetate-EDTA)	buffer	using	a	microwave	to	gently	heat	the	solution.	Once	the	agarose	had	dissolved,	8µl	of	ethidium	bromide	was	mixed	into	the	solution	by	swirling.	The	agarose	solution	was	poured	into	the	gel	setting	chamber,	a	comb	was	secured	into	the	chamber	and	the	gel	was	allowed	to	set	for	45	minutes.	The	comb	was	removed	and	the	gel	was	released	from	the	chamber	and	transferred	to	BioRad	electrophoresis	clear	chamber.	1xTAE	solution	was	added	to	the	electrophoresis	chamber	until	the	gel	was	covered.	2.5μL	of	loading	buffer	was	added	directly	to	PCR	samples	and	8µl	of	each	sample	was	pipetted	into	respective	wells	of	the	gel.	5µl	of	DNA	ladder	was	pipetted	into	the	end	wells	(Figure	2.9).	The	chamber	lid	was	attached,	and	conditions	were	set	to	100v,	250mA,	25W	for	1	hour.		
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Figure	2.9	Gel	electrophoresis.	The	DNA	ladder	used	to	compare	DNA	sizes	and	a	photo	of	a	2%	gel	electrophoresis	ran	with	PCR	products	with	loading	dye.			Figure	2.10	shows	a	completed	gel	electrophoresis	used	to	verify	product	length,	primer	specificity	and	annealing	temperature	(A	and	B).	Negative	controls	(containing	no	cDNA	during	amplification)	were	included	(B).	Amplified	genes	produced	single	bands	which	corresponded	with	product	length.	No	bands	were	visualised	for	negative	controls.	
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Figure	 2.10	 Agarose	 gel	 electrophoresis	 of	 PCR	 products	 for	 optimised	 primers	
GAPDH,	 TGFb,	 COL1A1,	 ACTA,	 ELN	 and	 NQO1.	 Showing	 the	 migration	 of	 RT-PCR	products	as	follows	for	image	A:	Lanes	1	and	2:	GAPDH,	3	and	4:	TGFb1,	5	and	6:	ACTA2,	7	and	8:	COL1A1,	9	and	10:	ELN,	11	and	12:	NQO1.	RT-PCR	products	for	image	B:	1,	2	and	3:	COL1A1,	4:	COL1A1	negative,	5,	6	and	7:	NQO1,	8:	NQO1	negative,	9:	ELN	negative,	10:	ACTA2	 negative,	 11:	 GAPDH	 negative,	 12:	 TGFb	 negative.	 A	 molecular	 marker	 was	included	(M).		
2.12 Proteinase	K	digestion	
Proteinase	K	is	a	broad	range	protease	which	digests	proteins.	It	can	therefore	be	used	to	break-down	collagen	hydrogels	and	cell	lysis.	The	proteinase	K	solution	is	provided	at	a	concentration	 of	 20mg/ml	 and	 was	 diluted	 with	 dH2O	 to	 a	 stock	 concentration	 of	2.5mg/ml,	aliquoted	and	stored	at	-20°C.	Once	ready	to	be	used,	the	stock	concentration	is	 thawed	 at	 room	 temperature	 and	 diluted	with	 dH2O	 to	 a	working	 concentration	 of	50µg/ml.	Medium	was	aspirated	from	samples	and	using	sterile	tweezers	collagen	gels	were	carefully	placed	 into	sterile	microcentrifuge	 tubes	containing	0.5ml	proteinase	K	working	solution,	vortexed	briefly	and	placed	in	a	60°C	oven	for	1-2	hours	until	gels	were	
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digested.	 For	 cells	 in	 monolayers,	 medium	 was	 aspirated	 off	 and	 0.5ml	 proteinase	 K	working	solution	was	pipetted	onto	cell	monolayer.	Samples	were	left	at	37°C	for	a	few	minutes	until	cell	 lysis	was	observed	under	phase	contrast	microscope.	The	cell	 lysate	solution	 was	 pipetted	 into	 microcentrifuge	 tubes	 and	 vortexed	 briefly.	 Following	digestion	all	samples	were	stored	at	-20°C	until	use.			
2.13 Quant-iT™	PicoGreen™	dsDNA	assay	
The	PicoGreen	dsDNA	assay	allows	the	quantification	of	double	stranded	DNA	from	cell	lysate.	Cell	lysate	from	proteinase	K	digestion	(section	2.12)	was	left	to	thaw	on	ice.	1X	Tris-EDTA	 (TE)	 buffer	 was	 prepared	 by	 diluting	 20x	 TE	 in	 sterile	 deionised	 H2O.	 A	standard	curve	was	created	using	the	stock	DNA	provided	with	the	kit	(Table	2.7).		The	PicoGreen	solution	was	prepared	by	diluting	the	PicoGreen	stock	solution	1:200	with	1X	TE	buffer.	50µl	of	the	standards	and	cell	lysate	samples	were	pipetted	into	a	96	well	plate	in	duplicate.	Blanks	were	included	which	consisted	of	the	acellular	gels	digested	using	the	same	proteinase	K	digestion	method.	50µl	of	the	PicoGreen	working	solution	was	then	added	 to	 each	 sample.	 The	 samples	 were	 protected	 from	 light	 before	 measuring	fluorescence	 at	 excitation	480	nm,	 emission	520nm	on	 a	 plate	 reader.	 Concentrations	were	 determined	 by	 plotting	 fluorescence	 emission	 intensity	 versus	 known	 DNA	concentration	using	GraphPad	Prism	7.0a	(Figure	2.11).							
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Table	2.7	PicoGreen	standard	curve	created	to	quantify	DNA	in	unknown	samples	
Standard	
(µg/ml)	
Volume	of	DNA	3µg/ml	working	
solution	(µl)		
Volume	of	1x	TE	buffer	(µl)	
0	 0	 300	0.005	 0.375	 299.625	0.01	 0.75	 299.25	0.05	 1.5	 298.5	0.1	 7.5	 292.5	0.5	 15	 285	1.0	 75	 225	2.0	 150	 150	3.0	 300	 0		
	
Figure	2.11	PicoGreen	ds	DNA	assay	standard	curve				
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2.14 TEER	analysis		
Transepithelial	electrical	resistance	(TEER)	analysis	examines	the	integrity	of	epithelial	monolayers.	TEER	analysis	was	carried	out	on	A549	cells	cultured	in	monolayer	on	well	inserts	 using	 the	 Millipore® RS2 as illustrated in Figure	 2.12.	 Culture	 medium	 was	aspirated	from	samples	and	replaced	with	PBS	within	the	well	and	well	insert.	The	longer	electrode	(E1)	was	inserted	to	the	bottom	of	the	well	plate	and	the	shorter	electrode	(E2)	was	 placed	 within	 the	 well	 insert	 (close	 to	 but	 not	 disturbing	 the	 cells)	 and	 held	horizontally	 at	 90°	 for	 a	 few	 seconds	 whilst	 a	 reading	 was	 recorded.	 Following	 the	measurement,	the	PBS	was	aspirated	and	replaced	with	culture	media.	To	calculate	the	electrical	resistance	the	following	equation	was	used:		 𝑈𝑛𝑖𝑡	𝑎𝑟𝑒𝑎	𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒	(W𝑐𝑚_) = 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒	(W) 	× 	𝑚𝑒𝑚𝑏𝑟𝑎𝑛𝑒	𝑎𝑟𝑒𝑎	(𝑐𝑚_)	
	
Figure	2.12	 Illustration	 showing	 the	 set-up	 to	measure	 transepithelial	 electrical	
resistance	of	cells	cultured	in	monolayer	in	a	well	insert.	The	longer	electrode	(E1)	is	placed	with	the	well	plate	and	the	shorter	electrode	(E2)	is	placed	in	the	well	insert.	The	electrodes	are	held	at	90°	whilst	an	electrical	resistance	reading	is	taken.		
2.15 AlamarBlue®	Assay	
The	 alamarBlue®	 assay	 is	 designed	 to	 measure	 the	 metabolic	 activity	 of	 cells	 by	exploiting	the	reduction	of	resazurin	to	resorufin. The	AlamarBlue	reagent	was	added	to	culture	media	at	a	1:10	dilution.	The	AlamarBlue	solution	was	added	directly	to	the	cells	
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and	 left	 in	 culture	 at	 37°C	 for	 2	 hours	 protected	 from	 light.	 100µl	 of	 the	 alamarBlue	solution	was	removed	from	each	sample	in	duplicate	and	pipetted	directly	into	a	96	well	plate.	Fluorescence	was	measured	on	a	plate	reader	at	excitation	wavelength	of	530nm.	Following	 measurements,	 the	 remaining	 alamarBlue	 solution	 was	 removed	 from	 all	samples	and	replaced	with	fresh	culture	media.		
 
 
2.16 Culturing	cells	at	hyperoxia	
	Cells	 were	 exposed	 to	 a	 hyperoxia	 environment	 using	 a	 previously	 described	method177,178.	 Tissue	 culture	 plates	 were	 placed	 into	 polycarbonate	 containers	 with	sealed	lids	(using	petroleum	jelly	to	make	them	air-tight).	The	containers	were	flushed	with	pre-mixed	gas	of	40%	O2,	5%	CO2,	and	65%	N2	(sourced	from	BOC)	by	pumping	the	gas	into	one	of	the	holes	of	the	container	(Figure	2.13).	After	one	minute	the	empty	hole	was	sealed	using	a	bung.	After	another	2	minutes	the	gas	source	was	removed,	and	a	bung	was	swiftly	placed	into	the	hole	to	seal	the	container.	Containers	were	re-gassed	following	media	changes	or	gel	measuring.	
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Figure	2.13	Exposing	cells	to	hyperoxia.	Cell	culture	well	plates	stacked	within	a	sealed	polycarbonate	air-tight	container.	The	plates	were	inserted	into	the	container	and	the	lid	(L)	was	sealed	using	petroleum	jelly	to	make	it	air-tight.	A	tube	leading	from	a	gas	cylinder	container	 pre-mixed	 40%	 oxygen	 gas	 (G)	was	 fed	 into	 one	 of	 the	 holes	 (H).	 Gas	was	pumped	into	the	container	(arrow)	and	after	1	minute	the	top	hole	was	sealed	using	a	bung	(B).	After	a	further	2	minutes	the	tube	was	removed,	and	the	second	bung	was	put	into	the	hole	to	seal	the	container	.
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Chapter	3 	Designing	an	in	vitro	model	to	represent	the	lung	alveolus	
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3.1 Introduction	
BPD	can	be	a	life-threatening	condition	for	premature	neonates.	Our	current	knowledge	of	the	disease	has	relied	heavily	on	animal	models	which	do	not	accurately	represent	the	disease	pathogenesis	 in	humans60.	This	has	led	to	a	 limit	 in	our	understanding	of	BPD.	Advances	in	regenerative	medical	methodologies	has	provided	new	ways	to	investigate	diseases	in	vitro.	Collagen	hydrogels	provide	a	3D	biocompatible	scaffold	which	can	mimic	native	tissue.	Collagen	and	elastin	are	key	molecules	found	in	the	lung	mesenchyme.	Both	molecules	provide	mechanical	 capabilities	 to	 allow	expansion	and	 recoil	 of	 the	alveoli	during	breathing.	Collagen	and	elastin	provide	the	lung	architecture	and	are	thought	to	be	 the	driving	 force	of	 lung	maturation.	 It	has	been	demonstrated	 in	BPD,	where	 lung	maturation	 is	 distorted,	 that	 there	 is	 an	 abnormal	 collagen-elastin	 architecture.	 It	 is	therefore	appropriate	that	collagen-elastin	hydrogels	form	the	basis	of	an	in	vitro	model	to	represent	BPD.	Previous	work	from	our	lab	compared	the	Young’s	modules	of	collagen-elastin	 hydrogels	 to	 the	 expected	 Young’s	 modules	 of	 a	 human	 lung	 alveolus	 (Figure	3.1)97.	 	 It	 was	 found	 that	 the	 addition	 of	 lung	 fibroblasts	 and	 elastin	 increased	 the	theoretical	 Young’s	 modules	 value	 for	 a	 single	 alveolar	 wall	 (≈5	kPa).	 Due	 to	 the	advantageous	mechanical	properties	of	collagen-elastin	hydrogels,	this	was	used	as	the	starting	point	to	develop	a	more	complex	alveolar	model.		
 	
Figure	3.1	Young’s	modules	of	collagen	hydrogels.	The	Young’s	modulus	is	improved	with	the	addition	of	soluble	elastin	and	lung	fibroblasts	(Image	sourced	from	Dunphy	et	
al.97).	
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The	human	lung	alveoli	are	a	complex	multicellular	tissue.	The	alveolus	wall	comprises	of	AEC1	and	AEC2	which	are	exposed	to	an	air	interface	to	allow	gas	exchange.	Surrounding	the	lung	alveoli	is	the	pulmonary	mesenchyme	containing	the	lung	fibroblasts	which	are	thought	to	drive	the	collagen	and	elastin	architecture.	Based	on	this	design	we	proposed	an	in	vitro	model	which	would	represent	the	multicellular	lung	alveolus	whilst	providing	an	air	interface	(Figure	3.2).			
	
Figure	3.2	Designing	an	in	vitro	model	to	represent	the	human	lung	alveolus.	The	alveolus	 is	 a	 multicellular	 tissue	 which	 allows	 gas	 exchange	 during	 breathing.	 It	 is	composed	of	AEC1	and	AEC2	which	form	the	alveolus	wall.	Surrounding	the	alveolus	is	the	 lung	mesenchyme	which	 consists	mostly	of	 collagen	and	elastin	produced	by	 lung	fibroblasts.	 The	 proposed	 in	 vitro	 model	 is	 composed	 of	 a	 collagen-elastin	 hydrogel	seeded	with	lung	fibroblasts	and	lung	epithelial	cells.	The	construct	is	set	within	a	well	insert	to	provide	an	air	interface.	The	model	aims	to	represent	the	human	alveolus.			The	suggested	model	consists	of	a	collagen-elastin	hydrogel	seeded	with	lung	fibroblasts.	Lung	epithelial	cells	can	be	seeded	on	the	hydrogel	surface.	The	cell	seeded	hydrogel	is	
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set	within	a	well	insert	which	provides	the	ability	to	expose	the	epithelial	cells	to	an	air	interface.	 This	 is	 a	 vital	 part	 of	 the	model	 since	 BPD	 is	 thought	 to	 be	 exacerbated	 by	mechanical	ventilation	at	high	oxygen	levels	>21%	(hyperoxia)	78,132.			
3.2 Aims	
This	study	aims	to	develop	a	lung	alveolus	model	consisting	of	a	collagen-elastin	hydrogel	that	would	allow	the	co-culture	of	human	lung	epithelial	and	human	lung	fibroblast	cells.	The	model	will	be	designed	to	allow	for	hyperoxygen	exposure	and	mechanical	stimulus	to	represent	the	clinical	ventilation	of	BPD	patients.				
3.3 Study	design	
Initially	we	examined	the	contractibility	and	viability	of	adult	and	foetal	lung	fibroblasts	(35FL	 and	 IMR90	 respectively)	 when	 seeded	 within	 collagen	 hydrogels	 and	 how	 the	addition	of	elastin	affected	cell	and	hydrogel	performance.	Next,	we	established	if	 lung	epithelial	cells	could	be	successfully	cultured	as	a	monolayer	on	the	hydrogel	surface	and	whether	 they	 could	 be	 removed	 for	 single-cell	molecular	 analysis.	 The	 lung	 epithelial	hydrogels	were	exposed	to	hydrostatic	stimulation	to	evaluate	the	effect	on	cell	viability,	cell	migration	and	compression	of	hydrogels.	We	assessed	the	effect	of	80%	oxygen	on	human	lung	cells	IMR90,	35FL	and	A549	cell	viability.	A	diagram	of	the	study	design	is	shown	in	Schematic	3.1.	
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Schematic	3.1	A	schematic	to	show	the	flow	of	experimental	design	for	chapter	3.								
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3.4 Methods	
3.4.1 Examining	the	effect	lung	fibroblast	seeding	density	has	on	
hydrogel	contraction	and	cell	viability	To	investigate	cell	contraction	and	viability,	lung	fibroblasts	were	seeded	within	collagen	hydrogels	of	varying	collagen	concentrations	and	seeding	densities.	Collagen	hydrogels	of	concentration	1.5mg/ml	and	3.5mg/ml	were	made	as	described	previously	(section	2.9).	Before	gelation,	IMR90	cells	or	35FL	cells	were	resuspended	into	the	collagen	solution	at	a	density	of	1x105	cell/gel	or	2.5x105	cells/gel.	500µl	collagen	solution	per	hydrogel	was	set	 into	 the	 well	 of	 a	 12	well	 plate	 and	 incubated	 at	 37°C	 for	 30	minutes.	 Following	gelation	1.5ml	growth	medium	was	added	to	the	samples	and	they	were	incubated	at	37°C	for	up	to	25	days	with	media	changes	every	2-3	days.	At	day	0	and	day	20	hydrogels	were	digested	 with	 proteinase	 K	 (section	 2.12)	 and	 DNA	 was	 quantified	 (section	 2.13).	Hydrogel	diameter	was	measured	every	5	days	and	depth	was	measured	at	day	0	and	day	20	 to	 calculate	 percentage	 change	 (section	 2.10).	 At	 day	 2	 phase	 contrast	 light	microscopic	images	were	taken	and	at	day	25	the	LiveDead	assay	was	performed	(section	2.7).			
3.4.2 Investigating	IMR90	DNA	content	in	collagen	hydrogels	To	assess	how	DNA	content	changed	through	a	20-day	experiment,	collagen	hydrogels	of	concentration	3.5mg/ml	were	made	as	previously	described	 (section	2.9)	with	 IMR90	cells	at	a	concentration	of	1x105	cells/gel.	On	day	1,	day	10	and	day	20	hydrogels	were	digested	with	proteinase	K	digestion	(section	2.12)		and	DNA	quantified	(section	2.13).	Hydrogel	depth	and	diameter	were	measured	 (section	2.10)	every	 couple	of	days	and	phase	contrast	microscope	images	were	taken	to	observe	cell	morphology.		
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3.4.3 Establishing	cell	seeding	density,	cell	viability	and	cell	
migration	for	A549	on	collagen	hydrogels	Collagen	hydrogels	of	concentration	3.5mg/ml	were	cast	in	a	12	well	plate	(section	2.9)	and	incubated	at	37°C	for	30	minutes	to	allow	for	gelation.	Once	the	hydrogels	had	set	A549	cells	were	trypsinised,	counted	and	(section	2.2.3)	gently	seeded	onto	the	hydrogel	surface	at	a	concentration	of	10,000,	100,000	or	250,000	cells/gel.	Cells	were	cultured	at	37°C	with	1.5ml	growth	medium	per	gel	for	6	days.	Phase	contrast	images	were	taken	at	day	3	and	at	day	6	the	LiveDead	assay	was	performed	(section	2.7).		
3.4.3.1 A549	removal	from	hydrogels	Following	on	from	the	culture	of	A549	on	hydrogel	surface	we	looked	at	the	removal	of	the	 epithelial	 cells	 for	 future	 analysis.	 Trypsin	 was	 initially	 trialled	 using	 techniques	already	described	(section	2.2.1).	Briefly,	growth	medium	was	aspirated	and	the	samples	were	washed	carefully	with	PBS.	Trypsin	was	added	in	varying	concentrations	(1x,	2x,	5x	and	10x	concentration).	The	cells	were	observed	under	phase	contrast	microscopy	 for	rounding.	 Cell	 removal	 using	 TrypLE	 (recombinant	 enzyme)	was	 tested	 by	 aspirating	growth	media	and	adding	1ml	of	TrypLE	to	the	samples.	The	samples	were	incubated	for	an	 hour	 at	 37°C	 cells.	 Cells	 were	 imaged	 under	 phase	 contrast	 microscopy	 every	 10	minutes	to	check	for	cell	detachment.	After	60	minutes	of	 incubation	cells	had	become	rounded	and	the	Tryp-LE	was	aspirated	to	remove	detached	cells	and	centrifuged	at	3500	rpm	for	5	minutes	 to	 form	a	cell	pellet.	Hydrogel	samples	were	observed	under	phase	contrast	microscopy	to	establish	if	all	A549	cells	had	been	removed.	Physical	cell	removal	using	a	cell	scraper	was	tested	by	aspirating	growth	media,	adding	1ml	PBS	and	gently	scraping	the	hydrogel	surface.				
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	3:	Designing	an	in	vitro	model		
	 68	
3.4.4 Exposing	collagen	hydrogels	seeded	with	A549	to	hydrostatic	
stimulation	A549	cells	were	cultured	as	described	(section	2.2).	3.5mg/ml	collagen	hydrogels	were	prepared	using	 the	protocol	 described	 (section	2.9).	 3	 sample	 types	were	 included	 as	shown	 in	Figure	3.3:	A549	seeded	on	collagen	hydrogels	 in	 tissue	culture	plastic	 (TC),	A549	seeded	on	collagen	hydrogels	in	well	plate	insert,	and	A549	seeded	within	collagen	hydrogels	in	well	plate	inserts.	For	the	samples	which	had	cells	seeded	on	the	hydrogel	surface,	 once	 the	 hydrogels	 had	 set	 2.5x105	 cells/gel	were	 seeded	 as	 a	monolayer	 on	hydrogel	 surface.	 For	 cellular	 hydrogels,	 2.5x105	 cells/gel	 were	 resuspended	 in	 the	collagen	 solution	 before	 gelation.	 Once	 all	 hydrogels	 had	 set,	 growth	 medium	 was	pipetted	onto	 the	cells	and	 into	 the	well	where	a	well	 insert	was	used.	The	cells	were	cultured	 at	 37°C	 for	 24	hours	 to	 allow	 cell	 attachment	 at	which	point	 the	 cell	 culture	medium	was	aspirated	 from	within	 the	well	 insert.	Cells	were	 cultured	 for	10	days	 to	achieve	a	confluent	monolayer.	Every	24	hours	the	samples	were	exposed	to	intermittent	hydrostatic	stimulation	utilized	using	a	DynaGen®	Hydrostatic	Pressure	Tissue	Culture	Plate	Bioreactor	Chamber	(Instron)	at	a	frequency	of	1Hz,	with	a	pressure	level	of	1.5	KPa	in	a	sinusoidal	wave	for	1	hour.	1.5KPa	is	the	expected	pressure	ventilated	babies	would	be	exposed	to	(based	on	information	provided	by	NICU	clinicians).	Samples	that	were	not	exposed	to	hydrostatic	pressure	were	used	as	static	controls.	The	static	controls	under-went	 the	 same	 media	 changes	 as	 the	 stimulated	 samples.	 Immediately	 following	stimulation	samples	were	stained	using	the	LiveDead	kit	(section	2.7).	Cells	were	imaged	using	a	phase	contrast	microscope	and	a	confocal	microscope	to	observe	cell	morphology,	cell	alignment	and	cell	migration.		
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Figure	3.3	Experimental	set-up	to	examine	the	effect	of	hydrostatic	stimulation	on	
A549	cells	culture	on	or	within	collagen	hydrogels.	A549	were	seeded	on	collagen	hydrogel	in	a	well	insert	(A)	or	in	a	well	plate	(C),	A549	cells	were	seeded	within	a	collagen	hydrogel	and	set	in	a	well	insert	(B).		
3.4.5 Examining	the	effect	elastin	has	on	human	lung	fibroblasts	cell	
viability	and	contraction	To	assess	 the	effect	elastin	had	on	cell	viability	and	contraction	 lung	 fibroblast	seeded	collagen-elastin	 hydrogels	 were	 cultured.	 Collagen-elastin	 hydrogels	 were	 made	 as	described	previously	(section	2.9).	The	hydrogels	consisted	of	varying	concentrations	of	elastin	 whilst	 the	 collagen	 concentration	 remained	 the	 same	 at	 3.5mg/ml.	 The	concentration	ratio	consisted	of	1:1	(collagen:elastin),	2:1	and	1:0	(Table	3.1).			
Table	3.1	Concentrations	of	collagen	and	elastin	in	hydrogels		
	 Collagen	concentration	 Elastin	concentration	
1:1	 3.5mg/ml	 3.5mg/ml	
2:1	 3.5mg/ml	 1.75mg/ml	
1:0	 3.5mg/ml	 0mg/ml		
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Before	gelation	1x105cells/gel	lung	fibroblasts	IMR90	or	35FL	were	resuspended	into	the	hydrogel	solution	and	500µl	of	the	solution	was	set	in	a	well	of	a	12	well	plate.	1.5mg/ml	collagen	 only	 hydrogels	 seeded	 with	 1x105	 cells/gel	 were	 also	 made	 as	 an	 internal	control.	On	day	1	and	20	hydrogels	were	digested	with	Proteinase	K	solution	 (section	2.12)	and	DNA	quantified	(section	2.13).	Every	5	days	hydrogel	depth	and	diameter	were	measured	(section	2.10)	and	phase	contrast	images	were	taken.	The	LiveDead	imaging	using	confocal	microscopy	was	achieved	on	day	20	(section	2.7).	
	
3.4.6 Assessing	lung	fibroblasts	seeding	density	for	collagen-elastin	
hydrogels	Collagen-elastin	 hydrogels	 were	made	 as	 described	 previously	 (section	 2.9).	 Collagen	hydrogels	consisting	of	3.5mg/ml	collagen	with	varying	concentrations	of	elastin	(1:1,	2:1	and	1:0)	were	seeded	with	lung	fibroblasts	35FL	at	a	seeding	density	of	1x105,	7.5x104,	5x104,	1x104	cells/gel	were	set	in	a	12	well	plate	and	cultured	for	20	days.	Hydrogel	depth	and	diameter	were	measured	every	5	days	(section	2.9).	Hydrogels	were	digested	using	proteinase	 K	 and	 DNA	 was	 quantified	 (2.12	 and	 2.13)	 on	 day	 20.	 Phase	 contrast	microscope	images	were	taken	on	day	7	and	day	20.				
3.4.7 Exposing	cells	in	monolayer	to	hyperoxia		Cells	were	exposed	 to	hyperoxia	 to	assess	 the	effect	of	 cell	 viability.	 IMR90,	35FL	and	A549	 cells	 were	 expanded	 and	 trypsinised	 ready	 for	 seeding	 as	 described	 previously	(section	2.2).	All	cells	were	seeded	in	a	24	well	plate	at	a	density	of	4	x104	cells/well.	Cells	were	cultured	at	21%	oxygen	or	80%	oxygen,	achieved	using	an	O2	controlled	incubator	(PHCBI	IncuSafe	MCO-5M)	for	7	days	at	37°C.		Phase	contrast	microscopy	images	were	taken	 on	 day	 1	 and	 day	 10.	 Alamar	 blue	 assay	was	 performed	 on	 day	 2,	 5	 and	 10	 as	described	(section	2.15).	On	day	10	cells	were	trypsinised	and	counted	(section	2.2.1).	
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3.4.8 Statistical	analysis	Hydrogel	measurements	 and	DNA	quantification	were	 all	 statistically	 compared	 using	two-way	 ANOVA	 with	 Tukey’s	 multiple	 comparisons	 test	 to	 determine	 the	 statistical	significance,	p≤0.05	was	considered	significant.	Analysis	was	performed	using	GraphPad	Prism	version	7.01.	All	values	quoted	in	the	results	are	mean	±	standard	deviation.	 	
3.5 Results	
3.5.1 Assessment	of	human	lung	fibroblast	seeding	density	into	
collagen	hydrogels	Human	 lung	 fibroblasts	 35FL	 and	 IMR90	 were	 seeded	 within	 collagen	 hydrogels	 of	concentration	 1.5mg/ml	 and	 3.5mg/ml	 at	 a	 seeding	 density	 of	 1x105	 and	 2.5x105	cells/gel.	The	hydrogels	were	cultured	for	20	days	at	21%	oxygen,	37°C.	As	the	hydrogels	began	 to	 contract	 the	 diameter	 was	 measured	 every	 5	 days.	 Hydrogel	 depth	 was	measured	on	day	1	and	day	20	and	DNA	was	quantified.	All	hydrogels	contracted	over	the	20-day	period	as	shown	in	Figure	3.5.	Hydrogels	of	a	lower	collagen	concentration	and	a	higher	cell	seeding	density	contracted	the	most.	There	was	no	contraction	in	the	hydrogel	diameter	of	3.5mg/ml	collagen	concentration	with	1x105	cells/gel.	There	was	an	increase	in	DNA	quantity	in	35FL	hydrogels	but	a	decrease	in	DNA	quantity	for	IMR90	hydrogels.	Cell	viability	was	assessed	using	the	LiveDead	cell	viability	kit	after	25	days	of	culture.	Cell	 viability	 is	 suggested	 to	 be	 good	 since	 the	 cells	 show	 green-fluorescence	 for	 all	samples	and	displayed	a	fibroblastic	morphology	consisting	of	elongated	spindly-shape	which	is	illustrated	in	Figure	3.4.	
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Figure	 3.4	 Lung	 fibroblast	 morphology.	 Phase	 contrast	 microscope	 image	 of	 lung	fibroblasts	in	culture	(indicated	by	arrows).	The	typical	fibroblast	morphology	consists	of	a	large,	flat,	elongated	spindle-shape.	Processes	extend	outwards	from	the	cell	body.			
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Figure	 3.5	 Collagen	 hydrogels	 seeded	 with	 human	 lung	 fibroblasts.	 Collagen	hydrogels	3.5mg/ml	were	seeded	with	35FL	or	 IMR90	cells.	Hydrogel	contraction	was	monitored	by	measuring	hydrogel	diameter	and	depth	over	a	20	day	period.	Hydrogels	with	a	higher	cell	number	and	a	lower	collagen	concentration	contracted	more	rapidly.	DNA	was	quantified	on	day	0	and	day	20.	IMR90	hydrogels	reduced	in	DNA	by	day	20.	All	35FL	 hydrogels	 had	 a	 similar	 DNA	 quantity	 by	 day	 20.	 Data	 is	 expressed	 as	 mean	 ±	standard	deviation,	n=9.	
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Figure	 3.6	 Microscopic	 images	 of	 collagen	 hydrogels	 seeded	 with	 human	 lung	
fibroblasts.	Cell	viability	was	checked	using	the	LiveDead	cell	viability	kit	after	culture	for	 25	 days.	 Cells	 with	 compromised	 membranes	 exhibit	 red-fluorescence	 from	 the	nucleic	acid	stain	ethidium	homodimer.	Cells	with	intact	cell	membranes	exhibit	green-fluorescence	by	calcein.	
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3.5.2 A549	cells	form	monolayer	of	collagen	hydrogel	surface	A549	 of	 varying	 seeding	 densities	were	 seeded	 on	 3.5mg/ml	 collagen	 hydrogels.	 Cell	morphology,	confluence	and	viability	was	assessed	by	imaging	the	samples	on	day	3	and	day	6.	Cells	seeded	at	2.5x105	cells/gel	were	observed	to	form	a	confluent	monolayer	by	day	6	(Figure	3.7).	Cell	viability	was	good	as	shown	by	the	LiveDead	cell	viability	stain	(Figure	3.7).	Cell	migration	was	checked	by	imaging	the	whole	hydrogel,	but	cells	could	only	be	observed	on	the	hydrogel	surface.	For	future	investigatory	purposes	we	examined	the	possibility	of	removing	the	A549	cells	from	the	hydrogel	surface.	The	use	of	trypsin	in	high	concentrations	was	unsuccessful.	This	is	thought	to	be	due	to	FBS	from	the	growth	media	 remaining	 in	 the	 hydrogels	 preventing	 the	 action	 of	 trypsin.	 The	 cell	 scraper	proved	ineffective	because	the	hydrogels	were	too	delicate	for	manual	handling.	Tryp-LE	was	the	most	successful	cell	removal	technique.	Cells	were	observed	to	become	rounded	after	 a	 long	 incubation	 time	 however	 some	 cells	 remained	 attached	 to	 the	 collagen	hydrogel	surface	and	couldn’t	be	aspirated.				
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Figure	3.7	A549	cells	cultured	on	collagen	hydrogels.	Cells	were	imaged	using	phase	contrast	light	microscopy	and	confocal	flourecence	imaging	after	staining	with	LiveDead	staining	 kit.	 Cells	 formed	 a	monolayer	 on	 the	 hydrogel	 surface.	 Cells	 are	more	 tightly	compact	when	seeding	density	of	250,000	cells/gel				
3.5.3 Elastin	in	collagen	hydrogels	does	not	affect	cell	viability	Collagen-elastin	hydrogels	of	varying	concentrations	of	elastin	(collagen:elastin	1:1,	2:1,	1:0)	were	seeded	with	250,000	cells/gel	human	lung	fibroblasts	35FL	or	IMR90.	Hydrogel	contraction	was	monitored,	and	DNA	quantified	(Figure	3.8).	For	35FL	seeded	hydrogels	
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the	 addition	 of	 elastin	 had	 a	 significant	 effect	 on	 hydrogel	 contraction.	 Hydrogels	containing	 elastin	 contracted	 in	 diameter	 and	 hydrogel	 depth	 initially	 decreased	 but	increased	 again	 by	 day	 20.	 35FL	 DNA	 increased	 by	 day	 20	 and	 was	 not	 statistically	affected	 by	 the	 addition	 of	 elastin.	 The	 IMR90	 hydrogels	 did	 not	 contract	 in	 hydrogel	diameter	but	did	contract	in	hydrogel	depth.	The	1.5mg/ml	collagen	hydrogel	seeded	with	1x105	 cells/gel	 acted	 as	 an	 internal	 control	 and	 had	 the	 expected	 results	 in	 terms	 of	hydrogel	contraction	and	DNA	quantity.	Phase	contrast	images	were	taken	every	5	days	and	 confocal	 images	 on	 day	 20	 (Figure	 3.9	 and	 Figure	 3.10).	 Initially	 IMR90	 cell	morphology	was	more	rounded	and	did	not	become	elongated	until	day	20.	The	35FL	cells	become	elongated	by	day	5	and	continued	 to	have	 this	morphology	until	day	20.	 	Cell	number	visually	increases	over	the	20	days	and	hydrogels	were	very	confluent	by	day	20.	The	presence	of	green	fluorescence	indicates	cell	viability	was	good	and	unaffected	by	the	addition	of	elastin	for	both	cell	types.		
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Figure	3.8	Human	 lung	 fibroblasts	 (IMR90	and	35FL)	collagen-elastin	hydrogels.	Hydrogel	contraction	was	measured	and	DNA	quantified	over	20	days	in	culture.	IMR90	hydrogels	did	not	contract	so	have	been	omitted	from	the	figure.	The	addition	of	elastin	caused	hydrogels	to	contract	more	rapidly.	DNA	increased	for	35FL	hydrogels	indicating	elastin	had	no	effect	on	cell	proliferation.	DNA	decreased	for	IMR90	hydrogels	indicating	there	was	cell	death.	Data	is	expressed	as	mean	±	standard	deviation,	N=6.	
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Figure	3.9	Human	lung	fibroblast	IMR90	collagen-elastin	hydrogels.	Hydrogels	were	imaged	 every	 5	 days	 in	 culture	with	 phase	 contrast	microscopy.	 On	 day	 20	 cell	were	stained	with	the	LiveDead	kit	and	imaged	using	confocal	microscopy.	Cell	viability	and	cell	morphology	was	not	observed	to	be	affected	by	the	addition	of	elastin.	
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Figure	3.10	Human	 lung	 fibroblasts	35FL	 cultured	 in	 collagen-elastin	hydrogels.	Hydrogels	were	imaged	every	5	days	in	culture	with	phase	contrast	microscopy.	On	day	20	cell	were	stained	with	the	LiveDead	kit	and	imaged	using	confocal	microscopy.	Cell	viability	and	cell	morphology	was	not	observed	to	be	affected	by	the	addition	of	elastin	
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3.5.4 Monitoring	DNA	quantity	of	IMR90	seeded	collagen	hydrogels	To	 examine	 the	 change	 in	 DNA	 quantification	 of	 IMR90	 collagen	 hydrogels,	 collagen	hydrogels	of	3.5mg/ml	collagen	concentration	were	seeded	with	1x105cells/gel	and	set	in	 the	 wells	 of	 a	 12	 well	 plate.	 Hydrogel	 depth	 and	 DNA	 were	 measured,	 and	 phase	contrast	images	were	taken	(Figure	3.11).	Hydrogel	depth	decreased	at	a	similar	rate	as	in	previous	experiments.	Phase	contrast	images	show	cell	morphology	was	elongated	and	fibroblasts-like	 throughout	 the	 20	 days	 of	 culture	 and	 cell	 number	 increases.	 DNA	quantification	significantly	increases	by	day	10	but	significantly	decreases	by	day	20.		
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Figure	 3.11	 Collagen	 hydrogels	 seeded	 with	 human	 lung	 neonatal	 fibrobalsts	
IMR90.	Hydrogel	contraction	was	monitored	over	20	days	in	culture.	DNA	was	quantified	every	10	days	and	phase	contrast	images	were	taken	every	5	days.	DNA	increased	by	day	10	but	decreased	by	day	20	and	which	point	contraction	 levels	out.	 Images	show	cells	with	a	 fibroblastic	morphology.	Data	are	expressed	as	mean	±	standard	deviation,	n=3	(*p≤0.05).	
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3.5.5 Decreasing	cell-seeding	density	for	35FL	collagen-hydrogels	
prevents	contraction	of	hydrogel	diameter	Human	 lung	 fibroblasts	 35FL	 were	 cultured	 at	 varying	 seeding	 densities	 (100,000,	75,000,	50,000,	10,000	and	1,000	cells/gel)	in	collagen-elastin	hydrogels	and	cultured	for	20	days.	Hydrogel	 contraction	was	monitored,	 and	DNA	quantified.	Hydrogels	 did	not	contract	in	diameter	when	the	seeding	density	was	reduced	to	7.5x105	cells/gel	or	below	(Figure	3.12).	Elastin	had	no	significant	effect	on	DNA	quantification.		
PhD	Thesis	by	J.	A.	J.	Bratt	 	 Chapter	3:	Designing	an	in	vitro	model		
	 84	
	
Figure	3.12	The	effect	of	cell	seeding	density	on	the	contraction	of	collagen-elastin	
hydrogels.	Collagen-elatsin	hydrogels	 (collagen:elastin	 rato	1:1,	2:1,	1:0)	were	seeded	with	human	adult	lung	fiborblasts	35FL.	Contraction	was	monitored	for	20	days	in	culture	and	DNA	quantified.	 Graphs	will	 only	 the	 high	 seeding	densty	 have	 been	 included	 for	clarity.	 Collagen-elastin	 hydrogels	 with	 a	 seeding	 density	 of	 75,000	 cells/gel	 did	 not	contract	 in	diameter	but	still	displayed	contraction	in	gel	depth.	Data	are	expressed	as	mean	±	standard	deviation,	N=6	
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3.5.6 Hydrostatic	stimulation	does	not	compress	collagen	hydrogels	
and	does	not	affect	cell	viability		Human	lung	epithelial	cells	A549	were	cultured	on	the	surface	of	collagen	hydrogels	(in	well	inserts	or	directly	in	a	well	of	a	12-well	plate)	or	within	collagen	hydrogels.	Samples	were	subjected	 to	hydrostatic	pressure	at	a	 frequency	of	1Hz,	with	a	pressure	 level	of	1.5KPa	in	a	sinusoidal	wave	for	1	hour	each	day	for	10	days.	Phase	contrast	and	confocal	images	were	taken	of	all	samples	(Figure	3.13).	The	bioreactor	stimulation	had	no	effect	on	 cell	 morphology	 or	 viability	 when	 visualised	 with	 phase	 contrast	 microscopy	 and	LiveDead	staining	kit.	There	was	no	sign	of	migration	of	cells	seeded	as	a	monolayer	of	the	collagen	hydrogel	 surface.	Hydrogel	depth	was	measured	using	OCT	(Figure	3.14).	Hydrostatic	 stimulation	 had	 no	 statistically	 significant	 effect	 on	 hydrogel	 depth	 after	stimulation.	These	results	also	demonstrate	that	A549	can	be	cultured	successfully	as	a	monolayer	on	a	hydrogel	without	growth	medium	directly	on	the	cells	(growth	medium	only	surrounded	the	well	insert).			
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Figure	3.13	Human	lung	epithelial	cells	A549	cultured	within	or	on-top	of	collagen	
hydrogels	 and	 subjected	 to	 hydrostatic	 conditions.	The	 cells	were	 imaged	 using	 a	phase	contrast	microscope	or	confocal	microscope	using	the	LiveDead	staining	kit	on	day	10.	The	hydrostatic	stimulation	had	no	observed	effect	on	cell	viability	or	morphology.	
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Figure	3.14	Human	lung	epithelial	cells	A549	cultured	within	or	on-top	of	collagen	
hydrogels	and	subjected	to	hydrostatic	conditions.	The	hydrogel	depth	was	measured	using	OCT	and	compared	on	day	0	and	day	20	in	either	static	or	hydrostatic	conditions.	The	hydrogel	depth	did	not	change	when	subjected	to	hydrostatic	stimulation.	Data	are	expressed	as	mean	±	standard	deviation,	N=3		
3.5.7 Culturing	cells	at	80%	oxygen	affects	cell	proliferation	Cells	35FL,	IMR90	and	A549	were	cultured	in	a	monolayer	at	80%	oxygen	for	10	days	after	 which	 cell	 counts	 and	 Alamar	 blue	 assay	 were	 performed	 to	 assess	 the	 effect	hyperoxia	 has	 on	 cell	 proliferation.	 Examining	 the	 effect	 hyperoxia	 has	 on	 cells	 is	important	when	investigating	BPD	since	patients	are	placed	on	ventilation	of	up	to	100%	oxygen.	 	 Figure	3.15	 shows	phase	 contrast	 images	of	 the	 cells	A549,	35FL	and	 IMR90	cultured	over	a	10-day	period	at	21%	and	80%	oxygen.	With	all	three	cell	types	there	are	fewer	 cells	 visualised	 at	 day	 10	 when	 cultured	 80%	 oxygen.	 When	 cell	 counts	 are	performed	 on	 day	 10	 (Figure	 3.16)	 there	 are	 statistically	 fewer	 cells	 at	 80%	 oxygen.	Alamar	Blue	assay	was	performed	on	the	cells	at	day	2,	5	and	7.	There	was	a	significantly	
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lower	 fluorescence	value	 for	all	 cells	 cultured	at	80%	oxygen	when	compared	 to	21%	oxygen.	This	indicates	there	was	reduced	metabolic	activity	likely	due	to	the	presence	of	fewer	cells.				
	
Figure	3.15	Human	lung	cells	IMR90,	35FL	and	A549	cultured	for	10	days	at	21%	
oxygen	 and	80%	oxygen.	Phase	 contrast	 images	were	 taken	 at	 day	 1	 and	 day	 10	 of	culture.	Fewer	cells	can	be	visualised	on	day	10	at	80%	oxygen	when	compared	to	21%	oxygen	for	all	cell	types.		
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Figure	3.16	Human	lung	cells	IMR90,	35FL	and	A549	cultured	for	10	days	at	21%	
oxygen	and	80%	oxygen.	Cell	counts	were	performed	on	day	10	and	AlamarBlue	assay	was	 performed	 on	 day	 2,	 5	 and	 10	 of	 culture.	 80%	 oxygen	 significantly	 reduced	 cell	number	and	metabolic	activity.	Data	are	expressed	as	mean	±	standard	deviation,	N=3	(**p≤0.005,	***p≤0.001,	****p≤0.0001).	
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3.6 Discussion	
Knowledge	of	BPD	has	 relied	heavily	on	 the	use	of	 animal	models60.	Whilst	 they	have	contributed	 to	our	 current	knowledge	and	understanding	of	 the	disease	pathogenesis,	they	lack	biological	relevance	and	can	be	expensive.	In	terms	of	BPD	the	most	common	animal	model	are	rodents	which	lack	biological	significance	since	they	do	not	follow	the	same	 developmental	 pathway	 as	 humans61.	 Animal	 models	 that	 are	 developmentally	relevant,	such	as	primates,	are	associated	with	high	cost,	 logistical	and	ethical	 issues65.		3D	 in	 vitro	 models	 have	 come	 at	 the	 forefront	 of	 regenerative	medicine	 due	 to	 their	biological	relevance	and	accurate	representation	of	tissue	architecture.	The	development	of	 in	vitro	 lung	models	has	focused	mainly	on	the	conducting	airway	since	 it	 is	a	more	simple	 structure	 to	 mimic87.	 Current	 lung	 alveolar	 models	 rarely	 offer	 the	 ideal	combination	of	multicellular,	3D,	hyperoxygen	exposure	and	mechanical	stimulus.	In	this	study	 we	 have	 begun	 to	 investigate	 the	 possibility	 of	 designing	 such	 a	 model.	 The	following	describes	in	detail	aspects	of	the	model	this	chapter	has	considered.	
3.6.1.1 Collagen	hydrogel	concentration	and	cell	seeding	density		Collagen	hydrogels	are	the	ideal	material	for	a	lung	alveolar	model	and	BPD.	Collagen	is	one	 of	 the	 key	 components	 in	 the	 human	 lung	 mesenchyme.	 It	 provides	 structural,	mechanical	 and	 biological	 support90,92	 and	 is	 thought	 to	 be	 a	 driving	 force	 for	alveologenesis	during	development66.		Aberrant	collagen	has	consistently	been	associated	with	BPD66,95.	Our	initial	investigatory	work	looked	at	collagen	construct	fabrication	and	the	encapsulation	of	human	fibroblastic	cells.			Collagen	hydrogels	of	concentration	1.5mg/ml	and	3.5mg/ml	were	prepared	seeded	with	human	lung	cells	IMR90	and	35FL.	These	two	cell	types	were	chosen	since	they	derive	from	a	developing	human	foetus	lung	and	a	human	adult	lung	respectively.	The	cells	were	encapsulated	 in	 the	 hydrogel	 solution	 before	 gelation.	 The	 hydrogel	 contraction	 was	
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measured,	 DNA	 quantified,	 and	 microscopic	 images	 taken	 to	 examine	 the	 following	questions:-	 do	 the	 cells	 contract;	 to	what	 extent	 do	 the	 cells	 contract;	 is	 cell	 viability	affected;	do	the	cells	proliferate.	Measuring	the	contraction	of	the	hydrogel	diameter	was	important	 since	we	did	not	want	 the	hydrogel	 contracting	 along	 the	diameter.	 This	 is	because	 when	 an	 epithelial	 monolayer	 is	 eventually	 seeded	 on	 the	 hydrogel	 surface,	contraction	could	cause	the	epithelial	monolayer	to	peel	off.	 	Hydrogel	contraction	has	previously	 been	 used	 as	 a	 measure	 of	 fibroblast	 function	 and	 ECM	 production179,180.	Hydrogels	of	a	higher	collagen	concentration	and	 lower	cell	number	contracted	 less,	a	recurring	observation	in	the	literature181.	We	found	that	collagen	hydrogels	of	3.5mg/ml	with	 1x105	 cells/500µl	 gel	 did	 not	 contract	 in	 diameter	 and	 were	 therefore	 the	appropriate	sample	type	to	take	forward	in	future	experiments.			Cell	 viability	 was	 unaffected	 by	 culture	 conditions	 as	 demonstrated	 by	 the	 LiveDead	viability	 staining.	 35FL	 DNA	 quantity	 increased	 for	 all	 sample	 conditions	 further	supporting	 that	 culture	 conditions	 were	 favoured	 by	 the	 human	 lung	 fibroblasts.	However,	a	decrease	in	DNA	was	observed	for	IM90	samples	suggesting	cell	number	was	decreasing.	This	was	a	consistent	observation	and	lead	to	DNA	quantification	on	day	10.	DNA	 significantly	 increased	 on	 day	 10	 but	 significantly	 decreased	 by	 day	 20.	 It	 is	hypothesised	 that	 the	 hydrogels	 were	 not	 favoured	 by	 the	 IMR90	 cells	 since	 phase	contrast	microscopic	images	show	the	IMR90	cells	to	be	more	rounded	and	fewer	cells	could	be	observed	with	confocal	imaging.	Phase	contrast	imaging	is	not	an	ideal	technique	to	 image	 3D	 constructs	 since	 images	 can	 only	 target	 one	 section	 of	 the	 hydrogel	 and	therefore	may	not	 represent	 the	hydrogel	 as	 a	whole.	The	working	distance	 (distance	between	the	objective’s	front	lens	and	the	closest	surface	and	the	specimen	to	allow	the	specimen	to	be	in	sharp	focus)	was	also	a	limiting	factor	when	imaging	hydrogels	which	were	 thick	 and	 therefore	 couldn’t	 be	 imaged	 in	 focus.	 Confocal	 imaging	 provides	 the	
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option	to	produce	z-stacks	that	are	capable	of	imaging	the	hydrogel	as	a	whole.	Confocal	imaging	also	mitigates	the	issue	of	autofluorescence	from	the	collagen	fibres.			
3.6.1.2 A549	cells	can	be	cultured	in	monolayers	on	hydrogel	surface	After	successfully	identifying	a	stable	collagen	hydrogel	and	fibroblast	seeding	density,	we	investigated	the	possibility	of	seeding	lung	epithelial	cell	line	A549	on	the	hydrogel	surface	which	has	previously	been	achieved	for	lung	cancer	modelling182.	The	A549	cells	formed	 a	 cell	 monolayer	 on	 the	 hydrogel	 surface	 with	 good	 cell	 attachment	 and	 cell	viability	 as	 shown	 by	 the	 LiveDead	 staining	 and	 confocal	 imaging.	 There	 was	 no	 cell	migration	 observed.	 This	 is	 important	 because	 we	 want	 to	 maintain	 a	 confluent	monolayer	on	the	hydrogel	surface	 to	accurately	represent	 the	alveolus	cell	wall.	Cells	seeded	at	2.5x105	were	observed	to	be	confluent	by	day	6,	1x105	were	confluent	by	day	15	and	1x104	were	confluent	by	day	35.	Since	the	future	aim	is	to	have	long-term	culture,	a	culture	period	of	20	days	at	a	seeding	density	of	1x105	is	appropriate.				For	 end-of-experiment	 analysis	 we	 looked	 at	 removing	 the	 A549	 cells	 using	 various	techniques;	 cell	 scraper	 and	 trypsin	 were	 unsuccessful	 with	 only	 Tryp-LE	 capable	 of	removing	some	cells	after	long	incubation	times.	Although	the	removal	of	some	A549	cells	meant	 some	 analysis	 could	 be	 achieved	 on	 A549	 cells,	 the	 inefficiency	 of	 this	 this	technique	means	the	hydrogels	remain	in	a	co-culture	state	so	future	molecular	analysis	would	 be	 contaminated	with	 epithelial	 cells	 and	 not	 purely	 fibroblasts	 cells.	 The	 long	incubation	period	for	Tryp-LE	may	have	a	detrimental	effect	on	cells	so	molecular	analysis	would	not	be	representative	of	experiment	conditions.	Research	by	Tsuji	et	al.	examined	the	effect	of	Tryp-LE	and	antigen	expression	after	30	minutes	exposure	and	found	it	did	not	affect	surface	marker	expression183	however	our	exposure	time	reached	60	minutes.			
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3.6.1.3 The	addition	of	elastin	causes	a	higher	rate	of	hydrogel	contraction	but	doesn’t	affect	cell	viability	An	important	feature	found	in	the	lung	tissue	samples	of	BPD	patients	and	animal	models	has	 been	 an	 abnormal	 elastin	 network32,94.	 Along	 with	 collagen,	 elastin	 provides	structural	 and	 mechanical	 support	 for	 respiration	 and	 is	 thought	 to	 influence	alveologenesis49.	 Previous	 work	 from	 our	 lab	 demonstrated	 the	 cell	 seeded	 collagen	hydrogel	has	the	same	Young’s	modulus	of	the	theoretical	Young’s	modulus	of	the	lung	alveolus97.	We	 can	 therefore	 be	 confident	 that	 the	 hydrogel	 provides	 the	 appropriate	mechanical	properties	as	well	as	biological	relevance.	Elastin	was	included	into	collagen	hydrogels	 at	 2	 collagen:elastin	 ratios:	 1:1	 and	 2:1.	 Collagen	 only	 hydrogels	were	 also	included	(1:0).	The	elastin	had	no	effect	on	cell	viability	in	terms	of	cell	morphology,	cell	proliferation	 (assessed	 by	 DNA	 quantification)	 or	 cell	 viability.	 However,	 the	 elastin	caused	 the	hydrogel	diameter	 to	 contract	at	 a	 faster	 rate	which	 is	not	appropriate	 for	epithelial	 cell	 culture.	We	went	 on	 to	 investigate	 an	 appropriate	 cell	 number	 to	 avoid	contraction	of	hydrogel	diameter	which	was	achieved	with	a	seeding	density	of	7.5x105	cells/gel.	We	seeded	varying	A549	cell	seeding	densities	onto	collagen-elastin	hydrogels	to	establish	an	appropriate	seeding	density	of	7.5x104	cells/gel.		
3.6.1.4 Hydrogels	can	be	exposed	to	hydrostatic	bioreactor	stimulation	and	hyperoxia	BPD	patients	can	fall	into	2	categories:	ventilator	dependant	or	those	that	require	non-invasive	support.	Which	group	they	fall	into	depends	on	gestational	age	or	weight;	those	under	 27	 weeks	 GA	 or	 under	 1Kg	 falling	 into	 the	 ventilator	 dependant	 group	 and	older/bigger	babies	needing	 less	support.	 It	 is	 thought	 that	 it	 is	a	combination	of	high	oxygen	 and	 mechanical	 strain	 which	 exacerbates	 the	 disease66,116.	 	 In	 this	 study	 we	wanted	to	examine	severe	BPD	so	exposed	the	model	to	an	environment	consistent	with	
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the	ventilator	dependant	group.	This	included	culture	at	>40%	oxygen	and	mechanical	stress	typical	of	invasive	ventilation.	Although	predominately	used	for	bone	research,	the	hydrostatic	bioreactor129	possess	attributes	which	may	bode	well	for	lung	research.	It	can	provide	cyclic	hydrostatic	pressure	 that	mimics	 the	mechanical	ventilators	used	to	aid	neonatal	respiration	in	the	clinical	environment.	The	hydrostatic	bioreactor	can	provide	simulation	 of	 1.5kPA,	 the	 expected	 mean	 airway	 pressure	 ventilated	 babies	 would	experience.	 Preliminary	 experiments	 confirmed	 that	 incorporating	 hydrostatic	stimulation	could	be	achieved	and	this	did	not	have	a	detrimental	effect	of	epithelial	cell	viability,	collagen	compression	or	cell	migration.	This	study	also	demonstrated	that	A549	cells	were	capable	of	maintaining	a	cell	monolayer	on	the	surface	of	a	hydrogel	without	growth	media	 directly	 on	 top	 of	 the	 cells.	 All	 the	 necessary	 nutrients	 for	 cell	 growth	sufficiently	diffused	through	the	hydrogel.	This	allows	the	model	to	be	maintained	at	an	air	interface	therefore	mimicking	in	vivo	oxygen	exposure.	Hyperoxia	of	80%	oxygen	was	achieved	using	an	incubator	IncuSafe	MCO-5M	capable	of	achieving	high	oxygen	culture.	80%	oxygen	had	a	detrimental	effect	on	all	lung	cells	exposed	(A549,	35FL	and	IMR90)	which	 is	 representative	 of	 previous	 published	work	 in	which	 very	 high	 oxygen	 levels	cause	growth	arrest184,185.  		
3.7 Conclusion	
We	have	established	an	in	vitro	3D	co-culture	alveolar	model	that	can	be	used	to	represent	the	 complex	 lung	 alveolus.	 The	 model	 is	 biologically	 relevant	 to	 human	 disease	 and	capable	of	being	exposed	to	numerous	environmental	factors	to	make	it	applicable	to	a	variety	of	 lung	diseases	or	used	as	a	drug	testing	 tool.	Out-put	measures	can	be	easily	achieved	 by	 assessing	 hydrogel	 contraction	 using	 measuring	 techniques,	 molecular	analysis	and	imaging	with	phase	contrast	microscopy	and	confocal	fluorescent	imaging.	
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We	were	unable	 to	establish	an	efficient	method	 to	 separate	 the	 two	cell	populations.	Future	work	would	examine	the	potential	use	of	FACS	to	isolate	the	cell	populations.		
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Chapter	4 	The	extraction	and	characterisation	of	placenta	mesenchymal	stem	cells	and	neonatal	lung	cells			
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4.1 Introduction	
This	chapter	 looks	at	extracting	and	characterising	primary	cells.	Firstly,	primary	 lung	cells	 were	 isolated	 and	 expanded	 for	 future	 culture	 in	 the	 in	 vitro	 model	 previously	designed	in	Chapter	3.	The	addition	of	these	cells	adds	novelty	and	biological	relevance	for	 further	 experimental	 investigations	 into	 BPD.	 Secondly,	 we	 sourced,	 cultured	 and	characterised	placenta	derived	MSCs	to	assess	their	potential	as	a	cell	therapy	for	BPD.		
4.1.1 Human	neonatal	lung	cells		The	previously	proposed	in	vitro	model	has	been	designed	to	represent	the	human	lung	alveolus	by	providing	a	collagen-elastin	substrate	which	can	support	lung	cell	co-culture.	Cells	 from	 numerous	 tissue	 sources	 could	 be	 incorporated	 into	 the	model	 to	 provide	biological	or	disease	relevance.	In	the	case	of	a	BPD	model	we	sought	to	incorporate	lung	fibroblastic	 and	 epithelial	 cells	 that	 represent	 the	 immature	 lung	 of	 a	 premature	ventilated	 neonate.	 This	 would	 provide	 a	 more	 accurate	 representation	 of	 cellular	behaviour	 and	 interaction	 when	 examining	 the	 effects	 of	 hyperoxygen	 or	mechanical	stress	which	BPD	patients	are	exposed	to.	In	this	chapter	we	firstly	examine	the	ability	to	extract	and	culture	lung	fibroblast	cells	and	epithelial	cells	from	tracheal	suctionings	of	ventilated	babies	from	the	NICU.	We	looked	at	two	approaches	to	isolate	the	appropriate	cells:	Endotracheal	suctionings	and	nasal	scrapings.		
4.1.1.1 Tracheal	suctionings	Tracheal	suctionings	are	routine	practice	for	endotracheal	intubated	patients to	maintain	airway	patency186.	They	are	performed	following	clinical	observations	indicating	excess	mucus	 or	 fluid	 obstructing	 ventilation.	 Occasionally	 the	 sample	 may	 be	 required	 for	microbiological	assessment	but	typically	the	sample	is	immediately	disposed	of	making	it	an	ideal	source	for	research	purposes.	The	procedure	involves	introducing	a	suctioning	catheter	 into	 the	 patients	 trachea	 and	 applying	 negative	 pressure187.	 Assessment	 of	
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cytokines	and		fibrinolysis	in	tracheal	suctions	has	been	previously	achieved188,189.	Ahn	and	Hwang	reported	on	the	cytological	component	of	tracheal	suctionings	demonstrating	the	potential	of	tracheal	suctionings	as	a	research	tool190.		
4.1.1.2 Nasal	scrapings	The	 collection	 of	 nasal	 scrapings	 or	 brushings	 is	 an	 established	 method	 for	 isolating	respiratory	cells191–197,	studying	ciliary	ultrastructure	and	evaluating	inflammation198,199.	The	 technique	 benefits	 from	being	 easy	 to	 collect,	minimally	 invasive,	 possessing	 few	ethical	concerns	and	is	associated	with	a	low	site	morbidity.	However,	the	procedure	is	not	routine	practice	and	can	be	accompanied	with	some	discomfit	for	the	patient.	 	The	disease	 relevance	 of	 nasal	 cells	 for	 BPD	 is	 questionable	 since	 BPD	 is	 a	 disease	 of	 the	respiratory	 zone	 not	 the	 conducting	 airway	 (upper	 respiratory	 tract).	 However	 nasal	epithelial	cells	have	been	shown	to	be	a	potential	surrogate	for	bronchial	epithelial	cells	for	paediatric	asthma	studies	in	that	they	have	a	similar	response	to	IL-13	(interleukin-	13)200.	 Since	 BPD	 is	 also	 a	 paediatric	 disease	 nasal	 epithelial	 cells	 may	 be	 a	 suitable	candidate	for	BPD	investigation.			
4.1.2 MSCs	for	BPD		In	 the	 last	 decade	 MSCs	 have	 become	 one	 the	 most	 widely	 researched	 cell	 type	 in	regenerative	 medicine.	 First	 described	 by	 Friedenstein	 et	 al.201	MSCs	 possess	 certain	attributes	 which	 make	 them	 an	 ideal	 candidate	 for	 cell	 therapies	 including	immunomodulatory	properties,	differentiation	capacity	and	proliferative	capacity165,202.	Bone	marrow	was	the	first	established	source	of	MSCs	and	has	since	become	the	most	widely	 investigated	 stem	 cell	 which	 is	 now	 easily	 attainable	 commercially203.	 More	recently	alternative	sources	of	MSCs	have	been	investigated	which	are	arguably	better	in	terms	 of	 acquisition,	 cell	 proliferation	 and	 immunoregulation.	 In	 this	 instance	we	 are	particularly	interested	in	the	human	term	placenta.	The	placenta	is	a	recognised	source	
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of	MSCs	which	can	be	extracted	from	both	the	chorion	membrane	(maternal	side)	and	the	amnion	membrane	(foetus	side).	The	placenta	is	a	waste	material	normally	disposed	of	after	birth	which	makes	it	an	attractive	MSC	source	since	it	avoids	issues	of	acquisition,	morbidity	 and	ethical	dilemmas.	 Studies	 suggest	 that	placental	MSCs	 (pMSCs)	possess	better	 immunoregulatory	 properties	 than	 other	 sources	 77,161,	 they	 also	 have	 a	 high	capacity	 for	 self-renewal,	 adhere	 to	 plastic,	 possess	 stromal	markers	 (CD166,	 CD105,	CD73,	CD90),	are	negative	for	haematopoietic	markers	(CD14,	CD34	and	CD45)	and	have	differentiation	 potential167,204,205.	 The	 placenta	 is	 an	 underutilised	 source	 of	 MSCs	possibly	due	to	the	lack	of	availability	for	research	facilities.	Sourcing	placentas	in	the	UK	requires	the	participation	of	busy	NHS	medical	personnel	who	often	lack	the	facilities	and	knowhow	to	acquire	and	store	placentas	 for	research	purposes.	Despite	 this,	 in	recent	years	placenta	derived	MSCs	have	come	at	the	forefront	for	cell	therapies	for	a	variety	of	diseases	because	they	have	the	potential	to	restore	normal	function.	For	BPD	in	particular	there	is	extensive	evidence	to	suggest	that	MSCs	could	help	alleviate	the	detrimental	effect	of	oxygen	ventilation	and	promote	normal	 lung	development158,159.	 It	has	now	become	evident	 that	 the	 lung	 possess	 its	 own	 endogenous	 MSCs	 suggesting	 they	 are	 a	 key	modulator	in	normal	lung	maturation	and	function206.			
4.2 Aims	
We	 aimed	 to	 develop	 a	 method	 to	 isolate	 and	 culture	 human	 lung	 fibroblasts	 and	epithelial	cells	from	the	tracheal	suctioning	of	ventilated	neonates	and	nasal	scrapings.	We	also	 investigated	the	 isolation	of	placenta	derived	mesenchymal	stem	cell	(chorion	and	amnion	membrane)	and	the	effect	hyperoxia	has	on	their	characteristics.	Results	in	the	previous	chapter	demonstrated	80%	oxygen	had	a	detrimental	effect	on	lung	cells.	Therefore	hyperoxia	experiments	utilised	40%	oxygen	which	is	representative	of	oxygen	levels	for	endotracheal	ventilated	severe	BPD	infants.	
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4.2.1 Study	design	
	
Schematic	4.1	A	schematic	to	show	the	flow	of	experimental	design	for	chapter	4.		
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4.3 Methods	
4.3.1 Tracheal	suctioning	sample	processing,	cell	extraction	and	cell	
culture	Patient	 recruitment	 and	 consent	 was	 sought	 in	 accordance	 with	 the	 study	 protocol.	Tracheal	 suctionings	 were	 collected	 from	 neonates	 on	 ventilation	 and	 processed	 as	described	in	(section	2.3).	When	collecting	the	suctionings,	clinical	staff	may	have	used	saline	to	loosen	thick	mucus	or	to	wash	endotracheal	tubes.	Consent	was	sought	for	all	samples	prior	to	collection	and	the	relevant	patient	medical	details	were	provided.	Cell	counts	were	performed	using	the	trypan	blue	exclusion	assay	(section	2.2.3)	to	provide	a	live/dead	cell	count.	Cells	which	were	isolated	and	expanded,	hence	forth	referred	to	as	neonatal	 lung	 fibroblasts	 (NLF),	 were	 imaged	 every	 5-7	 days	 with	 phase	 contrast	microscopy.	Once	confluency	was	achieved	cells	were	passaged	and	cell	counts	recorded.			
4.3.2 Culturing	lung	tracheal	cells	in	collagen	hydrogels	To	aid	in	the	characterisation	of	the	NLF	cells,	cells	were	cultured	in	collagen	hydrogels	to	assess	contraction	and	cell	viability.	NLF	cells	were	resuspended	in	1.5mg/ml	collagen	solution	 (section	 2.9)	 at	 a	 seeding	 density	 of	 1x105	 cells	 per	 500µl	 collagen	 hydrogel	solution	and	cultured	in	12	well	plates.	Hydrogels	were	cultured	at	37°C	for	30	minutes	to	 allow	 gelation	 at	 which	 point	 growth	medium	was	 gently	 added	 to	 samples.	 35FL	seeded	 hydrogels	 were	 prepared	 under	 the	 same	 conditions.	 Percentage	 change	 in	hydrogel	 depth	 and	 diameter	 were	 calculated	 (section	 2.10).	 Hydrogels	 were	 stained	using	the	LiveDead	cell	viability	kit	and	imaged	using	confocal	microscopy	(section	2.7).						
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4.3.3 Extracting	epithelial	cells	from	tracheal	suctionings	Tracheal	suctioning	sample	PWTA05	was	processed	and	cultured	as	described	(section	2.3.4).	Cells	were	seeded	at	a	seeding	density	of	4x104	cells/cm2	and	cultured	with	various	commercially	available	lung	epithelial	media	types:	BEGM,	LHC-9	and	CA	media	(Table	2.4)	at	37°C	for	30	days.	Phase	contrast	microscopic	images	were	taken	at	day	10.		
4.3.4 Nasal	scrapings	sample	processing	and	cell	isolation	Nasal	 scrapings	were	 taken	 from	 the	 lower	 edge	of	 the	 inferior	 turbinate	of	 the	nasal	cavity.	 This	 is	 an	 easily	 accessible	 area	 associated	 with	 a	 low	 risk	 of	 bleeding.	 Two	methods	 of	 specimen	 collection	were	 used	due	 to	 their	 small	 size:	 a	 cervical	 cytology	brush	and	a	sterile	swab.	Each	method	was	used	for	one	nostril	of	the	same	patient	and	was	performed	by	a	consultant	obstetrician.	Both	swab	and	cytology	brush	were	inserted	and	gently	rotated	with	the	aim	of	collecting	epithelial	cells	from	the	nasal	mucosa.	The	implements	were	removed	and	inserted	into	separate	collection	tubes	containing	sterile	PBS	and	agitated.	The	samples	were	taken	to	the	laboratory	where	they	were	labelled	as	PWNB01B	(for	the	brush	sample)	and	PWNS01S	(for	the	swab	sample)	and	processed	using	sterile	techniques.			
4.3.4.1 Nasal	scrapings	cell	isolation	The	sample	collection	implement	was	removed	from	the	sterile	PBS	and	a	cell	count	was	performed	using	the	trypan	blue	exclusion	assay	(section	2.2.3).	The	PBS	was	centrifuged	at	400G	for	20	minutes.	The	supernatant	was	aspirated	and	the	pellet	resuspended	in	the	appropriate	culture	media.	Cells	were	seeded	at	2x105	cells/well	in	a	collagen	coated	24	well	plate.	Samples	were	cultured	at	37°C	for	20	days	with	media	changes	every	2-3	days.			
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4.3.5 Placenta	derived	MSC	
4.3.5.1 Cell	extraction	and	culture	in	21%	oxygen	and	40%	oxygen	MSC	 extraction	 for	 the	 chorion	 and	 amnion	membrane	was	 achieved	 as	 described	 in	section	0.	To	assess	the	effect	of	hyperoxia	on	derived	cells,	cells	were	trypsinised	(section	2.2.1)	and	plated	at	2x104	cells/well	of	a	12	well	plate	and	cultured	for	25	days	at	37°C	at	21%	 oxygen	 or	 40%	 oxygen	 (40%	 oxygen	 achieved	 using	 polycarbonate	 containers,	section	2.16).	The	AlamarBlue	assay	was	performed	(section	2.15)	every	few	days	and	DNA	was	quantified	(section	2.13)	at	day	25.	Samples	were	stained	using	the	LiveDead	cell	 viability	 assay	 (section	 2.7)	 and	 imaged	 using	 phase	 contrast	 and	 fluorescence	microscopy.	
4.3.5.2 MSC	characterisation	To	 validate	 MSC	 identity	 of	 extracted	 cells	 tri-lineage	 differentiation	 and	 marker	expression	(using	flow	cytometry)	was	used	as	described	in	section	2.8.	Cells	previously	isolated	in	4.3.5.1	were	cultured	at	21%	oxygen	and	40%	oxygen	until	100%	confluency	was	achieved.	Cells	were	trypsinised	and	underwent	the	protocol	described	in	section	2.5	for	tri-lineage	analysis	and	section	2.8	for	marker	expression.	Results	were	analysed	using	Flowing	Software	2.5.1.		
4.3.6 Statistical	analysis	Hydrogel	measurements,	DNA	quantification	and	Alamar	blue	results	were	all	statistically	compared	using	two-way	ANOVA	with	Tukey’s	multiple	comparisons	test	to	determine	the	 statistical	 significance,	 p≤0.05	was	 considered	 significant.	Analysis	was	performed	using	GraphPad	Prism	version	7.01.	All	values	quoted	in	the	results	are	mean	average	±	standard	deviation.	 	
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4.4 Results	
4.4.1 Sample	collection	and	cell	isolation	Tracheal	suctionings	were	collected	from	recruited	patients	as	described.	Details	of	each	sample	 and	 patient	were	 collected	 as	 shown	 in	 Table	 4.1.	 Three	 of	 the	 patients	were	consented	 but	 samples	were	 not	 processed	 in	 the	 laboratory	 due	 to	 patient	 death	 or	logistical	disturbances.			Samples	were	successfully	collected	 from	6	 infants;	each	sample	underwent	a	 live	and	dead	 cell	 count	 (Figure	 4.1	A);	 of	 those	 samples	 cells	 were	 successfully	 isolated	 and	cultured	from	60%	(Figure	4.1	B).	Cells	from	the	samples	were	cultured	on	tissue	culture	plastic	or	collagen	coated	tissue	culture	plastic	until	90-100%	confluency	was	achieved.	Cells	were	passaged	up	to	10	times	and	cell	doubling	times	were	determined	(Figure	4.1	
C	 and	D).	Most	of	 the	 isolated	cells	maintain	a	 constant	doubling	 time	except	 samples	PWTA013C	and	PWTA021P	which	dramatically	increased	their	doubling	time	at	passage	6	 and	 3	 respectively	 indicating	 the	 cells	 senesced	 (cells	 ceasing	 to	 divide).	 Cells	were	imaged	every	few	days	with	phase	contrast	light	microscope	(Figure	4.2-Figure	4.4).	Cells	from	 samples	 PWTA011,	 PWTA013	 and	 PWTA021	 exhibited	 a	 fibroblast	morphology	which	was	maintained	through	further	passaging	and	hence	forth	referred	to	as	NLF	cells.	Images	 for	 the	 other	 samples	 consistently	 show	 rounded	 detached	 cells	 which	 were	indirectly	aspirated	during	media	changes.		
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Table	4.1	Information	from	patients	who	have	given	their	consent	to	their	samples	
being	collected	
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Figure	4.1	Cell	counts	of	tracheal	suctionings	collected	from	ventilated	babies	on	
the	NICU.	Cells	extracted	from	tracheal	suctionings	were	counted	using	the	trypan	blue	exclusion	assay	 (A).	The	number	of	patients	 in	which	 samples	were	 sourced	and	how	successful	 cell	 extraction	 was	 in	 shown	 (B).	 Samples	 which	 cells	 were	 successfully	cultured	from	are	highlighted	with	a	red	box	(A).	The	cell	doubling	time	for	each	passage	was	calculated	and	recorded	(C).		
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Figure	4.2	Phase	contrast	light	microscopic	images	of	cells	extracted	from	tracheal	
suctionings	 of	 ventilated	 babies	 at	 passage	 0.	 Representative	 images	 of	 sample	PWTA011,	PWTA013,	PWTA021	and	PWTA014	were	taken	every	5	days	in	culture	for	each	sample.		
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Figure	4.3	Phase	contrast	light	microscopic	images	of	cells	extracted	from	tracheal	
suctionings	of	ventilated	babies	at	passage	1	and	4.	Representative	images	of	samples	PWTA011,	PWTA013,	PWTA021	and	PWTA014	were	taken	at	passage	1	and	4.	Scale	bar	represent	200µm.	
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Figure	4.4	Phase	contrast	light	microscopic	images	of	cells	extracted	from	tracheal	
suctionings	 of	 ventilated	 babies.	 Representative	 images	 of	 samples	 PWTA014,	PWTA012,	PWTA022	and	PWTA031	were	taken	every	5	days	in	culture	for	each	sample.	Scale	bar	represent	200µm.								
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4.4.2 Extracted	cells	from	neonatal	tracheal	aspirates	contract	
collagen	hydrogels	Extracted	and	cultured	NLF	cells	(sample	PWTA013P)	were	seeded	in	1.5mg/ml	collagen	hydrogels	 at	 a	 density	 of	 100,000	 cells/gel	 and	 cultured	 for	 20	 days	 to	 assess	contractibility.	Percentage	change	in	hydrogel	depth	and	diameter	was	calculated	(Figure	4.5).	35FL	hydrogels	were	prepared	in	the	same	manner	as	an	internal	control.	Confocal	z-stacks	were	collated	to	assess	cell	morphology	and	viability	(Figure	4.6).	35FL	seeded	hydrogels	contracted	in	the	same	manner	as	previously	shown.	The	NLF	seeded	hydrogels	contracted	 at	 a	 significantly	 higher	 rate	 in	 comparison.	 Z-stack	 images	 show	 the	 cells	fluorescing	green	 indicating	good	cell	viability.	The	NLF	cells	are	more	highly	compact	with	 smaller	 cells	 that	 the	35FL	 cells.	The	 z-stack	 images	 indicate	NLF	and	35FL	 cells	migrated	to	the	bottom	of	the	hydrogel	(Figure	4.6).	
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Figure	4.5	Adult	lung	cells	35FL	and	NLF	cells	cultured	in	collagen	hydrogels.	Change	in	 hydrogel	 depth	 and	 diameter	was	measured	 over	 20	 days	 in	 culture	 to	 assess	 cell	function.	 Data	 is	 expressed	 as	mean	 ±	 standard	 deviation,	 n=4	 (**p≤0.05,	 ***p≤0.001,	****p≤0.0001)	
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Figure	 4.6	 Adult	 lung	 cells	 35FL	 and	 NLF	 cells	 cultured	 in	 collagen	 hydrogels.	Confocal	 z	 stack	 images	 were	 taken	 of	 hydrogels	 stained	 with	 LiveDead	 staining	 kit.	Images	shows	hydrogels	from	on	top	through	the	z-axis	(A	and	D)	and	in	the	x	and	y	axis	(B,	C,	E	and	F).	Green	fluorescence	indicates	cell	viability	is	good.			
4.4.3 Extracting	epithelial	cells	from	tracheal	aspirates	was	
unsuccessful	To	encourage	the	culture	of	epithelial	cells	from	neonatal	lung	tracheal	aspirates	sample	PWTA051	 was	 immediately	 cultured	 in	 commercially	 available	 lung	 epithelial	 media.	Samples	were	 imaged	with	phase	contrast	microscopy	at	day	7	of	culture	(Figure	4.7).	
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Cells	were	rounded,	clumped	and	appeared	detached	(due	to	rounded,	free-floating	cells)	from	the	plate.	Observed	cells	reduced	in	number	over	the	30	days	in	culture.			
	
Figure	 4.7	 Tracheal	 suctioning	 sample	 (PWTA05)	 cultured	 in	 commercial	 lung	
epithelial	 medias	 BEGM,	 LHC-9	 and	 CA	 media	 day	 7.	 Cells	 displayed	 a	 rounded	morphology,	clumping	and	detached	from	the	culture	plate.	Through	media	changes	the	detached	cells	were	aspirated	away.			
4.4.4 Cell	extraction	from	infant	nasal	scrapings		Samples	were	taken	from	the	inferior	turbinate	of	the	nasal	cavity	of	a	healthy	infant	using	either	a	swab	or	a	brush.	A	cell	count	was	performed	on	each	sample	and	phase	contrast	microscope	 images	 taken	 (Figure	4.8).	The	brush	 technique	had	a	 cell	 count	of	over	3	times	 larger	 than	 the	swab	 technique	and	possessed	a	 lower	percentage	of	dead	cells.	Observations	 with	 phase	 contrast	 microscopic	 imaging	 showed	 small	 rounded	 cells	clustering	together	for	both	extraction	techniques.	Cells	did	not	demonstrate	attachment	to	the	tissue	culture	plastic	which	were	washed	away	through	medium	chages.	During	the	culture	period	fewer	cells	could	be	observed.	
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Figure	 4.8	 Cultured	 nasal	 scrapings.	 Samples	 were	 taken	 using	 a	 brush	 technique	(PWNB01B)	 or	 a	 swab	 (PWNB01S).	 Cells	 counts	were	 achieved	using	 the	 trypan	blue	exclusion	method.	Phase	contrast	light	microscopic	images	were	captured	of	samples	in	culture.	The	brush	 technique	removed	more	cells	and	had	a	 lower	percentage	of	dead	cells.	
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4.4.5 Hyperoxia	affects	placenta	derived	MSCs	proliferation	Extracted	amnion	and	chorion	MSCs	were	cultured	for	25	days	at	21%	and	40%	oxygen.	Cells	were	imaged	with	light	microscopy	and	confocal	fluorescence	microscopy	with	the	LiveDead	 cell	 viability	 kit	 (Figure	 4.9).	 Both	 amnion	 and	 chorion	 cells	 were	 100%	confluent	at	21%	oxygen,	but	cell	density	was	much	lower	at	40%	oxygen.	The	LiveDead	staining	showed	the	cells	were	viable	in	all	conditions	as	shown	by	the	green	fluorescence.	No	red	fluorescence	was	observed.	The	cells	at	21%	oxygen	have	a	more	elongated	cell	morphology	 than	 cells	 at	 40%	 oxygen.	 For	 the	 AlamarBlue	 assay	 a	 statistically	 lower	fluorescence	value	was	measured	at	later	time	points	for	cells	cultured	at	40%	oxygen.	This	trend	was	the	same	for	both	amnion	MSCs	and	chorion	MSCs.	Quantified	DNA	was	statically	lower	at	day	25	for	both	cell	types	when	cultured	at	40%	oxygen.	The	effect	was	more	evident	for	chorion	MSCs	(Figure	4.9).	
PhD	Thesis	by	J.	A.	J.	Bratt	 	Chapter	4:	The	extraction	&	characterisation	
	 118	
	
Figure	4.9	MSCs	extracted	from	placentas	cultured	at	21%	oxygen	and	40%	oxygen.	Cells	from	the	amnion	membrane	and	chorion	membrane	were	imaged	after	20	days	in	culture	with	phase	contrast	microscopy	and	confocal	imaging	using	the	LiveDead	staining	kit.	The	AlamarBlue	assay	was	performed	every	few	days	and	DNA	quantified	day	25.	40%	oxygen	significantly	affects	placenta	MSCs	proliferation	and	metabolic	activity.	Data	are	expressed	as	mean	±	standard	deviation,	n=6	(*p≤0.05,	**p≤0.05,	****p≤0.0001).						
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4.4.6 Hyperoxia	affects	placental	MSC	characterisation.	Cells	extracted	from	the	amnion	and	chorion	placenta	membranes	were	cultured	at	21%	and	40%	oxygen	with	two	aims:	
• to	characterise	isolated	MSCs	
• to	assess	the	effect	hyperoxia	has	on	placenta	derived	MSCs	characterisation	and	proliferation		Characterisation	was	achieved	using	flow	cytometry	to	measured	marker	expression	and	tri-lineage	 differentiation	 capacity.	 Both	 chorion	 and	 amnion	 MSCs	 expressed	 the	expected	stromal	markers	associated	with	MSCs	when	cultured	at	21%	oxygen	(Figure	4.10	 and	 Figure	 4.11).	 However,	 chorion	 MSCs	 at	 40%	 oxygen	 marker	 expression	indicates	2	populations	of	cells.	Two	peaks	are	seen	for	markers	CD73,	CD90	and	CD105.	For	markers	CD34,	CD45	and	HLADR	there	is	a	shift	in	peak	to	the	right	suggesting	some	cells	expressed	these	markers.	Marker	expression	seems	less	affected	by	hyperoxygen	for		the	 amnion	MSCs	which	 is	 as	 expected	 for	MSCs	with	 the	 exception	of	 CD90	which	 is	shifted	to	the	right.			Tri-lineage	differentiation	was	positive	for	all	sample	conditions	and	was	unaffected	by	hyperoxygen	(Figure	4.12	and	Figure	4.13).	There	is	a	marked	difference	in	staining	levels	comparing	amnion	and	chorion	MSCs.	More	intense	staining	levels	can	be	seen	for	amnion	MSCs.	 Staining	 for	 lipid	 accumulation	 for	 amnion	 MSCs	 at	 40%	 oxygen	 was	 slightly	reduced	 compared	with	 amnion	MSCs	 at	 21%	 oxygen.	 Control	 samples	 cultured	with	growth	media	only	were	negative	for	all	staining.	
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Figure	4.10	Flow	cytometry	results	for	chorion	placenta	derived	MSCs.	Expression	of	MSC	related	markers	was	analysed	for	MSC	extracted	from	chorion	placenta	membrane	and	 cultured	 in	 21%	oxygen	 and	40%	oxygen.	MSC	markers	 typically	 negative:	 CD19,	CD14,	CD34,	CD45	and	HLADR.	MSC	markers	typically	positive:	CD73,	CD90	and	CD105.	Grey	fill	represents	isotype	control	IgG1	or	IgG2a,	yellow	fill	represents	antibody	marker.	Cells	cultured	at	40%	affects	the	expression	of	markers	CD73,	CD90	and	CD105.	
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Figure	4.11	Flow	cytometry	results	for	amnion	placenta	derived	MSCs.	Expression	of	MSC	related	markers	was	analysed	for	MSC	extracted	from	amnion	placenta	membrane	and	 cultured	 in	 21%	oxygen	 and	40%	oxygen.	MSC	markers	 typically	 negative:	 CD19,	CD14,	CD34,	CD45	and	HLADR.	MSC	markers	typically	positive:	CD73,	CD90	and	CD105.	Grey	fill	represents	isotype	control	IgG1	or	IgG2a,	yellow	fill	represents	antibody	marker.	Cells	cultured	at	40%	affects	the	expression	of	marker	CD90.	
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Figure	4.12	Tri-lineage	differentiation	staining	for	chorion	placenta	MSCs.	Images	of	cells	cultured	under	the	appropriate	conditions	to	encourage	MSC	differentiation	into	adipocytes,	osteocytes	and	chondrocytes.	Cells	cultured	in	either	21%	or	40%	oxygen	and	were	fixed	and	stained:	Osteogenic	samples	were	stained	with	alizarin	red	S	for	calcium	deposits,	 chondrogenic	 samples	 were	 stained	 with	 alcian	 blue	 for	 SGAGs,	 Adipogenic	samples	are	stained	with	oil	red	O	for	lipid	droplets.	Images	of	control	cells	cultured	in	standard	culture	media	and	stained	as	appropriate	are	inset	for	comparison.	Scale	bars	represent	200µm.				
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Figure	4.13	Tri-lineage	differentiation	staining	for	amnion	placenta	MSCs.	Images	of	cells	 cultured	 at	 the	 appropriate	 conditions	 to	 encourage	 MSC	 differentiation	 into	adipocytes,	osteocytes	and	chondrocytes.	Cells	cultured	at	either	21%	or	40%	oxygen	and	were	fixed	and	stained:	Osteogenic	samples	were	stained	with	alizarin	red	S	for	calcium	deposits,	 chondrogenic	 samples	 were	 stained	 with	 alcian	 blue	 for	 SGAGs,	 Adipogenic	samples	are	stained	with	oil	red	O	for	lipid	droplets.	Images	of	controls	cells	cultured	in	standard	culture	media	and	stained	as	appropriate	are	inset	for	comparison		
4.5 Discussion	
4.5.1 Tracheal	suctioning	for	isolation	and	expansion	of	neonatal	
lung	cells	Cell	counts,	cytokine	analysis	and	RNA	expression	have	all	been	previously	achieved	from	tracheal	suctionings	from	adult	and	neonates	207–209.	However,	there	are	few	examples	of	the	isolation	of	cells	for	long-term	culture.	Here	we	investigated	whether	cells	could	be	isolated	and	expanded	for	use	in	an	in	vitro	model	of	BPD.	Tracheal	suctioning	is	a	routine	procedure	 to	 maintain	 patency	 of	 the	 airways	 of	 artificially	 ventilated	 infants.	 The	aspirated	secretions	are	usually	disposed	of	and	offer	an	advantage	for	research	purposes	since	there	are	no	additional	risk	factors	to	the	infant.	Recruitment	and	seeking	consent	
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were	relatively	straight	forward	procedures	with	parent/guardians	overall	being	willing	to	participate	in	the	study	since	there	was	no	additional	risk	to	the	infant.	Definite	BPD	diagnosis	is	made	28	days	after	birth	so	during	the	time	of	sample	collection	diagnosis	of	BPD	had	not	been	confirmed.	However,	clinicians	have	a	strong	idea	based	of	gestational	age	and	birth	weight.	Tracheal	suctioning	collection	is	an	unplanned	procedure	based	on	clinical	 indications.	 This	 proved	 difficult	 for	 laboratory	 purposes	 since	 equipment	preparation	time	is	limited.	It	is	also	not	possible	to	foresee	how	many	tracheal	suctions	each	 infant	 will	 need	 to	 have	 during	 their	 time	 in	 NICU.	 Sample	 collection	 from	 the	hospital	was	straightforward	with	no	major	issues	arising.	However	due	to	the	nature	of	the	 NHS,	 samples	 may	 have	 been	 left	 waiting	 at	 room	 temperature	 for	 various	 time	periods,	 it	 wasn’t	 possible	 to	 document	 this	 or	 to	 store	 samples	 in	 a	 temperature-controlled	unit.			Cells	were	successfully	 isolated	from	40%	of	patients.	Multiple	samples	were	collected	from	each	patient,	but	cells	were	not	always	isolated	from	samples	of	the	same	patient.	This	indicates	cell	culture	success	is	not	necessarily	based	on	the	patient	themselves	but	possibly	external	factors	such	as	the	procedure,	personnel	performing	the	procedure	or	time	of	sample	collection.	Tracheal	suctionings	can	be	deep,	or	shallow	determined	by	how	far	the	catheter	is	inserted.	With	deep	tracheal	suctionings	the	catheter	is	inserted	until	 respiratory	 wall	 or	 the	 tracheal	 bifurcation	 is	 met.	 With	 shallow	 insertion	 the	catheter	only	goes	as	deep	as	the	trachea.	The	technique	used	was	not	recorded	and	may	have	 affected	 sample	 quality.	 However	 reports	 have	 indicated	 there	 is	 no	 difference	between	cellular	component	of	deep	versus	shallow	tracheal	suctionings	190.			Cell	counts	varied	considerably	between	samples	and	there	was	no	observed	correlation	between	 cell	 counts	 and	 the	 isolation	 of	 cells.	 Cultured	 cells	 possessed	 a	morphology	indicative	of	fibroblasts	in	terms	of	their	spindle-like,	elongated	morphology,	adhesion	to	
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tissue	culture	plastic,	high	proliferation	and	contractibility	of	collagen	hydrogels.	Their	ability	to	maintain	good	cell	viability,	proliferative	function	and	contraction	in	collagen-elastin	 hydrogels	makes	 them	 an	 ideal	 candidate	 for	 use	 in	 our	 previously	 developed	alveolus	 model.	 Further	 investigation	 is	 required	 to	 state	 with	 confidence	 that	 the	extracted	 cells	 are	 fibroblasts	 in	 origin.	 Staining	 for	 a	 mesenchymal	 marker	 such	 as	vimentin	 along	 with	 the	 absence	 of	 non-fibroblast	 markers	 such	 as	 epithelial	 or	haemopoietic	markers	would	provide	 a	more	detailed	understanding	of	 cell	 type.	The	identification	of	antibody	TE-7	and	smooth	muscle	actin	have	also	been	acknowledge	as	a	lung	fibroblast	marker	210.	The	isolation	of	fibroblast-like	cells	is	further	supported	by	work	 done	 by	 Hennrick	 et	 al.	 They	 isolated	 cells	 from	 the	 tracheal	 aspirate	 fluid	 of	premature,	 ventilated	 neonates	 that	 possessed	 characteristics	 typical	 of	mesenchymal	stem	 cells	 157.	 They	 observed	 a	 trend	 relating	 the	 isolation	 of	 cells	 and	 more	 severe	ventilation	suggesting	that	MSCs	home	in	to	the	site	of	injury.	This	postulates	the	idea	that	the	 cells	we	 isolated	 could	demonstrate	MSC	characteristics.	 Further	 analysis	 into	 cell	markers	 and	 differentiation	 potential	would	 be	 required	 to	 further	 evaluate	 cell	 type.	Unlike	Hennrick	et	al.	we	did	not	find	any	trend	between	cell	isolation	and	patient	type.	However,	we	had	a	much	smaller	sample	size	of	only	6	patients	with	a	success	rate	of	33%	which	is	under	the	55%	success	rate	observed	by	Hennrick	et	al.			We	 further	 investigated	 whether	 epithelial	 cells	 could	 be	 isolated	 from	 tracheal	suctionings.	In	initial	experiments	we	used	attachment	time	and	collagen	coating	to	select	the	 attachment	 of	 fibroblasts	 and	 epithelial	 cells	 (fibroblasts	 attach	 quicker	 than	epithelial	 cells	 and	 collagen	 coating	 encourages	 epithelial	 attachment211).	 This	 time-dependant	 and	 substrate-dependant	 technique	 failed	 to	 isolated	 both	 fibroblasts	 and	epithelial	 cells	 with	 only	 fibroblast-like	 cells	 being	 cultured.	 To	 promote	 epithelial	isolation,	we	sourced	three	types	of	commercially	available	lung	epithelial	media	which	were	used	 to	 culture	 cells	 from	sample	PWTA05	but	again	 this	was	unsuccessful.	 It	 is	
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likely	that	epithelial	cells	are	present	in	tracheal	suctions	due	to	accidental	damage	to	the	tracheal	 mucosa	 during	 the	 procedure,	 however	 these	 cells	 may	 not	 be	 viable190.	 To	evaluate	 the	cell	populations,	present	 in	 tracheal	suctionings,	 flow	cytometry	could	be	performed.	 Cells	would	 be	 fluorescently	 labelled	 for	 cell	membrane	markers	 typically	associated	with	certain	cell	types.	Flow	cytometry,	previously	used	for	bronchoalveolar	lavage	analysis	212,	could	also	be	used	to	assess	cell	heath	and	be	used	for	cell	sorting.			Nasal	 scrapings	 were	 investigated	 as	 an	 alternative	 source	 of	 cells.	 Nasal	 biopsies	 or	lavage	are	a	common	tool	to	monitor	inflammation	and	isolating	respiratory	cells	191–197.	Two	samples	were	collected	using	a	brush	and	a	 swab.	Both	 techniques	delivered	cell	numbers	comparable	to	those	seen	in	previous	published	work191.	The	brush	technique	has	 been	 found	 to	 have	 better	 diagnostic	 accuracy	 when	 used	 for	 paediatric	 disease	diagnosis213	 and	 we	 found	 the	 technique	 extracted	 72,000	 cells	 compared	 with	 only	21,000	 cells	 for	 the	 swab	 technique.	 Both	 extraction	 techniques	 proved	 futile	 for	 cell	expansion.	 Further	 investigation	 is	 required	 to	 optimise	 culture	 techniques	 and	conditions	 such	 as	 plating	 substrate,	media	 composition	 and	 seeding	 density.	 Sample	collection	was	logistically	more	difficult	since	the	procedure	isn’t	current	routine	practice	and	can	cause	mild	discomfort	to	the	child.	Our	attention	moved	away	from	using	nasal	scrapings	for	cell	isolation	and	we	focused	on	the	tracheal	suctionings	as	a	cell	source.			
4.5.2 Placenta	derived	MSCs	MSCs	 are	 a	 well-established	 cell	 type	 for	 their	 regenerative	 capacity	 and	 function	 in	development.	Multiple	studies	have	identified	their	presence	in	the	developing	lung	157,214.	Work	 by	 Popova	 et	 al.	 suggested	MSC	 isolation	 from	 tracheal	 aspirates	 can	 be	 used	 a	prediction	 of	 BPD	 and	 suggests	 that	 lung	MSCs	 have	 a	 role	 in	 BPD	 progression.	 This	indicates	that	MSCs	may	provide	an	ideal	candidate	for	a	cell	therapy	for	the	treatment	of	
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BPD.	 There	 have	 been	many	 experimental	 studies	 examining	 the	 effect	MSCs	 have	 on	animal	models	of	BPD.	A	meta-analysis	by	Augustine	et	al.	showed	that	administration	of	MSCs	significantly	improved	lung	injury	in	rodents	215.	A	phase	I	dose-escalated	clinical	trial	was	conducted	to	assess	the	intratracheal	transplantation	of	human	umbilical	cord	blood	(UCB)-derived	MSCs	in	preterm	infants	at	high	risk	of	BPD	171.	The	study	concluded	the	 cell	 therapy	was	 a	 safe	 and	 feasible	 treatment	 for	 BPD.	 The	 group	 now	 hopes	 to	conduct	a	phase	2	clinical	 trial	 (ClinicalTrials.gov	 Identifier	NCT03392467).	UCB	MSCs	possess	similar	attributes	to	placenta	derived	MSCs	in	that	they	are	both	sourced	from	gestational	tissue,	they	are	waste	materials	associated	with	no	additional	morbidities	and	therefore	provides	an	ideal	source	of	stem	cells.	Protocols	have	been	established	for	MSC	isolation	from	the	chorion	and	the	amnion	placenta	membranes.			In	 this	 chapter	we	have	 successfully	 isolated	amnion	and	 chorion	membrane	placenta	MSCs	sourced	from	routine	caesarean	sections	of	healthy	term	births.	We	did	not	face	any	logistical	 issues	 when	 collecting	 placentas	 for	 processing.	 The	 only	 difficulty	 for	researchers	is	timing;	routine	caesarean	sections	are	planned	procedures	so	scheduling	can	be	 estimated,	 however,	 emergency	 cases	will	 take	 priority	 and	push	back	 routine	procedures.	This	therefore	disrupts	timing	and	can	cause	issues	for	laboratory	planning.	The	MSC	isolation	procedure	we	used	was	based	on	a	previous	established	protocol	165	and	further	developed	in	our	laboratory.	The	isolated	cells	from	both	the	chorion	and	the	amnion	 were	 compliant	 with	 the	 differentiation	 potential	 and	 marker	 expression	associated	 with	 MSCs	 as	 recommended	 by	 the	 Mesenchymal	 and	 Tissue	 Stem	 Cell	Committee	 of	 the	 International	 Society	 for	 Cellular	 Therapy	 (Table	 4.2).	 To	 further	develop	this,	we	wanted	to	understand	the	effect	hyperoxia	had	on	MSC	markers	since	this	 cell	 therapy	would	 be	 used	 for	 BPD	 infants	 likely	 to	 be	 undergoing	 hyperoxygen	ventilation	 (ranging	 from	 >21%-100%	 oxygen).	 We	 exposed	 the	 isolated	 aMSCs	 and	cMSCs	to	40%	oxygen	during	culture	and	compared	this	with	culture	at	21%	oxygen.	Both	
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sets	 of	 cells	 had	 a	 similar	 response	with	 those	 cells	 at	 21%	oxygen	possessing	 all	 the	expected	characteristics	of	MSCs	however	cells	at	40%	oxygen	had	reduced	proliferative	capacity,	 senescent-like	 morphology	 (larger,	 flattened	 cells)216	 and	 distorted	 marker	expression.	The	marker	expression	suggests	there	are	two	populations	of	cells.			The	 effect	 of	 cultivated	 oxygen	 level	 has	 been	 well	 documented	 when	 comparing	atmospheric	 oxygen	 (21%)	 with	 physiological	 (<5%)	 oxygen.	 Atmospheric	 oxygen	impedes	cell	proliferation	and	affects	marker	expression	due	to	oxidative	stress	217,218.	aMSCs	and	cMSCs	possessed	similar	responses	and	displayed	morphological	similarities	as	has	been	previously	demonstrated219.	 	There	 is	 very	 little	 evidence	available	which	looks	at	the	effect	of	hyperoxia	of	>21%	on	MSCs,	emphasising	the	novelty	of	this	work.	A	couple	of	reports	have	demonstrated	oxidative	stress	impedes	cellular	proliferation	and	leads	to	senescence163,220.	A	recent	publication	by	Popova	et	al.	221	showed	that	resident	foetal	 lung	 mesenchymal	 cells	 cultured	 at	 60%	 oxygen	 alters	 surface	 markers	 and	production	 of	 extracellular	matrix.	 However,	 in	 contrast	 umbilical	 cord	 blood	 derived	MSCS	cultured	at	60%	oxygen	dramatically	increased	antioxidant	and	anti-inflammatory	factors221.	This	suggests	hyperoxia	exposure	may	impede	endogenous	MSCs	which	leads	to	 BPD	 phenotype.	 Umbilical	 cord	 blood	 MSCs	 on	 the	 other	 hand	 could	 provide	beneficiary	effects	to	protect	the	organ.			The	importance	of	considering	the	effect	of	hyperoxia	on	cell	therapies	depends	on	the	administered	 route.	 In	 animal	 models	 MSCs	 have	 been	 delivered	 systemically,	intratracheally	and	intraperitoneally222.	The	most	obvious	delivery	route	for	the	lung	is	intratracheal	because	 this	 is	a	similar	method	to	surfactant	delivery,	a	current	routine	procedure	and	would	deliver	cells	directly	to	the	diseased	tissue.	Intratracheal	delivery	has	been	found	to	be	a	more	efficient	delivery	route	when	compared	with	IV163.	The	cell	therapy	would	be	exposed	to	atmospheric	oxygen	(21%)	or	hyperoxygen	(>21%)	if	the	
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patient	is	requiring	oxygen	ventilation.	A	current	discussion	point	surrounding	MSCs	as	a	cell	 therapy	 is	 the	mode	of	 action.	Evidence	 suggests	 that	MSC	cell	 engraftment	 is	not	necessary	for	these	stem	cells	to	influence	native	tissue.	MSCs	may	stimulate	native	cells	through	 paracrine	 mechanisms223	 meaning	 that	 the	 hyperoxygen	 environment	 a	 cell	therapy	 is	 exposed	 to	 would	 not	 matter;	 or	 that	 pre-conditioned	 media	 could	 be	 as	advantageous	as	administering	the	cells.	Previous	work	has	demonstrated	both	aMSCs	and	cMSCs	excrete	large	amounts	of	soluble	factors;	however	some	differences	have	been	noted	 for	 example	 aMSCs	 have	 an	 enhanced	 secretion	 of	 PGE2	 leading	 to	 reduced	 T-lymphocyte	 proliferation	 224.	 So,	 although	 aMSCs	 and	 cMSCs	 possess	 similar	characteristics	in	terms	of	proliferative	capacity	and	marker	expression,	one	cell	type	may	perform	better	as	a	cell	therapy	for	certain	diseases.	At	this	point	it	is	difficult	to	establish	which	MSC	source	would	provide	a	better	outcome	for	BPD	since	the	disease	mechanism	is	still	uncertain.	 	
Table	4.2	Mesenchymal	and	Tissue	Stem	Cell	Committee	of	the	International	Society	
for	Cellular	Therapy	recommended	MSC	markers	
 
Characteristic 
  
1 Adherence to plastic in culture 
  
2 Marker expression  Positive Negative  
CD105 CD45  
CD73 CD34  
CD90 CD14 or 
CD11b   
CD79 or CD19   
HLA-DR 
3 In vitro differentiation to osteoblasts, adipocytes and chondrocytes 					
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4.6 Conclusion	
We	have	demonstrated	that	tracheal	suctionings	from	ventilated	neonates	can	be	used	for	the	 isolation	 and	 expansion	 of	 human	 lung	 neonatal	 cells.	 These	 cells	 (NLF)	 were	fibroblastic	in	nature	and	are	a	suitable	candidate	for	use	in	an	in	vitro	model	of	BPD	since	they	can	be	cultured	long-term	in	collagen-elastin	hydrogels.	Further	cell	characteristic	analysis	is	necessary	to	identify	cell	type.	Previous	published	work	has	isolated	cells	in	a	similar	 manner	 and	 identified	 them	 as	 possessing	 MSC	 characteristics.	 The	 cells	 we	isolated	could	indeed	also	possess	similar	characteristics	and	we	therefore	hypothesise		that	MSCs	are	recruited	in	lung	injury	and	are	necessary	for	normal	lung	maturation	and	healing.		MSCs	 were	 successfully	 isolated	 and	 expanded	 from	 chorion	 and	 amnion	 placenta	membranes.	Characterisation	using	the	tri-lineage	differentiation	technique	and	marker	expression	indicated	these	cells	possess	the	necessary	attributes	of	MSCs	as	described	by	Mesenchymal	and	Tissue	Stem	Cell	Committee	of	 the	 International	Society	 for	Cellular	Therapy	recommended	MSC	markers225. Both	aMSCs	and	cMSCs	marker	expression	and	proliferation	were	affected	by	hyperoxia	exposure.	This	could	have	detrimental	impacts	if	MSC	cell	therapy	could	ever	potentially	be	used	as	a	cell	therapy	for	BPD	infants	who	require	hyperoxygen	ventilation.	
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Chapter	5 	Examining	the	therapeutic	capabilities	of	placenta	MSCs	when	exposing	lung	cells	to	hyperoxia
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5.1 Introduction	
In	recent	years	the	regenerative	and	repair	capabilities	of	MSCs	have	been	the	focus	of	regenerative	medicine.	For	the	 lung	in	particular	stem	cells	have	been	of	 interest	 for	a	variety	 of	 chronic	 conditions	 including	 idiopathic	 pulmonary	 fibrosis,	 emphysema,	asthma	 and	 chronic	 obstructive	 pulmonary	 disease	 (COPD).	 Data	 gathered	 from	 BPD	animal	models	suggests	stem	cells	could	play	a	significant	role	in	alleviating	the	effects	of	lung	 injury	 found	 in	 BPD	 through	 their	 immunomodulatory	 properties,	 antifibrotic	effects,	 and	 antioxidative	 properties.	 In	 the	 early	 days	 of	 stem	 cell	 research	 it	 was	suggested	 that	 administered	 MSCs	 function	 through	 migration	 and	 engraftment.	However,	emerging	evidence	indicates	therapeutic	MSCs	may	function	through	paracrine	mechanisms.	The	paracrine	effect	of	MSCs	has	been	investigated	for	a	variety	of	diseases	including	cardiovascular	disease,	acute	kidney	disease,	liver	fibrosis,	neurological	disease	and	 wound	 healing226.	 For	 BPD	 in	 particular	 MSCs	 have	 been	 shown	 to	 release	 anti-inflammatory	 cytokines	 and	 exosomes	 to	 ameliorate	 the	 parenchymal	 injury	 found	 in	preclinical	BPD	models158,159,227,228.	This	offers	a	viable	alternative	to	cell	therapies	since	the	use	of	pre-conditioned	media	or	purified	exosomes	would	avoid	the	inherent	risks	of	cell	 therapies	 such	 as	 tumorigenesis,	 autoimmune	 reaction	 and	 disease	transmission229,230.			The	 limiting	 factor	of	many	reports	on	BPD	is	 the	use	of	rodent	models.	As	previously	explained	 rodent	 models	 arguably	 do	 not	 accurately	 represent	 the	 human	 pre-term	lung231.	In	previous	chapters	we	have	established	a	human	relevant	3D	alveolus	model	in	which	we	incorporated	human	lung	cells	isolated	from	the	lung	of	ventilated	neonates.	In	this	 chapter	we	 expose	 human	 lung	 adult	 and	 neonatal	 cells	 in	 a	 2D	 and	 3D	 state	 to	hyperoxia	representative	of	clinical	ventilation	experienced	by	BPD	patients.	We	initially	assessed	 the	 cellular	 response	when	 the	 cells	 are	 exposed	 to	 hyperoxia.	We	 then	 co-
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culture	 the	 adult	 and	 neonatal	 lung	 cells	 with	 placenta	 derived	 MSCs	 to	 assess	 the	potential	alleviation	of	oxidative	stress.	Since	emerging	evidence	suggests	MSCs	act	in	a	paracrine	 manner	 an	 indirect	 co-culture	 method	 using	 well-inserts	 has	 been	incorporated.		
 
5.2 Aims	
The	 aim	 of	 this	 chapter	 was	 to	 integrate	 aspects	 developed	 from	 the	 previous	 two	experimental	chapters.	Firstly,	we	exposed	adult	lung	cells	(35FL	and	A549)	and	neonatal	lung	cells	(isolated	NLF)	to	40%	oxygen	in	both	a	2D	state	and	the	3D	model	previously	established.	The	effects	of	hyperoxygen	compared	to	atmospheric	oxygen	was	assessed	through	 examining	 cell	 proliferation,	 function	 and	 DNA	 expression.	 Secondly,	 we	 co-cultured	the	lung	cells	with	placenta	MSCs	to	evaluate	the	potential	protective	value	MSCs	house	to	cells	undergoing	oxidative	stress.	A	diagram	of	the	experimental	design	is	shown	in	Schematic	5.1.
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5.3 Study	design	
	
Schematic	5.1	A	schematic	to	show	the	flow	of	experimental	design	for	chapter	5.	Adult	lung	cells	and	neonatal	lung	cells	were	cultured	in	3D	hydrogels	or	in	2D	monolayer	and	exposed	to	hyperoxia.	The	adult	lung	cells	35FL	and	A549	were	cultured	in	the	3D	model	as	single	cell	cultures	or	co-culture.	Both	the	neonatal	and	adult	lung	fibroblasts	were	 exposed	 to	 placenta	 derived	MSCs	 to	 assess	 therapeutic	 effect	when	 exposed	 to	hyperoxia.	Culture	at	atmospheric	oxygen	was	included	as	a	control.	
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5.4 Methods	
In	Chapter	3	we	developed	an	in	vitro	model	to	represent	the	lung	alveolus.	We	concluded	elastin	did	not	affect	cell	viability	and	therefore	we	employed	a	collagen-elastin	hydrogel	of	ratio	1:1.	Previously,	no	contraction	in	hydrogel	diameter	was	observed	when	collagen-elastin	hydrogels	were	seeded	with	75,000	cells	per	500µl	gel.	 In	 this	study	hydrogels	were	set	within	a	well	insert	to	provide	an	air	interface.	The	well	inserts	have		a	smaller	surface	 area	 than	 the	 wells	 of	 a	 12	 well	 plate	 hydrogels	 were	 previous	 set	 into.	 To	maintain	consistency	a	hydrogel	volume	of	145µl	was	included	which	requires	a	seeding	density	of	21,750	cells/gel.			
5.4.1 Exposing	adult	lung	cells	to	hyperoxia	cultured	in	monolayer	
and	3D	culture	Lung	cells	A549	and	35FL	were	cultured	as	previously	described	(section	2.2).	Cells	were	trypsinised	and	seeded	as	a	monolayer	in	a	12	well	plate	well	insert	at	a	density	of	21,750	cells/well	 (section	 2.2.1).	 Cell-seeded	 collagen-elastin	 hydrogels	 (1:1)	 were	 made	(section	2.9).	Before	gelation	35FL	were	resuspended	in	the	hydrogel	solution.	145µl	of	solution	was	pipetted	into	12	well	plate	well	inserts		and	incubated	at	37°C	for	30	minutes	to	 allow	 gelation.	 A549	 cells	 were	 trypsinised,	 counted	 and	 seeded	 on	 the	 hydrogel	surface	at	a	density	of	21,750	cells/gel.	Hydrogels	were	cultured	with	culture	media	at	21%	oxygen	for	24	hours	after	which	medium	was	aspirated	from	inside	the	well	insert.	All	samples	were	incubated	at	37°C	at	21%	oxygen	or	40%	oxygen	(section	2.16)	for	20	days.	Every	5	days	cell-seeded	hydrogels	were	measured	using	the	OCT	(section	2.10).	The	LiveDead	assay	was	performed	 (section	2.7)	on	day	20	and	 imaged	with	 confocal	microscopy	and	phase	contrast	light	microscopy.	On	day	20	DNA	was	quantified	using	the	PicoGreen	DNA	assay	(section	2.13)	and	RNA	was	extracted	for	RT-PCR	analysis	(section	2.11).	
PhD	Thesis	by	J.	A.	J.	Bratt																																					Chapter	5:	Therapeutic	capabilities	of	MSCs	
	 137	
5.4.2 The	effect	of	40%	on	A549	cell	monolayer	integrity	using	
TEER	analysis	To	 assess	 if	 hyperoxia	 affects	 cell	 monolayer	 integrity,	 the	 TEER	 (Transepithelial	Electrical	Resistance)	method	was	used.	A549	cells	were	trypsinised,	counted	and	seeded	at	a	density	of	21,750	cells/well	 in	12	well	plate	well	 inserts	 (section	2.2.1)	or	on	 the	surface	 of	 collagen-elastin	 hydrogel	 (1:1)	made	 in	 12	well	 plate	 inserts	 (section	 2.9).	Collagen-elastin	hydrogels	were	either	acellular	or	seeded	with	35FL	cells	at	a	density	of	21,750	cells/gel.	Samples	were	cultured	at	37°C	at	21%	oxygen	or	40%	oxygen	(section	2.16)	for	up	to	28	days.	TEER	analysis	was	performed	as	previously	described	(section	2.14).	Images	were	taken	with	phase	contrast	microscopy.		
5.4.3 Exposing	neonatal	lung	cells	to	hyperoxia	in	monolayer	and	
3D	culture	Lung	 cells	 NLF	 were	 cultured	 as	 previously	 described	 (section	 2.3.3).	 Cells	 were	trypsinised	and	seeded	in	monolayer	in	a	12	well	plate	well	insert	at	a	density	of	21,750	cells/well	 (section	 2.3.3).	 Cell-seeded	 collagen-elastin	 hydrogels	 (1:1)	 were	 made	(section	2.9).	Before	gelation	NLF	were	resuspended	in	the	hydrogel	solution.	145µl	of	solution	was	pipetted	into	12	well	plate	inserts	and	incubated	at	37°C	for	30	minutes	to	allow	gelation.	Hydrogels	were	cultured	with	culture	media	for	24	hours	at	21%	oxygen	after	which	medium	was	 aspirated	 from	 inside	 the	well	 insert.	All	 samples	were	 then	incubated	at	37°C	at	21%	oxygen	or	40%	oxygen	(section	2.16)	for	20	days.	Every	5	days	cell-seeded	hydrogels	were	measured	using	the	OCT	(section	2.10).	The	LiveDead	assay	was	performed	(section	2.7)	on	day	20	and	imaged	with	confocal	microscopy	and	phase	contrast	light	microscopy.	On	day	20	DNA	was	quantified	using	the	PicoGreen	DNA	assay	(section	2.13)	and	RNA	was	extracted	for	RT-PCR	analysis	(section	2.11).		
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5.4.4 Assessing	the	protective	effect	of	placenta	MSCs	when	lung	
cells	are	exposed	to	hyperoxia	To	assess	if	the	co-culture	of	placenta	derived	MSCs	(aMSCs	and	cMSCs)	could	alleviate	the	effect	hyperoxygen	has	on	lung	cells	we	examined	the	contraction,	DNA	quantity,	cell	morphology	and	cell	viability	of	lung	cells	35FL	and	NLF	when	cultured	at	40%	oxygen	in	2D	and	3D.			
5.4.4.1 Experimental	set-up	Cells	35FL	and	NLF	were	cultured	and	trypsinised	as	previously	described	(section	2.2	and	2.3.3).	 Cells	were	 plated	 either	 in	 3D	 (3.5mg/ml	 collagen-elastin	 hydrogels)	 or	 in	monolayer.	 For	 the	monolayer	 culture	 cells	were	 directly	 plated	 in	 12	well	 plate	well	inserts	at	a	seeding	density	of	21,750	cells/well	and	cultured	in	media	at	21%	oxygen	for	24	hours.	For	the	3D	constructs,	3.5mg/ml	collagen-elastin	hydrogel	solution	(1:1)	was	made	as	described	(section	2.9).	Before	gelation	35FL	or	NLF	cells	were	resuspended	in	the	solution.	The	hydrogel	solution	was	then	pipetted	into	12	well	plate	well	inserts	and	allowed	to	set	for	30	minutes.	Culture	medium	was	then	added	on	top	of	the	hydrogels	and	 cultured	 for	24	hours	 at	21%	oxygen.	Chorion	derived	MSCs	and	amnion	derived	MSCs	were	cultured,	trypsinised	and	counted	(section	0).	Cells	were	plated	at	a	density	of	20,000	cells/well	 in	12	well	plates	and	cultured	 in	culture	media	 for	24	hours	at	21%	oxygen.	Using	sterile	technique,	tweezers	were	used	to	remove	the	well	inserts	and	place	them	in	the	appropriate	well	containing	either	aMSCs	or	cMSCs	(illustrated	in	Figure	5.1).	Culture	medium	was	gently	aspirated	from	the	hydrogels	surface	and	cells	in	monolayer.	Control	samples	were	included	which	were	cultured	without	any	MSCs	but	underwent	the	same	conditions.	Samples	were	cultured	for	20	days	at	either	21%	oxygen	or	40%	oxygen	at	37°C.	Medium	was	changed	every	2-3	days.			
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Figure	 5.1	 Experimental	 set-up	 of	 human	 lung	 cells	 co-cultured	 with	 placenta	
derived	MSCS	and	exposed	to	21%	or	40%.	Lung	cells	(35FL	or	NLF)	were	cultured	on	porous	well	plate	inserts	in	3D	collagen-elastin	hydrogels	(image	A)	or	as	2D	monolayer	(image	B).	Placenta	derived	MSCs	(amnion	MSCs	or	chorion	MSCs)	were	co-cultured	with	the	lung	cells	at	the	bottom	of	the	well	plate.	All	cells	were	cultured	at	21%	oxygen	or	40%	oxygen	for	20	days.			
5.4.4.2 Experimental	analysis	To	 examine	 if	 the	 effect	 of	MSCs	 co-cultured	with	 lung	 cells	 at	 hyperoxygen	 the	 same	output	 measures	 as	 before	 were	 used	 to	 examine	 hydrogel	 contraction,	 DNA	quantification	and	cell	 imaging.	On	day	20	hydrogels	were	digested	(section	2.12)	and	DNA	 quantified	 (section	 2.13).	 Samples	 were	 stained	 with	 LiveDead	 staining	 assay	(section	2.7)	and	imaged	using	confocal	microscopy,	including	z-stacks	to	produce	a	3D	representative	 image.	 All	 cells	 (35Fl,	NLF,	 aMSCs	 and	 cMSCs)	were	 also	 imaged	 using	phase	contrast	microscopy.	Every	5	days	of	culture	hydrogel	depth	was	measured	using	OCT	(section	2.10)	and	percentage	change	in	gel	depth	calculated.				
5.4.5 Statistical	analysis	Hydrogel	measurements,	DNA	quantification,	 gene	 analysis	 and	TEER	 results	were	 all	statistically	compared	using	two-	way	ANOVA	with	Tukey’s	multiple	comparisons	test	to	
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determine	 the	 statistical	 significance,	 p≤0.05	was	 considered	 significant.	 Analysis	was	performed	using	GraphPad	Prism	version	7.01.	All	values	quoted	in	the	results	are	mean	average	±	standard	deviation.	 	
5.5 Results		
5.5.1 Adult	lung	cells	
5.5.1.1 The	effect	of	hyperoxia	on	adult	lung	cells	cultured	in	2D	and	3D	at	21%	oxygen	and	40%	oxygen		Adult	lung	fibroblasts	cells	(35FL)	and	epithelial	cells	(A549)	were	cultured	in	monolayer	or	3D	collagen-elastin	hydrogels	(1:1)	for	20	days	at	21%	or	40%	oxygen.	Cells	were	co-cultured	with	placenta	derived	MSCs	or	single	cell	culture.	Hyperoxia	caused	a	decrease	in	hydrogel	contraction	for	35FL	seeded	hydrogels	suggesting	high	oxygen	culture	affects	the	contraction	of	adult	lung	fibroblasts	(Figure	5.2).	However,	this	effect	was	not	shown	to	be	significant.	Co-culture	hydrogels	also	contracted	more	rapidly	at	21%.	It	is	likely	this	contraction	was	due	to	the	35FL	cells	because	there	was	negligible	contraction	of	A549	only	gels.	DNA	quantity	significantly	(P<0.0001)	increased	for	all	sample	types	except	for	35FL	samples	cultured	at	40%	oxygen,	these	cells	whether	in	monolayer	or	hydrogels	did	not	significantly	increase	DNA	quantity.	This	indicates	cell	proliferation	of	35FL	cells	is	affected	by	40%	oxygen	culture.	This	is	further	supported	by	microscopic	images	in	which	fewer	35FL	cells	could	be	observed	at	40%	oxygen	than	21%	oxygen	(Figure	5.3).	The	LiveDead	staining	assay	indicated	cell	viability	was	good	with	only	green	fluorescently	stained	cells	observed	in	all	samples.	The	stained	35FL	in	monolayer	have	a	less	elongated	morphology	at	40%	than	21%	oxygen.		The	z-stacks	(Figure	5.4)	demonstrates	A549	cells	remain	as	a	monolayer	on	the	hydrogel	surface.	The	35FL	are	dispersed	throughout	the	gel	 and	 have	 migrated	 towards	 the	 bottom	 of	 the	 hydrogel	 where	 medium	 is.	 No	difference	between	the	dispersion	of	cells	can	be	observed	at	21%	or	40%	oxygen.	
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Figure	5.2	Human	adult	lung	cells	cultured	in	3D	collagen-elastin	hydrogel	or	2D	
monolayer	 at	 21%	or	 40%	oxygen.	Lung	 fibroblast	 cells	 35FL	were	 cultured	 in	 3D	collagen-elastin	(1:1)	hydrogels	and	lung	epithelial	cells	A549	cultured	on	the	hydrogel	surface.	The	cells	were	cultured	as	a	single	cell	culture	or	in	co-culture.	The	same	cells	were	also	cultured	in	2D	monolayer.	All	samples	were	cultured	at	40%	oxygen	or	21%	oxygen	for	20	days.	Percentage	change	in	hydrogel	depth	was	measured	every	5	days	and	DNA	quantified	using	 the	PicoGreen	quantification	assay.	Contraction	of	hydrogel	was	observed	to	be	more	rapid	for	co-culture	3D	and	35FL	3D	at	21%	oxygen.	This	contraction	is	likely	due	to	the	35FL	cells	since	there	was	negligible	contraction	observed	for	A549	3D.	There	was	no	statistically	significant	change	in	3D	hydrogel	contraction	in	any	of	the	groups.	At	40%	oxygen	DNA	quantity	for	35FL	cells	in	3D	and	2D	does	not	significantly	increase	suggesting	hyperoxia	affects	cell	proliferation.	A549	cell	DNA	is	no	different	at	21%	 and	 40%	 oxygen.	 The	 co-culture	 hydrogels	 DNA	 was	 also	 not	 affected	 by	 40%	oxygen,	the	predominant	cell	in	these	samples	are	the	A549.	Data	are	expressed	as	mean	±	standard	deviation,	n=6	(****p≤0.0001).	
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Figure	5.3	Adult	lung	cells	cultured	in	monolayer	or	3D	collagen-elastin	hydrogels	
at	 21%	 and	 40%	 oxygen	 and	 imaged	 by	 fluorescence	 and	 phase	 contrast	
microscopy.	 Adult	 lung	 fibroblasts	 35FL	 and	 epithelial	 cells	 A549	 were	 seeded	 in	monolayer	or	collagen-elastin	(1:1)	hydrogels	and	cultured	at	21%	or	40%	oxygen.	The	cells	were	stained	with	the	LiveDead	staining	assay	and	imaged	with	confocal	microscopy	and	phase	contrast	microscopy.	The	presence	of	green	fluorescence	indicates	cell	viability	was	uncompromised	by	the	hyperoxia.	Fewer	cells	can	be	seen	in	both	the	phase	contrast	and	confocal	 images	of	35FL	 in	monolayer	at	40%	oxygen	suggesting	hyperoxia	slows	down	35FL	cell	proliferation.			
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Figure	5.4	Orientation	of	adult	lung	cell	populations	in	3D	collagen-elastin	hydrogel	
at	21%	and	40%	oxygen.	Adult	lung	fibroblasts	35FL	and	epithelial	cells	A549	were	co-cultured	in	collagen-elastin	(1:1)	hydrogels	and	cultured	at	21%	or	40%	oxygen.	The	cells	were	stained	with	 the	LiveDead	staining	assay	and	 imaged	by	confocal	microscopy.	Z-stacks	were	taken	of	the	samples	to	create	a	3D	image.	The	A549	cells	form	a	monolayer	on	the	hydrogel	surface	and	do	not	migrate	through	the	hydrogel.	The	35FL	are	dispersed	throughout	the	hydrogels	and	migrate	towards	the	bottom	of	the	hydrogel	likely	towards	the	medium	containing	nutrients.	The	dispersion	and	migration	of	35FL	are	unaffected	by	hyperoxia.		
	5.5.1.2 Adult	lung	cells	expression	of	BPD	related	genes	The	gene	expression	of	BPD	related	markers	relative	to	the	housekeeping	gene	GAPDH		is	shown	 in	 Figure	 5.5-Figure	 5.9.	 The	 genes	 of	 interest	 included	TGFb,	 Collagen	 type	 1,	Elastin,	 NQO1	 and	 smooth	 muscle	 actin	 (SMA).	 We	 analysed	 all	 sample	 types	 and	compared	cultures	at	21%	and	40%	oxygen,	2D	versus	3D	after	20	days	in	culture.	The	only	 significant	 result	 observed	was	 a	 raised	 expression	 level	 of	NQO1	 for	A549	 cells	
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cultured	in	monolayer	at	40%	oxygen	(P<0.05)	and	co-culture	collagen-elastin	hydrogels	cultured	at	40%	oxygen	(P<0.01).		We	 compared	 gene	 expression	 levels	 in	 2D	 versus	 3D	 culture	 to	 assess	 variations	 in	expression	of	ECM	related	markers	(collage,	elastin	and	smooth	muscle	actin).	COL1A	was	upregulated	in	A549	cells	cultured	in	3D.	Elastin	and	SMA	for	35FL	in	3D	culture	were	both	 downregulated.	 	 When	 cells	 were	 in	 co-culture	 TGFb,	 COL1A,	 SMA	 were	 all	downregulated	 compared	 to	 single	 cell	 cultures;	 however	 none	 were	 found	 to	 be	statistically	significant	(P>0.05).		
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Figure	 5.5	 Gene	 expression	 of	 lung	 cells	 A549	 cultured	 on	 collagen-elastin	
hydrogels	at	40%	or	21%	oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGFb,	Collagen,	Elastin,	NQO1	and	SMA	relative	 to	GAPDH	expression	of	A549	cells	cultured	on	the	surface	of	collagen-elastin	(1:1)	hydrogels	cultured	at	21%	of	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4.	
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Figure	5.6	Gene	expression	of	lung	cells	35FL	cultured	in	collagen-elastin	hydrogels	
at	40%	or	21%	oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGFb,	 Collagen,	 Elastin,	 NQO1	 and	 SMA	 relative	 to	 GAPDH	 expression	 of	 35FL	 cells	cultured	in	the	collagen-elastin	(1:1)	hydrogels	cultured	at	21%	of	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4.		
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Figure	5.7	Gene	expression	of	lung	cells	35FL	cultured	in	monolayer	at	40%	or	21%	
oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGFb,	Collagen,	Elastin,	NQO1	and	SMA	relative	to	GAPDH	expression	of	35FL	cells	cultured	in	monolayer	at	21%	of	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4.	
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Figure	5.8	Gene	expression	of	lung	cells	A549	cultured	in	monolayer	at	40%	or	21%	
oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGFb,	Collagen,	Elastin,	NQO1	and	SMA	relative	to	GAPDH	expression	of	A549	cells	cultured	in	monolayer	at	21%	of	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4	(*p≤0.05).	
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Figure	5.9	Gene	expression	of	lung	cells	35FL	and	A549	cultured	in	co-culture	in	3D	
constructs	at	40%	or	21%	oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGFb,	Collagen,	Elastin,	NQO1	and	SMA	relative	 to	GAPDH	expression	of	cells	cultured	in	the	collagen-elastin	(1:1)	hydrogels	cultured	at	21%	of	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4	(**p≤0.05).			
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5.5.1.3 TEER	of	A549	cells	cultured	at	21%	and	40%	oxygen.	To	assess	the	integrity	of	lung	epithelial	cell	monolayer	cultured	at	21%	and	40%	oxygen	A549	 cells	were	 seeded	 in	 12	well	 plate	well	 inserts	 and	 allowed	 to	 form	a	 confluent	monolayer	 or	 were	 seeded	 on	 the	 surface	 of	 collagen-elastin	 hydrogels	 (acellular	 or	seeded	with	35FL).	For	the	2D	culture	TEER	was	assessed	every	7	days	for	up	to	28	days	and	phase	contrast	images	taken.	For	the	3D	culture	TEER	was	assessed	at	day	28	(Figure	5.10).	At	day	7	TEER	was	significantly	reduced	(P<0.001)	for	A549	in	2D	monolayer	at	40%	oxygen.	From	day	14	onwards	TEER	was	the	same	in	both	oxygen	conditions.	For	3D	culture	TEER	was	significantly	improved	for	co-culture	samples.	Phase	contrast	images	show	 A549	 in	 2D	 monolayer	 at	 10x	 and	 20x	 magnification.	 	 No	 differences	 in	 cell	morphology	or	monolayer	formation	can	be	observed	in	the	different	oxygen	conditions.			
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Figure	 5.10	 TEER	 analysis	 of	 human	 lung	 cells	 A549	 cultured	 in	 monolayer	 on	
culture	well	plate	inserts	or	on	3D	collagen-elastin	hydrogels	cultured	at	21%	or	
40%	oxygen.	Lung	cells	A549	well	culture	at	21%	or	40%	oxygen	in	monolayer	directly	on	 well	 plate	 inserts	 or	 on	 collagen-elastin	 hydrogels	 (acellular	 or	 seeded	 with	 lung	fibroblasts	35FL).	Samples	were	cultured	up	to	28	days	and	TEER	measurements	taken.	The	co-culture	of	A549	and	35FL	significantly	increased	the	TEER.	Hyperoxia	affects	the	TEER	of	A549	cultured	at	40%	oxygen	by	day	7.	By	day	14	the	cells	recover	since	there	is	no	significant	difference	between	oxygen	concentrations.	Cells	were	imaged	using	phase	contrast	microscopy	showing	a	confluent	monolayer.	Data	were	normalised	with	acellular	hydrogels	and	are	expressed	as	mean	±	standard	deviation,	n=6	(*p≤0.05,	***p≤0.001).		
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5.5.2 Neonatal	cells	
5.5.2.1 The	effect	of	hyperoxia	on	neonatal	lung	cells	cultured	in	2D	and	3D	at	21%	oxygen	and	40%	oxygen		Isolated	 neonatal	 cells	 from	 tracheal	 suctionings	 of	 ventilated	 neonates	 (NLF)	 were	seeded	in	monolayer	or	in	collagen-elastin	hydrogels	and	cultured	at	21%	or	40%	oxygen.	All	 samples	 significantly	 increased	 in	 DNA	 over	 20	 days	 in	 culture.	 There	 was	 no	significant	difference	in	quantified	DNA	after	20	days	in	culture	when	cultured	at	40%	oxygen	compared	with	21%	oxygen	(Figure	5.11).	Hydrogels	cultured	at	21%	and	40%	oxygen	both	contract	at	a	similar	rate	with	hydrogels	cultured	at	21%	oxygen	culturing	slightly	more,	but	this	was	not	statistically	significant	(Figure	5.11).	Phase	contrast	images	of	the	cells	after	20	days	in	culture	so	no	variation	in	cell	numbers	or	morphology	(Figure	5.12).		
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Figure	5.11	Human	neonatal	lung	cells	cultured	in	collagen-elastin	hydrogels	or	in	
monolayer	at	21%	or	40%	oxygen.	Lung	cells	isolated	from	the	tracheal	aspirates	of	ventilated	neonates	were	cultured	 in	well	plate	 inserts	 in	monolayer	or	seeded	within	collagen-elastin	hydrogels	(1:1)	and	cultured	at	21%	or	40%	oxygen	for	20	days.	After	this,	DNA	was	quantified	using	the	PicoGreen	DNA	quantification	kit	and	compared	to	day	1.	Change	 in	hydrogel	depth	was	calculated	using	 the	OCT	 to	measure	hydrogel	depth	every	5	days.	DNA	significantly	increased	for	all	groups	indicating	cell	proliferation	was	not	affected	by	40%	oxygen.	Hydrogel	contraction	was	observed	to	be	reduced	at	40%	oxygen	 however	 this	 is	 not	 statistically	 significantly.	 Data	 are	 expressed	 as	 mean	 ±	standard	deviation,	n=9	(***	p≤0.001).			
PhD	Thesis	by	J.	A.	J.	Bratt																																					Chapter	5:	Therapeutic	capabilities	of	MSCs	
	 154	
	
Figure	5.12	Human	neonatal	lung	cells	cultured	in	collagen-elastin	hydrogels	or	in	
monolayer	at	21%	or	40%	oxygen.	Cells	isolated	from	tracheal	suctions	of	ventilated	neonates	 were	 cultured	 in	 monolayer	 on	 well	 plate	 inserts	 or	 in	 collagen-elastin	hydrogels	 (1:1)	 and	 imaged	after	20	days	of	 culture	using	phase	 contrast	microscopy.	Cells	 isolated	 from	 2	 samples	 (PWTA011	 and	 PETA013)	were	 cultured.	 There	 are	 no	observed	differences	in	cell	number	or	cell	morphology	at	21%	or	40%	oxygen.		
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5.5.2.2 Neonatal	lung	cells	gene	expression	of	BPD	related	markers		The	gene	expression	of	BPD	related	markers	relative	to	the	housekeeping	gene	GAPDH	is	shown	in	Figure	5.13.	The	genes	of	interest	included	TGFb,	Collagen	type	1,	Elastin,	NQO1	and	 smooth	 muscle	 actin	 (SMA).	 We	 analysed	 neonatal	 cells	 cultured	 in	 2D	 and	 3D	hydrogels	and	compared	culture	at	21%	and	40%	after	20	days.	There	was	no	significant	change	in	gene	expression	when	cultured	in	3D	or	under	hyperoxia.			
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Figure	5.13	Gene	expression	of	neonatal	lung	cells	cultured	in	2D	monolayer	or	in	
3D	collagen-elastin	hydrogels	at	40%	or	21%	oxygen.	RT-PCR	was	used	to	analyse	the	expression	of	BPD	related	genes	TGF	beta,	Collagen,	Elastin,	NQO1	and	SMA	relative	to	GAPDH	expression	of	cells	isolated	from	the	tracheal	suctions	of	ventilated	neonates	and	cultured	at	21%	or	40%	oxygen.	Data	are	expressed	as	mean	±	standard	deviation,	n=4.	
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5.5.3 Adult	human	lung	cells	co-cultured	with	placenta	MSCs	To	assess	if	MSCs	could	protect	lung	cells	from	the	effect	of	hyperoxia,	human	adult	lung	cells	35FL	were	co-cultured	with	cMSCs	and	aMSCs	in	monolayer	or	3D.	Well	inserts	were	used	for	co-cultures,	so	any	effect	seen	was	due	to	paracrine	signalling.	Single	cell	type	cultures	were	included	as	controls.			
5.5.3.1 Monolayer	cultures	As	previously	shown	in	monolayer	cultures	of	aMSCs,	cMSCs	and	35FL,	DNA	quantity	was	all	 reduced	when	cultured	at	40%	oxygen.	When	the	 lung	cells	35FL	were	co-cultured	with	MSCs,	both	aMSCs	and	cMSCs	significantly	increased	(*)	the	DNA	quantity	of	35FL	cells	(Figure	5.14).	This	is	representative	in	phase	contrast	images	in	which	more	35FL	cells	can	be	observed	when	co-cultured	with	MSCs	(Figure	5.15).		
5.5.3.2 3D	cultures	As	well	as	monolayer	cultures,	lung	cells	35FL	were	also	cultured	in	3D	collagen-elastin	(1:1)	hydrogels	in	well	inserts.	Placenta	MSCs	(aMSCs	and	cMSCs)	were	cultured	on	the	bottom	of	 the	well	so	cells	were	 indirectly	co-cultured.	40%	oxygen	had	a	detrimental	effect	 on	 DNA	 quantification	 for	 35FL	 hydrogels.	 The	 co-culture	 of	 aMSCs	 or	 cMSCs	statistically	increased	DNA	quantification	when	cultured	in	monolayer	40%	oxygen.	The	same	effect	was	not	seen	for	cells	in	3D.	At	21%	oxygen	the	co-culture	of	MSCs	with	35FL	hydrogels	 caused	 a	 significant	decrease	 in	DNA	quantity	 compared	 to	35FL	hydrogels	alone	(****).	Hydrogel	contraction	was	slightly	reduced	at	40%	oxygen	and	the	addition	of	MSCs	had	no	statistical	influence	on	this.	Confocal	microscopy	imaging	(Figure	5.16)	showed	green	fluorescent	staining	of	cells	indicating	cells	had	a	good	viability	at	both	21%	and	40%	oxygen	when	co-cultured	with	MSCs.	However,	cells	can	be	observed	to	have	migrated	less	at	40%	oxygen	
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Figure	5.14	Human	adult	lung	cells	co-cultured	with	placenta	MSCs	in	3D	hydrogels	
or	2D	monolayer	at	21%	or	40%	oxygen.	Human	adult	lung	cells	35FL	were	cultured	in	 3D	 collagen-elastin	 hydrogels	 and	 were	 co-culture	 with	 placenta	 MSCs	 (cMSCs	 or	aMSCs).	 Samples	 were	 exposed	 to	 either	 21%	 or	 40%	 oxygen	 for	 20	 days.	 DNA	was	quantified	using	the	PicoGreen	DNA	quantification	assay	on	day	1	and	day	20.	Hydrogel	depth	was	measured	using	OCT	every	5	days	and	change	in	depth	was	calculated.		40%	oxygen	prevents	35FL	DNA	increasing	but	when	they	are	in	monolayer	and	co-cultured	with	MSCs	a	statistically	significant	increase	is	observed.	The	rate	of	hydrogel	contraction	is	reduced	at	40%	oxygen	however	this	 is	not	significant.	Data	 is	expressed	as	mean	±	standard	deviation,	n=4	(*	p≤0.1,	***	p≤0.001,	****	p≤0.0001,	ns	not	significant).		
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Figure	5.15	Human	adult	lung	cells	co-cultured	with	placenta	MSCs	in	monolayer	
and	3D	hydrogels	at	21%	or	40%	oxygen.	Human	adult	lung	cells	(35FL)	were	cultured	in	 3D	 collagen-elastin	 hydrogels	 and	were	 co-cultured	with	 placenta	MSCs	 (cMSCs	 or	aMSCs).	Samples	were	exposed	to	either	21%	or	40%	oxygen	for	20	days.	Phase	contrast	images	were	 taken	on	day	20.	 Fewer	 cells	 can	be	 observed	 for	 35FL	 cultured	 at	 40%	oxygen	but	when	they	are	co-cultured	with	MSCs,	more	cells	can	be	observed.		
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Figure	5.16	Human	adult	lung	cells	co-cultured	with	placenta	MSCs	in	3D	hydrogels	
at	21%	or	40%	oxygen.	Human	adult	lung	cells	(35FL)	were	cultured	in	3D	collagen-elastin	hydrogels	and	were	co-cultured	with	placenta	MSCs	(cMSCs	or	aMSCs).	Samples	were	exposed	to	either	21%	or	40%	oxygen	for	20	days	after	which	they	were	stained	with	 the	 LiveDead	 staining	 kit	 and	 imaged	 with	 confocal	 microscopy.	 Z-stacks	 were	compiled	 to	produce	3D	 images	of	 the	hydrogels.	The	presence	of	 green	 fluorescently	stained	cells	shows	that	cell	viability	was	good	at	21%	and	40%	oxygen.	Cell	are	dispersed	throughout	the	gels.	At	40%	oxygen	there	seems	to	be	less	migration	of	cells.		
5.5.4 Neonatal	human	lung	cells	co-cultured	with	placenta	MSCs	Previous	results	have	indicated	40%	oxygen	has	no	detrimental	effect	on	NLF	cells.	We	repeated	 these	 experiments	 with	 the	 addition	 of	 placenta	 derived	 MSCs	 (cMSCs	 and	aMSCs)	to	assess	if	there	was	any	impact	on	cell	performance.	As	with	the	adult	lung	cells	previously,	NLF	cells	were	co-cultured	with	cMSCs	and	aMSCs	in	monolayer	or	3D.	Well	inserts	were	used	for	co-cultures,	so	any	effect	seen	was	due	to	paracrine	signalling.	Single	cell	cultures	were	included	as	controls.		
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5.5.4.1 Monolayer	cultures	NLF	monolayer	 cultures	were	unaffected	by	hyperoxia	 in	 terms	of	DNA	quantification	(Figure	5.17).	However,	the	DNA	quantity	of	NLF	cells	was	significantly	reduced	(*)	when	co-cultured	with	MSCs,	independent	of	oxygen	type	and	MSC	type.	Phase	contrast	images	display	NLF	cells	densely	packed	in	all	monolayer	cell	culture	conditions	(Figure	5.18).			
5.5.4.2 3D	cultures	Unlike	the	monolayer	cultures,	culture	of	NLF	cells	in	3D	at	40%	oxygen	or	the	co-culture	with	MSCs	had	no	significant	effect	of	DNA	quantity	(Figure	5.17).	The	co-culture	of	NLF	cells	 and	 MSCs	 did	 have	 a	 significant	 effect	 of	 hydrogel	 contraction	 at	 40%	 oxygen	(P<0.001)	with	 no	 significant	 difference	 observed	 between	 cMSCs	 and	 aMSCs	 (Figure	5.17,	 change	 in	 gel	 depth).	 At	 21%	 oxygen	 the	 co-culture	 with	 aMSCs	 significantly	increased	hydrogel	contraction	(P<0.01).	40%	oxygen	significantly	(P<0.001)	reduced	the	contraction	of	adult	lung	cells	35FL	when	cultured	alone.	As	was	observed	for	the	adult	lung	cells,	the	LiveDead	z-stack	confocal	images	(Figure	5.19)	demonstrated	the	migration	of	cells	was	less.	The	presence	of	green	fluorescence	demonstrates	cell	viability	was	good	and	unaffected	by	the	co-culture	of	MSCs.								
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Figure	 5.17	 Human	 neonatal	 lung	 cells	 co-cultured	 with	 placenta	 MSCs	 in	 3D	
hydrogels	or	2D	monolayers	at	21%	or	40%	oxygen.	Human	neonatal	lung	cells	NLF	were	cultured	in	3D	collagen-elastin	hydrogels	or	in	monolayer	and	were	co-culture	with	placenta	MSCs	(cMSCs	or	aMSCs).	Samples	were	exposed	to	either	21%	or	40%	oxygen	for	20	days.	Hydrogel	depth	was	measured	using	OCT	every	5	days	and	change	in	depth	was	 calculated.	 DNA	 was	 quantified	 at	 day	 1	 and	 day	 20	 using	 the	 PicoGreen	 DNA	quantification.		The	co-culture	of	NLF	cells	in	monolayer	with	MSCs	caused	a	significantly	reduced	DNA	quantity	at	day	20	(****).	40%	oxygen	had	no	effect	on	DNA	quantification	of	NLF	cells	in	monolayer	or	3D.	40%	oxygen	reduced	hydrogel	contraction,	but	the	effect	was	not	statistically	significant.	Data	are	expressed	as	mean	±	standard	deviation,	n=4	(***	p≤0.001,	****	p≤0.0001).	
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Figure	5.18	Neonatal	lung	cells	co-cultured	with	placenta	MSCs	in	monolayer	and	
3D	hydrogels	at	21%	or	40%	oxygen.	Human	neonatal	lung	cells	(NLF)	were	cultured	in	 3D	 collagen-elastin	 hydrogels	 and	 were	 co-culture	 with	 placenta	 MSCs	 (cMSCs	 or	aMSCs).	Samples	were	exposed	to	either	21%	or	40%	oxygen	for	20	days.	Phase	contrast	images	were	taken	on	day	20.		
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Figure	 5.19	 Human	 neonatal	 lung	 cells	 co-cultured	 with	 placenta	 MSCs	 in	 3D	
hydrogels	at	21%	or	40%	oxygen.	Human	neonatal	lung	cells	(NLF)	were	cultured	in	3D	 collagen-elastin	 hydrogels	 and	 were	 co-cultured	 with	 placenta	 MSCs	 (cMSCs	 or	aMSCs).	Samples	were	exposed	to	either	21%	or	40%	oxygen	for	20	days.	Z-stacks	were	compiled	 to	produce	3D	 images	of	 the	hydrogels.	The	presence	of	 green	 fluorescently	stained	cells	shows	that	cell	viability	was	good	at	21%	and	40%	oxygen.	Cell	are	dispersed	throughout	the	gels.	At	40%	oxygen	there	seems	to	be	less	migration	of	cells.		
5.6 Discussion	
In	this	chapter	we	brought	together	aspects	developed	in	the	previous	2	chapters.	Firstly,	we	cultured	human	adult	lung	fibroblasts	(35FL)	and	human	neonatal	lung	cell	(NLF)	in	the	developed	3D	model	and	cultured	at	40%	oxygen	to	represent	the	high	oxygen	severe	BPD	neonates	receive	through	endotracheal	ventilation.	The	most	severe	BPD	neonates	
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will	commonly	receive	ventilation	of	40%	oxygen	or	above.	It’s	these	infants	that	require	the	most	clinical	intervention	and	therefore	need	to	be	targeted.					
5.6.1 The	effect	of	hyperoxia		
5.6.1.1 Adult	lung	cells	We	have	shown	that	in	vitro	culture	at	40%	oxygen	has	a	detrimental	effect	on	adult	lung	fibroblast	 cells.	 Collagen	 contraction	 assay	 is	 a	 key	 tool	 used	 widely	 to	 characterise	fibroblasts	 and	 assess	 wound	 healing232,233.	 At	 40%	 oxygen	 35FL	 cells	 cultured	 in	collagen-elastin	hydrogels	did	not	contract	the	hydrogels	as	rapidly	as	at	21%	oxygen.	A	reduced	ability	for	cells	to	contract	has	been	associated	with	cigarette	smoke	exposure234	and	 chronic	 lung	 conditions,	 correlating	 with	 disease	 severity235.	 In	 BPD	 there	 is	 a	disruption	in	ECM	protein	network,	a	process	which	is	thought	to	be	reliant	on	the	ability	of	myofibroblasts	to	deposit	and	remodel	collagen	and	elastin236,237.	Our	results	indicate	that	this	cell	mechanism	could	be	disrupted	during	oxidative	stress.	To	further	assess	the	link	between	hydrogel	contraction	and	protein	modelling	it	would	be	interesting	to	use	protein	analysis	techniques	such	as	Sircol	Collagen	Assay238	and	Fastin	Elastin	assay239	to	quantify	collagen	and	elastin	and	 immunofluorescent	 techniques	 to	stain	and	visualise	protein	alignment240	.			Hyperoxia	 culture	 prevented	 an	 increase	 in	 DNA	 quantity	 between	 day	 1	 and	 day	 20	indicating	 cell	 proliferation	 was	 prevented.	 This	 is	 supported	 by	 phase	 contrast	microscopic	images	and	Live	Dead	stained	confocal	images	which	show	live	cells	present	but	many	fewer	and	with	a	less	elongated	appearance	than	at	21%	oxygen	suggesting	the	cells	 were	 senescent	 due	 to	 the	 oxidative	 stress216,241.	 This	 phenomenon	 has	 been	previously	reported	in	numerous	publications184,242–244.	Balin	et	al.	observed	high	oxygen	disrupted	DNA	synthesis	during	mitosis	of	WI-38	(human	lung	fibroblast	from	a	3	month	
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GA	foetus)245,	preventing	cells	from	proliferating.	Davies	et	al.	suggested	that	rather	than	this	observed	growth	arrest	being	due	to	toxic	outcomes,	it	is	a	protective	mechanism	to	conserve	resources	and	protect	DNA244.	The	lack	of	cell	proliferation	may	account	for	the	reduced	rate	 in	contraction	since	we	have	shown	 in	Chapter	3	 that	contraction	rate	 is	dependent	on	cell	number,	or	the	cells	were	conserving	cellular	functions	as	a	protective	outcome.		Confocal	microscopy	 allows	 z-stacks	 to	 be	 taken	 to	 provide	 a	 3D	 image	 of	 the	whole	construct.	From	these	images	we	could	see	the	35FL	had	migrated	towards	the	bottom	of	the	 hydrogel,	 towards	 the	 medium.	 It	 is	 likely	 the	 cells	 are	 migrating	 towards	 high	concentrations	of	nutrients.	This	migration	was	also	observed	when	35FL	and	A549	were	in	co-culture	which	differs	from	observation	made	by	Chetty	et	al.	and	Infeld	et	al.	who	found	 fibroblasts	 sandwiched	 between	 collagen	 gels	migrated	 towards	 epithelial	 cells	located	 on	 the	 collagen	 gel	 surface	 112,246.	 However	 their	 co-culture	 model	 included	culture	 medium	 directly	 on	 top	 on	 the	 hydrogels	 suggesting	 the	 migration	 was	 not	favoured	by	nutrient	availability.	The	movement	of	cells	under	hyperoxia	suggests	that	even	though	cells	were	not	proliferating	they	were	still	responsive	and	able	to	migrate.	Senescing	 cells	 have	 been	 shown	 to	 lose	 the	 ability	 to	migrate247,248	 contradicting	 the	theory	that	our	cells	are	senescing.	To	examine	this	further	senescence	could	be	analysed	β-Galactosidase	activity;	a	biomarker	expressed	by	cells	senescing	249. 	The	A549	cells	seeded	on	the	hydrogel	surface	did	not	migrate	through	the	hydrogel	and	provided	a	monolayer	as	expected.	Initial	results	indicated	40%	oxygen	had	no	bearing	on	 DNA	 quantity	 (proliferation),	 cell	 morphology	 or	 monolayer.	 To	 investigate	 this	further	we	examined	the	TEER	of	A549	cells	cultured	in	monolayer	on	well	inserts	or	on	the	surface	of	acellular	or	cell-seeded	hydrogels	at	21%	and	40%	oxygen.	We	found	the	TEER	to	be	significantly	lower	at	day	7	of	culture	for	cells	cultured	at	40%	oxygen.	This	
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suggests	hyperoxia	initially	affects	monolayer	formation	either	through	cell	proliferation	or	through	cell	adhesion.	We	also	saw	resistance	significantly	increase	when	A549	cells	were	cultured	on	cell	seeded	hydrogels.	This	is	supported	by	work	previously	published	by	Harrington	et	al.	who	found	the	co-culture	of	epithelial	and	fibroblasts	cells	 in	a	3D	model	 enhanced	 the	 TEER250	 suggesting	 cell-cell	 interaction	 is	 necessary	 to	 	 enhance	tissue	integrity	and	encourage	cell	adhesion.	Therefore	the	inclusion	of	multiple	cell	types	is	a	vital	parameter	when	designing	in	vitro	models.	The	resistance	of	the	hydrogels	over-all	was	less	than	the	cells	cultured	in	2D	and	represents	observations	which	indicate	the	A549	cells	do	not	form	a	confluent	monolayer	on	hydrogel	surface	at	the	edges.	When	the	hydrogels	set,	they	are	concave	due	to	the	meniscus	of	the	hydrogel	solution.	The	A549	cells	 do	 not	 migrate	 towards	 the	 edges	 of	 the	 hydrogel	 possibly	 due	 to	 this	 shape.			We	looked	at	gene	expression	using	RT-PCR.	Altered	expression	of	genes	a-SMA,	TGFb,	
ELN	 and	 COL1A	 have	 all	 been	 notably	 associated	 with	 BPD.	NQO1	 is	 associated	 with	oxidative	stress	and	was	included	as	an	indicator	of	hyperoxygen	exposure236.	Table	5.1	describes	gene	expression	alterations	in	BPD.	There	were	no	significant	changes	in	gene	expressions	noted	at	40%	oxygen	compared	with	21%	except	for	NQO1	expression	which	significantly	 increased	 for	A549	cells	cultured	 in	co-culture	with	35FL	at	40%	oxygen.	A549	 culture	 in	 monolayer	 at	 40%	 oxygen	 also	 showed	 a	 significant	 increase	 in	expression	indicating	the	A549	cells	are	responding	to	the	hyperoxia.	Since	the	A549	cells	in	other	aspects	seem	unaffected	by	the	hyperoxia	it	is	hypothesised	they	are	producing	antioxidant	qualities	in	response	to	oxidative	stress.					
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Table	5.1	Genes	associated	with	BPD	
Gene	 Protein	 Expression	in	BPD	
aSMA	
Alpha	smooth	muscle	actin	
Actin	isoform	predominantly	found	in	myofibroblasts	and	associated	with	cell	contraction.	Increased	aSMA	positive	cells	 and	 over	 expression	 has	 been	 found	 in	 animal	models	of	BPD	and	hyperoxia	exposure236,251	
TGFb1	
Transforming	growth	factor	beta	
Over	expression	found	in	animal	models	of	BPD	and	in	the	BALF	fluid	of	preterm	infants	57,252–254.	TGFb	is	a	secreted	cytokine	 shown	 to	 regulate	 cell	 proliferation,	 fibroblast	contraction,	 wound	 healing	 and	 fibrosis255,256	 and	 is	responsible	 for	 the	 expression	 of	 aSMA	 in	 lung	parenchymal	fibroblasts	257.	Mechanical	forces	generated	through	the	cytoskeleton	can	stimulate	the	expression	of	TGFb258,259.	
ELN	 Elastin	
Elastin	 is	 an	 important	 protein	 in	 lung	 ECM	 providing	mechanical	 stability.	 Abnormal	 elastin	 structure	 is	associated	 in	 BPD.	 Upregulation	 of	 ELN	 in	 ventilated	infants	and	lamb	models	of	BPD	has	been	noted260,261.		
COL1A1	 Collagen	type	1	
Another	 protein	 found	 in	 the	 lung	 ECM	 to	 provided	mechanical	 capabilities.	 Irregular	 collagen	deposition/network	 is	 associated	 with	 clinical	 BPD.	
COL1A1	overexpression	has	been	associated	BPD	in	both	animal	models	and	premature	ventilated	infants236,237	
NQO1	
NAD(P)H	dehydrogenase	[quinone]	1	
A	 phase	 II	 enzyme	 activated	 by	 Nrf2	 in	 response	 to	oxidative	stress236,262,263.	
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5.6.1.2 Neonatal	lung	cells	Despite	attempts	we	were	not	able	to	isolate	epithelial	cells	from	tracheal	aspirates.	For	this	study	we	included	only	the	NLF	cells	previously	established	in	Chapter	4.	Since	these	cells	 demonstrate	 a	 fibroblastic	 nature,	 we	 cultured	 them	 within	 the	 collagen-elastin	hydrogel	to	represent	the	lung	mesenchyme.	Culture	at	hyperoxia	had	no	significant	effect	on	cell	presentation.	Hydrogel	 contraction,	DNA,	gene	expression	and	cell	morphology	remained	unchanged	when	cultured	at	21%	or	40%	oxygen.	This	observation	is	of	clinical	importance	because	it	is	not	consistent	with	adult	lung	cells	indicating	neonatal	cells	may	possess	protective	properties	against	oxygen	toxicity	which	allows	the	cells	to	continue	to	proliferate	and	re-organise	lung	ECM	during	maturation.	Similar	to	the	35FL	NLF	cells	also	migrated	towards	the	bottom	of	the	hydrogel	surface.			
5.6.2 Placenta	MSC	co-culture		Reports	have	indicated	that	MSCs	have	a	role	in	mitigating	oxygen-induced	lung	injury158.	Results	 in	 this	chapter	have	 indicated	hyperoxia	causes	damaging	effects	 to	adult	 lung	fibroblasts	 in	terms	of	proliferation,	morphology	and	contraction.	To	assess	if	placenta	derived	MSCs	 could	 alleviate	 such	 effects	we	 co-cultured	 placenta-derived	MSCs	with	35FL	and	NLF	cells	independently	in	2D	monolayer	or	3D	collagen-elastin	hydrogels	at	40%	oxygen.	MSCs	can	be	sourced	from	both	the	amniotic	membrane	and	the	chorionic	membrane	which	surround	the	foetus	in	the	womb	providing	protection	and	segregation	from	the	mother	(Figure	5.20).	The	chorion	is	the	outer	maternal	membrane	whereas	the	amnion	is	the	inner	membrane	which	is	in	direct	contact	with	the	developing	foetus.	As	shown	in	numerous	publications	both	membranes	are	an	abundant	source	of	stem	cells	which	possess	mesenchymal	related	markers,	tri-lineage	differentiation	potential	and	are	immune-privileged	cells264–267.	As	such,	we	examined	the	potential	therapeutic	effect	of	both	sources	of	stem	cells	as	a	comparison.		
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Figure	 5.20	 The	 amniotic	 sac.	 Image	 demonstrates	 the	 various	 structures	 of	 the	amniotic	sac	and	where	the	anion	and	chorion	lie.	Image	sourced	from	Kang	et	al.	268.			Interestingly,	we	 found	 that	35FL	cells	 in	monolayer	culture	at	hyperoxia	significantly	increased	 DNA	 by	 day	 20	 when	 co-cultured	 with	 placenta	 MSCs.	 The	 effect	 was	independent	of	MSC	type	(aMSCs	or	cMSCs)	and	was	not	observed	for	cells	in	hydrogels.	This	increase	in	DNA	is	likely	due	to	an	increase	in	cell	number	from	cell	proliferation	as	suggested	by	the	appearance	of	more	cells	in	microscopic	images.	These	results	suggest	placenta	MSCs	could	mitigate	oxygen	stress	that	adult	lung	fibroblasts	experience	through	a	paracrine	mechanism	and	corresponds	to	preclinical	hyperoxia	animal	models215.	When	cultured	at	21%	oxygen	DNA	was	significantly	lowered	for	cells	in	co-culture	for	35FL	and	NLF.	This	may	be	due	to	the	lack	of	available	nutrients	from	the	large	number	of	cells	in	culture.	Although	media	 changes	were	 achieved	 regularly	 there	was	no	 assessment	of	
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nutrient	availability.	Taking	 this	model	 forward	the	availability	of	nutrients	within	 the	culture	media	will	be	an	important	consideration	and	requires	optimisation.			
5.7 Conclusion	
This	chapter	expanded	on	the	previous	two	chapters.	Human	adult	and	neonatal	lung	cells	(A549,	 35FL	 and	 NLF)	were	 successfully	 cultured	 in	 3D	 collagen-elastin	 hydrogels	 at	hyperoxia.	 Hyperoxia	 had	 a	 detrimental	 effect	 of	 adult	 lung	 fibroblasts,	 preventing	proliferation	and	hydrogel	contraction.	It	 is	hypothesized	hyperoxia	causes	the	cells	to	senesce,	an	effect	also	observed	in	Chapter	4	with	placenta	derived	MSCs.	Interestingly,	the	co-culture	of	these	cells	with	placenta	MSCs	significantly	increased	DNA	content	and	cell	number	when	cells	were	cultured	at	hyperoxia.	This	suggests	the	MSCs	did	alleviate	the	 oxygen	 stress	 cells	 were	 experiencing	 however	 there	 was	 no	 improvement	 in	hydrogel	contraction.	The	NLF	cells	were	not	notably	affected	by	hyperoxia	suggesting	they	 possess	 protective	 features	 against	 oxygen	 stress.	 We	 did	 not	 highlight	 any	significant	alterations	if	BPD	related	gene	expression.	The	A549	adult	lung	epithelial	cell	line	was	not	affected	by	hyperoxia	over	 long-term	culture,	however	the	 formation	of	a	monolayer	was	delayed	as	shown	by	reduced	TEER	at	day	7	of	 culture.	The	 increased	NQO1	expression	for	A549	cells	suggests	these	cells	were	under	oxygen	stress.
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6.1 Discussion	
Bronchopulmonary	disease	is	a	chronic	lung	disorder	affecting	premature	infants.	Despite	advances	 in	 neonatal	 care	 BPD	 remains	 a	 significant	 clinical	 challenge	 instigating	financial,	emotional	and	physical	drain	on	those	affected.	BPD	develops	as	a	consequence	of	 premature	 birth	which	 interrupts	 the	 later	 stages	 of	 lung	 development,	 principally		alveologenesis10.	 As	 a	 consequence,	 BPD	 infants	 rely	 on	 artificial	 respiratory	 support	which,	for	the	most	severe	cases	delivers	high	oxygen	concentrations	under	pressure116.	This	 is	 thought	 to	 exacerbate	 the	 disease	 due	 to	 mechanical	 strain	 and	 oxidative	damage269.			Advances	in	BPD	research	have	been	restricted	by	a	lack	of	appropriate	disease	models60.	The	field	of	regenerative	medicine	now	allows	us	to	develop	complex	in	vitro	models	that	can	 provide	 a	 platform	 for	 understanding	 disease	mechanisms	 and	 evaluate	 potential	treatments	such	as	stem	cell	therapy.	Stem	cell	therapy	is	at	the	forefront	of	regenerative	medicine	and	published	work	has	suggested	it	holds	a	great	potential	for	BPD,	a	disease	which	is	predominately	caused	by	an	interruption	of	lung	generation158,159.	The	potential	for	stem	cell	therapy	as	a	BPD	treatment	is	supported	not	only	by	the	presence	of	stem	cells	in	the	normal	developing	lung	but	also	by	the	promising	effect	of	administration	of	stem	cells	in	BPD	preclinical	and	clinical	studies33,171,206,270.	However,	many	questions	still	remain	unanswered	such	as	the	optimal	route	of	administration,	MSC	source,	timing	of	the	therapy,	dosing	 for	MSC	delivery	and	mechanism	of	action.	Accumulating	evidence	suggests	 that	 stem	cells	 function	 through	a	paracrine	mechanism	 indicating	a	cell-free	approach	may	provide	a	safer,	cheaper	and	more	efficient	therapy223.			The	 objective	 of	 this	 work	 was	 to	 assess	 the	 potential	 therapeutic	 value	 of	 placenta	derived	 MSCs,	 an	 underutilised	 waste	 material.	 To	 achieve	 this,	 we	 established	 and	
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optimised	an	in	vitro	model	to	represent	the	lung	alveolus	in	BPD.		Secondly,	we	isolated	and	cultured	primary	cells	 from	the	suctionings	of	premature	neonates	on	ventilation.	These	cells	were	seeded	within	the	alveolus	model	to	provide	BPD	relevance.	Finally,	we	exposed	the	model	to	hyperoxygen	to	recreate	the	oxygen	stress	BPD	infants	experience	during	 clinical	 ventilation.	 Placenta	derived	MSCs	were	 co-cultured	with	 the	model	 to	assess	the	potential	therapeutic	value.			
6.1.1 Developing	an	in	vitro	model	for	BPD	research	As	previously	described,	there	is	a	lack	of	appropriate	in	vitro	models	for	BPD	research.	The	ideal	alveolus	model	encompasses	4	key	properties:	a	3D	structure,	human	lung	cells	in	co-culture,	mechanical	stimulation	and	opportunity	for	high	oxygen	exposure	(these	factors	have	been	described	in	detail	in	section	1.2.2).	Published	work	from	our	lab	has	previously	 demonstrated	 that	 collagen-elastin	 hydrogels	 provide	 a	 biologically	 and	mechanically	 relevant	 alveolus	 model97.	 Collagen	 and	 elastin	 are	 significant	 proteins	present	in	the	lung	mesenchyme	providing	the	lung	with	its	mechanical	properties	and	are	thought	to	be	the	key	driving	forces	in	alveoli	maturation45,90,91.	Disruption	to	their	deposition	and	alignment	are	hallmarks	of	clinical	BPD32,94	so	their	inclusion	in	a	hydrogel	provides	physiological,	mechanical	and	disease	relevance	mimicking	the	3D	in	vivo	lung	environment.			In	 this	 study	 we	 developed	 and	 optimised	 collagen-elastin	 hydrogels	 capable	 of	supporting	 the	 co-culture	 of	 lung	 epithelial	 and	 fibroblast	 cells.	 We	 showed	 that	 the	addition	of	elastin	into	collagen	hydrogels	did	not	affect	cell	viability	however	increased	hydrogel	contraction.	This	 led	us	to	optimise	an	 ideal	 fibroblast	seeding	density	which	prevented	hydrogel	contraction	along	the	diameter	allowing	an	epithelial	monolayer	to	be	cultured	on	the	hydrogel	surface.	The	hydrogels	can	be	analysed	in	a	number	of	ways:	
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calculating	 change	 in	 hydrogel	 contraction,	 DNA	 quantification,	 RNA	 extraction	 and	microscopic	imaging.	The	broad	availability	of	out-put	measures	means	the	model	could	be	utilised	for	a	number	of	lung	diseases.	The	main	difficulty	we	encountered	was	being	unable	 to	 isolate	 epithelial	 cells	 from	 the	 fibroblast-seeded	 hydrogel.	 However,	 FACS	could	be	utilised	for	this	application.	Table	6.1	describes	the	many	advantages	that	our	alveolus	in	vitro	model	possesses	and	the	associated	limitations.				
Table	6.1	The	advantages	and	drawbacks	of	the	in	vitro	alveolus	model.	
Advantages	 Drawbacks	Provides	 a	 3D	 matrix	 consisting	 of	proteins	 (collagen	 and	 elastin)	 relevant	to	the	alveolus	and	to	BPD	
Specialised	technology	is	required	for	isolation	of	co-culture	cells	(FACS)	
The	 inclusions	 of	 an	 air-liquid	 interface	which	 is	 tissue	 relevant	 and	 allows	 for	hyperoxia	exposure	
The	model	does	not	incorporate	a	pulmonary	capillary	component	
The	 model	 provides	 the	 ability	 to	 co-culture	multiple	cell	types		 The	model	is	not	representative	of	an	organoid		Collagen	hydrogel	is	transparent	to	allow	imaging,	 possesses	 mechanical	properties	 relevant	 to	 the	 lung	 alveoli	and	 is	 relatively	 straightforward	 to	manufacture	
The	 high	 concentration	 of	 collagen	 for	hydrogels	 and	 use	 of	 well	 inserts	 increases	costs	
Hydrostatic	 stimulation	 can	 be	incorporated	for	mechanical	stress	 		The	 model	 is	 simple	 to	 produce	 only	requiring	 standard	 cell	 culture	technique/equipment	
	
	Overall	our	model	 is	a	 suitable	 candidate	 for	BPD	research	and	could	be	exploited	 for	other	lung	conditions	such	as	emphysema	and	COPD.	It	successfully	meets	three	out	of	the	 four	properties	we	 identified	 that	 an	 alveolus	 in	 vitro	model	 should	possess.	 	 The	missing	property,	mechanical	stress,	is	discussed	later	in	this	chapter	(section	6.1.5).	The	
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model	 is	 simple	 to	 produce	 and	 requires	 only	 basic	 cell	 culture	 techniques.	 It	 can	 be	exposed	to	various	stimuli	(oxygen	stress,	hydrostatic	pressure,	drugs,	stem	cell	therapy)	and	allows	culture	of	a	variety	of	cells	making	it	easily	adaptable.				
6.1.2 The	extraction	and	culture	of	human	lung	cells	from	the	
suctionings	of	ventilated	infants	Tracheal	suctioning	is	a	routine	procedure	for	endotracheal	ventilated	infants	to	remove	and	dispose	excess	fluid	and	mucus	from	the	lungs186.	It	is	an	ideal	material	for	utilisation	in	 respiratory	 research	 since	 it	 avoids	 any	 additional	 morbidity	 to	 the	 patient	 and	provides	human/disease	relevance.	We	obtained	ethical	approval	to	collect	and	process	tracheal	suctionings	in	the	laboratory.	We	developed	a	simple,	cheap	protocol	to	extract	and	 culture	 lung	 cells	 from	 the	 suctionings.	 The	 extracted	 cells	 (referred	 to	 as	 NLF)	expressed	 attributes	 associated	 with	 fibroblastic	 cells	 and	 could	 be	 cultured	 in	 the	alveolus	 model.	 The	 addition	 of	 NLF	 cells	 adds	 human,	 gestational	 age	 and	 disease	relevance.	We	attempted	to	extract	and	culture	epithelial	cells	from	the	suctionings	using	collagen	 coating	 to	 encourage	 cell	 attachment;	 adhesion	 time	 to	differentiate	between	epithelial	and	fibroblast	cells	and;	incorporating	commercially	available	epithelial	media	to	encourage	cell	culture.	These	procedures	were	unsuccessful	at	isolating	epithelial	cells	and	this	requires	further	investigation	as	discussed	later	in	this	chapter.		
6.1.3 The	effect	of	hyperoxia	on	cell	function	Hyperoxia	is	a	key	modulator	of	BPD	and	is	commonly	used	to	induce	BPD	in	pre-clinical	models231.	We	employed	40%	oxygen	to	represent	clinical	ventilation	and	exposed	both	adult	and	neonatal	lung	cells	to	oxygen	stress.			
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Hyperoxia	had	a	pronounced	effect	on	adult	lung	fibroblasts.	Hydrogel	contraction	and	cell	 proliferation	 were	 both	 reduced.	 This	 represents	 observations	 made	 in	 other	published	 work.	 A549	 epithelial	 cell	 proliferation	 was	 not	 affected	 by	 40%	 oxygen	however	TEER	demonstrates	cell	monolayer	adhesion	was	compromised	initially	(day	7)	but	the	cells	recovered	by	day	20.	Interestingly,	the	neonatal	cells	were	unaffected	by	40%	oxygen	 suggesting	 they	 possess	 a	 prominent	 antioxidant	 stress	 mechanism	 which	 is	potentially	 lost	 into	 adulthood.	 Further	 assessment	 is	 necessary	 to	 determine	 if	 other	factors	were	affected	such	as	cell	marker	expression.		
6.1.4 Placenta	MSCs	as	a	cell	therapy	Pre-clinical	models	and	clinical	trials	have	demonstrated	that	MSCs	offer	a	promising	tool	for	 the	 treatment	 of	 BPD158,159.	 We	 assessed	 if	 placenta	 derived	 MSCs	 could	 offer	 an	advantageous	source	for	mediating	oxygen	stress.	Hyperoxygen	had	a	detrimental	effect	of	MSC	cell	marker	expression	but	not	differentiation	potential.	This	causes	us	to	question	the	suitability	of	MSCs	for	BPD	treatment	which	would	require	exposure	to	hyperoxygen.	However,	when	placental	MSCs	were	co-cultured	with	adult	lung	cells,	proliferation	was	improved	through	a	paracrine	mechanism;	independent	of	which	placenta	membrane	the	MSCs	 originated.	 This	 has	 important	 consequence	 since	 it	 indicates	 MSCs	 alleviate	oxidative	stress	through	a	paracrine	mechanism	suggesting	pre-conditioned	media	may	provide	a	viable	treatment	option.			
6.1.5 Limitations	of	the	study	This	study	successfully	applied	both	adult	and	neonatal	lung	cells	to	a	3D	alveolus	model,	applied	hyperoxygen	and	exposed	the	model	to	placenta	derived	MSCs.	However,	there	are	a	number	of	limiting	factors	to	consider	when	interpreting	this	data.		
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1. Choice	of	adult	lung	cells		In	this	study	we	used	cells	35FL	and	A549	to	represent	the	adult	lung.	These	cells	were	carefully	 chosen	 due	 to	 their	 biological	 and	 age	 relevance.	 However,	 they	 do	 possess	limitations.	 A549	 is	 a	 cell	 line	 commonly	 used	 to	 model	 AEC2	 cells	 and	 is	 used	 as	 a	surrogate	to	study	the	alveolar	epithelia271	but	these	cells	do	not	transition	to	or	represent	the	AEC1	cells	found	in	vivo.	A	more	accurate	representation	of	the	alveolus	wall	would	be	to	include	both	AEC1	and	AEC2.			As	previously	described	cells	35FL	are	fibroblast	cells	extracted	from	a	35	year	old	female	lung177	 and	 therefore	 represent	 fibroblasts	 found	 in	 an	 adult	 lung.	 	 To	 support	 our	findings	of	the	effects	of	hyperoxia	it	would	be	beneficial	to	repeat	the	hyperoxia	work	with	alternative	adult	cell	types.	Commercially	available	human	lung	fibroblasts	or	cells	extracted	 from	 the	 suctions	 of	 endotracheal	 ventilated	 adult	 patients	 would	 be	appropriate	alternative	cell	types.	 
	
2. Donor	cell	variability		Cells	 were	 successfully	 extracted	 from	 endotracheal	 suctions	 of	 BPD	 infants	 which	provided	 biological/disease	 relevance	 to	 the	model.	We	 experienced	 sample	 variation	which	 possess	 difficulties	 when	 using	 these	 cells	 for	 research	 purposes.	 Further	investigation	into	this	might	reveal	protocol	optimising	could	alleviate	this	problem.			
3. Mechanical	stimulation	Due	 to	unavoidable	 technical	 issues	we	were	unable	 to	continue	using	 the	hydrostatic	bioreactor	 to	provide	mechanical	 stimulus.	Although	advances	 in	medical	practice	has	provided	 less	 invasive	 ventilation	 systems,	 severe	 BPD	 infants	 will	 normally	 require	endotracheal	 mechanical	 intubation	 which,	 along	 with	 high	 oxygen,	 is	 thought	 to	exacerbate	 the	 disease272.	 	 Until	 strategies	 are	 developed	 to	 avoid	 high	 pressured	
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ventilation	 it	 is	 necessary	 to	 include	 mechanical	 stimulation	 in	 any	 BPD	 model.	 The	withdrawal	of	the	hydrostatic	bioreactor	meant	in	this	study	we	could	focus	on	the	effects	of	hyperoxia,	one	factor	of	a	multifactorial	disease.		 4. Isolating	cells	cultured	in	hydrogel	model	For	analysis	purposes	 it	 is	necessary	 to	separate	and	assess	cell	 types	 in	 isolation.	We	were	 unable	 to	 efficiently	 remove	 epithelial	 cells	 from	 the	 hydrogel.	 This	 meant	 co-cultured	hydrogels	(A549	and	35FL)	could	only	be	assessed	as	a	mixed	population	of	cells.	To	overcome	this,	we	assessed	the	cells	when	cultured	as	a	co-culture	and	when	cultured	individually.	This	prevented	us	from	accurately	assessing	cell-cell	interaction.	This	issue	could	be	avoided	by	using	fluorescence	activated	cell	sorting	(FACS).		
5. Oxygen	exposure	In	 initial	 experiments	 in	 Chapter	 3	 high	 oxygen	 exposure	 was	 achieved	 using	 an	automated	incubator	capable	of	providing	a	controlled	culture	environment	in-line	with	a	pre-programmed	oxygen	percentage.	Due	 to	 technical	problems	we	had	 to	 revert	 to	achieving	hyperoxia	using	a	sealed	container	filled	with	pre-mixed	gas.	Although	a	well-established	 technique	 this	 system	 does	 not	 allow	 constant	 monitoring	 of	 oxygen	percentage.	To	achieve	media	changes	or	daily	analysis	(such	as	imaging)	samples	were	removed	 from	 the	 sealed	 container	 and	 exposed	 to	 atmospheric	 oxygen.	 This	 meant	samples	 were	 experiencing	 a	 daily	 hyperoxia-normoxia	 transition.	 It	 has	 been	 well	characterised	 in	 BPD	 that	 infants	 experience	 episodes	 of	 hypoxia270,271	 suggesting	 the	change	in	oxygen	levels	may	provide	a	more	accurate	representation	of	clinical	BPD.				
PhD	Thesis	by	J.	A.	J.	Bratt	 	 	Chapter	6:	Summative	discussion		
	 181	
6.2 Future	directions	
The	work	described	has	raised	alternative	directions	which	could	strengthen	and	expand	on	the	conclusions	already	drawn.			Characterising	the	extracted	NLF	cells	was	achieved	through	cell	imaging	and	contraction	assays.	This	could	be	expanded	by	assessing	the	expression	of	alpha	smooth	muscle	actin	and	 vimentin,	 commonly	 used	 fibroblastic	 markers;	 and	 by	 assessing	 the	 absence	 of	epithelial	marker	e-cadherin	and	MSC	markers	(as	previously	listed	in	Chapter	4).		To	 further	 improve	 the	 efficiency	 of	 the	 cell	 extraction	 from	 tracheal	 suctionings	 we	would	look	at	optimising	the	protocol	further.	This	could	include	a	mucus	digestion	step	which	may	improve	cell	isolation.	We	would	also	look	at	collecting	many	more	samples	from	neonates	of	varying	ages	to	investigate	correlation	between	GA	and	cell	 isolation.	Future	work	could	include	developing	techniques	to	successfully	isolate	lung	epithelial	cells	 form	 the	 suctionings.	 Epithelial	 cells	 have	 previously	 been	 identified	 in	 similar	sample	 types275	 but	 require	 population	 identification	 through	 cell	 labelling	 and	 flow	cytometry	techniques.	Culturing	these	cells	may	entail	culture	at	an	air-liquid	interface276.	Sourcing	epithelial	cells	from	tracheal	suctionings	would	contribute	greatly	to	our	model	and	BPD	research.		The	 collagen	 and	 elastin	 network	 are	 of	 great	 importance	 in	 clinical	 BPD.	 Further	evaluation	 of	 the	 collagen-elastin	 hydrogels	 structure	 would	 provide	 information	regarding	protein	deposition	and	ECM	remodelling.	This	could	provide	new	evidence	into	the	disruption	of	collagen	and	elastin	distribution	during	hyperoxia	exposure.	Polarized	light	 microscopy	 to	 highlight	 collagen	 alignment277,	 fluorescent	 dye	 SRB for elastin 
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staining278 and histological	staining	with	Verhoeff's	van	Gieson to	highlight	collagen	and	elastin	fibres	are	potential	techniques	to	assess	protein	alterations.	 	We	have	shown	that	the	co-culture	of	placenta	MSCs	alleviated	the	effects	of	oxygen	stress	on	adult	lung	cells	through	a	paracrine	communication.	The	mechanism	of	this	effect	was	not	 investigated	 here	 but	 previous	 work	 has	 already	 demonstrated	 the	immunomodulatory	 and	 regenerative	 properties	 of	 MSCs	 are	 mediated	 through	 the	production	 of	 extracellular	 vesicles215,279.	 By	 examining	 the	 factors	 released	 by	 MSCs	cultured	in	our	model	we	could	begin	to	understand	the	mechanism	of	action.			
6.3 Conclusion	
BPD	 is	 a	multifactorial	 disease	 requiring	 the	 investigation	 of	many	 interacting	 factors	including	 oxygen	 exposure,	 mechanical	 stress,	 cell-cell	 interaction	 and	 cell-matrix	interaction.	While	 in	vivo	models	provide	an	 insight	 into	disease	mechanism,	 they	 lack	human	relevance	and	are	unable	to	recapitulate	the	alveoli	of	a	preterm	infant.	Current	in	
vitro	 lung	 research	 has	 focused	 on	 the	 conduction	 airway	 and	 there	 is	 a	 lack	 of	sophisticated	alveolus	models.	This	project	has	 successfully	developed	a	novel	 in	vitro	alveolus	model	capable	of	accommodating	multiple	cell	types	including	lung	fibroblasts	and	lung	epithelial	cells	in	a	3D	environment.	The	model	creates	an	air-liquid	interface	capable	of	 achieving	 clinically	 relevant	hyperoxygen	exposure	and	allows	 the	 study	of	cell-cell	and	cell-ECM	interactions	that	occur	in	vivo.	The	unique	inclusion	of	primary	cells	derived	from	BPD	infants	provides	a	disease	relevant	representation	of	cellular	behaviour	and	allows	the	assessment	of	prospective	treatment	options.			We	 have	 shown	 that	 hyperoxia	 has	 a	 detrimental	 effect	 on	 adult	 lung	 cells	 however	neonatal	lung	cells	may	possess	defence	mechanisms	which	alleviate	oxygen	stress.	The	
PhD	Thesis	by	J.	A.	J.	Bratt	 	 	Chapter	6:	Summative	discussion		
	 183	
co-culture	of	placenta	MSCs	with	adult	lung	cells	alleviated	oxygen	stress,	independent	of	membrane	 MSC	 source.	 These	 results	 support	 pre-clinical	 evidence	 of	 the	 promising	regenerative	potential	MSCs	possess	for	the	treatment	of	BPD.		
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Appendices	
Appendix	A:	Ethical	approval	for	the	use	of	tracheal	suctionings	and	nasal	scrapings	
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Appendix	B:	Letter	of	Access	
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Appendix	C:	Ethical	approval	for	the	use	of	placentas	for	cell	isolation	
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